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Abstract
The Bischler-Napieralski reaction has been used widely and for many years for the
preparation of isoquinoline derivatives. The reaction involves the cyclodehydration of
phenylethylamides. Chapter 2 describes the first example of asymmetric Bischler-
Napieralski reaction on chiral phenylethylamides. The cyclisation occurs in a highly
stereoselective manner to deliver 3,4-dihydroisoquinolines containing two at (C3 - C4)
contiguous stereogenic centres with a predominat trans geometry between substituents
at C(3) and C(4) (ratio between 20:1 and 9:1 depending on the substituents).
Fluorinated organic compounds are objects of studies in many areas such as organic
chemistry, biochemistry, medicinal chemistry and material sciences because of their
unusual chemical properties. The Fluorine atom is the most electronegative element in
the periodic table and this property can influence dramatically the chemical and physical
behaviour of the molecules. It is also well known that two consecutive fluorine atoms
prefer to assume a gauche conformation rather than an anti relationship.
Chapter 4 presents the synthesis of a new class of fluorinated compounds carrying
three fluorine atoms in vicinal positions and their properties with particular interest on
to the fluorine gauche effect. A new route in their synthesis has been established and
their use as new materials could be investigated.
In recent years, there has been an increasing demand for 'clean' and environmentally-
friendly chemical processes. Perfluorinated solvents satisfy these requirements because
they are non-toxic and biologically compatible.
Fluorous solvents are a class of perfluorinated and saturated aliphatic compounds like
perfluoroalkanes, perfluoroalkyl ethers and perfluoroalkylamines. The principal
characteristic of fluorinated solvents is the thermo-and pressure-controlled miscibility
with common organic solvents. Chapter 5 presents the synthesis of new fluorous


































5 'FDA: 5 ' -fluoro-5 ' -deoxyadenosine
FBC: fluorous biphasic catalysis
FBS: Fluorous Biphase System
FC-72: perfluorohexane
FdUMP: 5-fluoro-2'-deoxyuridine-5'-phosphate
FLC: Ferroelectric Fiquid Crystal
FPSG: Fluorous Phase Silica Gel
F-TEDA-BF4: selectfluor™
GC: gas chromatography
GCMS: Gas Chromatography-Mass Spectrometry
h: hour





FCD: Fiquid Crystal Display
M: molar
MAFDI Matrix Assisted Faser Desorption/Ionization








NMR {]H} : NMR proton decoupled
NMR {19F} : NMR fluorine decoupled
NMR: nuclear magnetic resonance
NOE: Nuclear Overhauser Effect
Nu" nucleophile







Rf : fluorous ponytail
RT: room temperature
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A Isoquinolines: Chemistry and reactivity
Part A
1.1 Introduction
Man has used natural products, albeit as crude plant extracts, since the early days.
Primitive men found the extracts were a good remedy for the relief of pain or alleviation
of the symptoms of diseases, as poisons for hunting or murdering, as narcotics,
hallucinogens or to reduce fatigue and hunger in life. Many of our modern drugs now
contain the same compounds or synthetic analogues and are typically used for the same
general purpose.
The study of natural products is now very much an interdisciplinary area, including the
chemistry biology interface. In vivo, chemical compounds are made and degraded by a
series of reactions, each facilitated by an enzyme. All organisms possess similar
metabolic pathways by which they synthesise chemical species considered vital for the
organism itself: sugars, amino acids, and fatty acids polymers. These compounds
essential for the survival of the cells are known as primary metabolites. The rest of the
chemical compounds, such as alkaloids, peptides, isoprenoids are usually surplus to




The majority of alkaloids occur in flowering plants although, in recent years, an
increasing numbers have been found in animals, insects and microrganisms. These are
secondary metabolites and their amine character produces an alkaline solution in water
hence they were originally termed the "vegetable alkalis". There is a wide variety of
structural types of alkaloids as shown in figure 1.1, which match a broad variety of
pharmacological effects.
Nicotine (1), the main alkaloid found in tobacco, is probably the most widely used
alkaloid by man, and its addictiveness has arguably caused the death of more people in
the world than any other compound.
Atropine (2) isolated from Atropa belladonna plants, is widely used in medicine for its
muscle relaxant properties. Thus, it is used as an antispasmotic agent, with one of its
effects being the dilation of the pupil by relaxation of the eye muscles. Cocaine (3),
which comes from the coca plant, has similar properties to atropine. At one time, it was
used as a local anaesthetic, however, now it is rarely used medically due to its toxic and
addictive effects.
Papaverine (4), with antispasmotic properties, and dimorphine (5) the most widely used
analgesic, are extracted from the opium poppy. One of the most widely used alkaloids
in therapy is quinine (6), isolated from the bark of the cinchona tree. It is used as an
antimalarial drug and at low concentrations is used to flavour tonic water.
2
 
1.3 Chemistry and Biosynthesis
If the 19th century represented the glory days for structural studies on the alkaloids, the
20th century has been notable for the large number of elegant total syntheses that have
been achieved. Many of these complex syntheses are biomimetic in character; where the
synthetic steps imitate Nature.
The first such example was the Robinson's synthesis of tropinol1 (7). At the beginning
of the 19th century the tropane ring (8) was a most challenging and attractive target. The
tropane alkaloids attracted enormous interest mainly due to the folklore surrounding
their potent activity. For example hyoscyamine (9) was used in the Middle Ages as a
hallucinogen while atropine (2), which is the racemate of hyoscyamine, was known for
its midriatic effect. During the Renaissance, fashionable ladies used the extract as drops
to dilate their pupils and to make themselves appear more attractive. Cocaine (3) was
well known for its local anaesthetic effect and as a stimulant of the CNS. (Figure 1.2).
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Willstatter's tortuous synthesis2 of tropine involved 20 steps and was the first synthesis
of the tropane ring system. It is also the first example of a total synthesis as it is viewed
today. Willstatter's early masterpiece was perhaps buried by the elegant approach of
Robinson's synthesis. Sir Robert Robinson published the synthesis of tropinone (8) in a
"one pot" process by addition of succinaldehyde (10) to an aqueous solution of
methylamine (11) and acetone (12) as shown in scheme 1.1. The yield improved to 45%
when acetone was replaced by the calcium salt of acetonedicarboxylic acid (13).
The mechanism of Robinson's synthesis shown in scheme 1.1 imitates to some extent
the biosynthesis of the tropane alkaloids.3"6 For example the intermediate (14) is
structurally related to intermediate (15) present on the biosynthetic pathway of the
tropane alkaloids. Robinson's preparation provided the inspiration for others to consider





















































Scheme 1.1. Mechanistic interpretation of Robinson's synthesis and the biosynthesis of
tropanone.
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The biosynthesis of the opium alkaloids has inspired numerous biomimetic syntheses.
Crude opium contains 25% by weight of alkaloids of which 10% is morphine (16). The
biosynthesis starts7'8 with a decarboxylation reaction on the amino acid tyrosine (17) to
produce tyramine (18). Condensation with 4-hydroxyphenylethanal (19) generates the
benzylisoquinoline alkaloid (5)- reticuline (21). (5)- Reticuline (21) is then epimerised
to the (R) isomer (22) prior to its conversion in salutaridine (23) by means of oxidative
phenolic coupling. After reduction to salutaridinol (24) the oxygen bridge is formed, by
a Sn2 reaction, to produce thebaine (25) which undergoes a demethylation reaction to
produce codeinone (26). After reduction of the ketone to give codeine (27), the
molecule undergoes another demethylation reaction to produce morphine (16).
Several syntheses were completed before this pathway was delineated. For example,
Spath and Burger9 prepared N-norlaudanosine (20) according to step (a) in the
biosynthesis (scheme 1.2). This condensation and subsequent ring-closure is an
example of the Pictet Spengler reaction,10 a process which has been widely used for
preparing this class of alkaloid. The oxidative biosynthetic phenol coupling reaction (b,
scheme 1.2) has inspired significant synthesis in the laboratory. For example, reticuline
(21) has been treated with Fe(III) complexes and although the yields were poor, the
product of the ortho/para coupling was obtained and used as an intermediate for the
total synthesis of morphine. More recently tandem biomimetic reactions have been
achieved. Tandem reactions combine several transformations in sequence to produce
fused ring structures. The biomimetic tandem reaction for the synthesis of
progesterone11 and carpanone,12' 13are early examples which have been followed by
14 15
























A benzene ring fuses to a pyridine ring to generate either a quinoline (28) or an
isoquinoline (29) (figure 1.3).
8 i 8 ì
28 29
Figure. 1.3. Numbering for quinoline and isoquinoline structures.
Isoquinoline (29) was first reported in 1885 by Hoogewerff and Van Dorp16 who
isolated a small amount from the quinoline fraction of coal tar by taking advantage of
the greater basicity of isoquinoline (pKa=5.1 vs 4.9 of quinoline). However the largest
number of isoquinoline compounds are found in plants as discussed in the previous
sections. Because of the importance of the isoquinoline alkaloids numerous synthetic
methods have been developed to generate the isoquinoline core. Many of them can be























The Bischler-Napieralski reaction (BNR),17 represented in figure 1.4, connects the
phenyl ring with C(l) of the resulting isoquinoline structure. It is indeed the most
valuable and frequently used method for the synthesis of isoquinoline compounds. The
reaction involves the cyclodehydration of an N-acyl derivative of (3-phenylethylamine
(30) to form a 3,4-dihydroisoquinoline (31). The reaction requires a Lewis acid and is









Figure 1.4. The Bischler-Napieralski reaction.
The condensation of (3-phenylethylamine with a carbonyl compound, usually an
aldehyde, in the presence of an acid generates 1,2,3,4-tertahydroisoquinoline (figure
1.5). This is the Pictet-Spengler reaction.10 The resultant bond is formed between the
phenyl ring and C(l) of the isoquinoline product, the same mode as illustrated for the
BNR. The reaction is carried out in concentrated hydrochloric acid and does not




Figure 1.5. The Pictet-Spengler cyclisation
During the biosynthesis of the tetrahydroisoquinoline alkaloids a similar enzymatic
reaction occurs although it is not acid catalysed. This process has been successfully
reproduced in the laboratory under physiological conditions. The reaction was
optimised at a pH between 4 and 10 yielding the desired 1,2,3,4-tetrahydroisoquinoline
in c.a. 83% yield. 18'19
The Pomeranz-Fritsch20'21 reaction is also included among the classical methods for the
preparation of the isoquinoline ring. Typically the cyclisation (figure 1.6) occurs in two
stages. Firstly an aromatic aldehyde (35) condenses with the acetal of
aminoacetaldehyde (36) to form the iminoacetal (37), which cyclises under acidic
condition to give the isoquinoline (38).
NH2CH2CH(OEt)2
o 36 H2SO4, A
Pomeranz-Fritsch -2EtOH
35 37
Figure. 1.6. The Pomeranz-Fritsch cyclisation.
An alternative method reported by Schlittler and Muller22 is available in the reaction of
benzylamine (39) with glyoxal semiacetal (40). Cyclisation of the product (41) obtained
with sulphuric acid gives the same isoquinoline achieved via the Pomeranz-Fritsch
cyclisation (figure 1.7). The reaction is useful when the desired isoquinoline posseses a
substituent in C(l). For example the synthesis of (43) does not progress under the
Pomeranz-Fritsch (yield 0.1%) due to the difficulty of reacting a ketone (42) with an
aminoacetal (36). The Schlittler -Muller alternative gives a modest 37% yield when

















Figure. 1.7. The Pomeranz-Fritsch and Schlittler-Muller cyclisations.
1.5 The Bischler-Napieralski reaction
The Bischler-Napieralski (BN) reaction is somewhat more attractive compared to the
other alternatives, as it employs easily accessible starting materials. Additionally, the
reaction affords 3,4-dihydroisoquinoline which can be potentially reduced to 1,2,3,4-
tetrahydroisoquinoline or oxidised to deliver a fully aromatised product.
Some of these transformations have been successfully applied to the synthesis of natural
products or pharmaceuticals. Mild dehydrogenation of 3,4-dihydroisoquinoline (46),
derived from amide (47) under BN conditions, with Pd, yields papaverine (4),9 one of
the constituents of the opium alkaloids; alternatively reduction of (46), with NaBHU,
gives a 1,2,3,4-tetrahydroisoquinoline (48) which is N-methylated under Eschweiler-
Clarke23 conditions to give the laudanosine24 (49) (scheme 1.3).
4
Scheme 1.3. Synthesis of some alkaloids via the Bischler-Napieralki reaction.
The reaction is carried out in a dry inert solvent, (eg. chloroform, benzene, toluene,
xylene, nitrobenzene, tetralin) and the choice depends on the reflux temperature
required for the reaction. The yield of the reaction has been improved when acetonitrile,
either at reflux25 or in a microwave oven,26 is used as solvent. Recently environmentally
friendly preparations of isoquinolines have been achieved at room temperature using
97
ionic liquids as alternative solvents.
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Phosphoryl chloride is the most popular dehydrating agent although phosphorous
pentoxide, solo or in combination with phosphoryl chloride28' 29 and phosphorous
pentachloride have been widely utilized.
1.5.1 Mechanism
For almost 80 years, the mechanism of the BN reaction was assumed to be as shown in
scheme 1.4. According to the scheme, traces of HC1 associated with phosphoryl
chloride mediate the protonation of the amide (30) to form the intermediate (50), which
cyclises to give a second intermediate, 1-hydroxy-tetrahydroisoquinoline (51). This
















Scheme 1.4. Original mechanistic hypothesis for the BN reaction
This mechanism was later invalidated by the work of Nagubandi and Fodor.2 '30 They
demonstrated that the amide (30) in the presence of Lewis acids such as POCI3 or
SOCI2, formed an imidoyl chloride (52) at room temperature without subsequent
cyclisation. Therefore dehydration must precede the ring closure. It was also observed
that the hydrochloride salt spontaneously lost F1C1 upon gentle heating in benzene to
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generate imidoyl chloride (53), which was purified, characterised and in some cases
crystallised. The imidoyl chloride (53) was then reacted with a variety of Lewis acids
(FeCl3, SnCU, ZnCU, POCI3) to give the final product of the Bischler-Napieralski
reaction as a salt (31). The Lewis acid converts the imidoyl chloride species (53) into a
nitrilium salt derivative (54) which is then attacked by the aromatic ring via an
electrophilic aromatic substitution, (scheme 1.5).
X=CI-, SbCls2',-OCOCF3, -0S02CF3
Scheme 1.5. The mechanism of the BN reaction by Nagubandi and Fodor.28'30
The new two steps protocol for the Bischler-Napieralki reaction gave excellent yields,
85-90 % vs 40-60% and above all, clarified the mechanism of the reaction.
Furthermore, the existence of a new intermediate (54) was demonstrated in the reaction
which was in some cases trapped as a stable crystalline salt31 of SbF6.~
As discussed above phosphorous pentoxide is employed alone or together with
phosphorous oxychloride for the BN reaction. In the first case, an imidoyl phosphate is
formed and in the latter, an imidoyl chloride is obtained, which explains the higher
yields obtained with a combination of 1:1. Of course the pyrophosphate group is a







The identification of a nitrilium ion as an intermediate in the BN reaction explains a
number of side reactions. For example cyclisation of (55) to form (56), does not take
place under the classical conditions of the BN reaction, the only products detectable are
stilbene (57) and the benzonitrile (58). (Scheme 1.6)
Scheme. 1.6. Side products of BN reaction
Nagubandi and Fodor rationalised28 this observation by assuming a "retro" Ritter
process, competing with the BNR. The Ritter reaction shown in scheme 1.7 allows
the synthesis of an amide (61) starting from alkene (59) and acetonitrile (60) in a
strongly acidic medium.
^>= + CH3CN HaS°4 >
59 60 ' 61
Scheme 1.7. A Ritter reaction
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The reaction proceeds through the same nitrilium ion (62) intermediate, postulated for
the BNR, which after hydrolysis yields amide (61). Therefore, compound (55) in
scheme 1.8, forms the corresponding nitrilium ion that loses the RCN fragment to
provide the stilbene (57) via a "retro" Ritter reaction rather than of the expected 3,4-
dihydroisoquinoline. The competitive reaction is probably enhanced due to the







Scheme 1.8. Competitive "retro" Ritter reaction
The competitive reaction can be avoided by conversion of amide (63) into the N-
acyliminium intermediate (64), with a mixture of oxalyl chloride and FeCls; removal33
of the oxalyl group in MeOH-E^SCU provides the desired 3,4-dihydroisoquinoline (65)







Scheme 1.9. Modified Bischler-Napieralski reaction for the synthesis of 3-Aryl-3,4-
dihydroisoquinoline
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The nitrilium ion is also responsible for another competitive reaction. It dissociates into
a carbonium ion, which reacts with the counter ion to yield the products of the Von
Braun degradation.34'35 For instance in the case of amide (63), the chloride ion displaces
benzylnitrile (58) to give a chlorinated Von Braun product (66). Scheme 1.10.
Scheme 1.10. Competitive Von Braun reaction
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1.5.2 Reduction of 3,4-dihydroisoquinoline
The BN reaction affords an imine (C=N) functionality which is amenable to reduction.
If the 3,4-dihydroisoquinoline is substituted on C(l), reduction generates a stereogenic
centre. An asymmetric process, as illustrated in figure 1.8, can be achieved via two
general routes:
a, reduction via an achiral reagent to give 1,2,3,4-tetrahydroisoquinoline followed by
conventional enantiomeric resolution techniques;
b, reduction using an asymmetric reducing reagent.
1. reduction then resolution
1. Asymmetric reduction
Figure 1.8. Asymmetric reduction of 3,4-dihydroisoquinolines
The imine functionality of the 3,4-dihydroisoquinoline, can readily be reduced by
various reagents: NaCNBH3, LÌAIH4, NaBHU and so on. Resultant racemates have been
resolved by crystallisation of diastereoisomeric salts, in which a substrate (usually a
racemic amine) is treated with one enantiomer of a chiral carboxylic acid. The
diastereoisomeric pairs are usually resolved via fractional crystallisation. This technique
$
has been extensively used in the resolution of CAPTIQ , a tertahydroisoquinoline used
for the asymmetric protonation of amides.36 38
CAPTIQ:( R )-l-(2-methylamino-5-chloro)-phenyl-l,2,3,4-tetrahydroisoquinoline.
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Asymmetric reduction of 3,4-dihydroisoquinoline has also been performed by using
chiral reducing agents that posses the ability to attack preferentially only one face of the
39imine functionality. Noyori and co-workers have developed chiral Ru(II) complexes
which catalyse the asymmetric reduction of the imine functionality with a mixture of
formic acid and triethylamine under mild condition as shown scheme 1.11. The
alkaloids salsolidine (67) and tetrahydro-P-carbolines40 have been prepared using this
methodology.
Asymmetric 1,2,3,4-tetrahydroisoquinolines, have also been prepared by achiral
reduction on an asymmetric substrate41. Chiral amide (68) undergoes BN cyclisation













Scheme 1.11. 1). Chiral reduction to salsolidine (67) in the presence of asymmetric Ru
(II) catalyst. 2). BN reaction on a chiral amide (68)
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The asymmetric BN reaction
2.1 Asymmetric synthesis of tetrahydroisoquinoline containing alkaloids
Several important asymmetric routes have been developed for the stereoselective
synthesis of tetrahydroisoquinoline alkaloids. The alkaloid salsolidine (67), for instance,
has been utilised as a convenient model for developing asymmetric methods to the
isoquinolines. For example, asymmetric hydrogenation of the 3,4-dihydroisoquinoline,
in the presence of a chiral ligand, has been already discussed section 1.2.3. Other
examples are found in the literature, eg. Yamato42, reported the synthesis of salsolidine
(67) via a chiral oxazolo [2,3-a]- tetrahydroisoquinoline (70) as shown in scheme 2.1.





Scheme 2.1. Asymmetric synthesis of alkyl and phenyl 1,2,3,4-tetrahydroisoquinolines
Chiral formamidines have also been used as chiral auxiliaries.43For example, (71) has
been used in the synthesis of alkaloids such as salsolidine (67) and homolaudanosine
(72) as shown in scheme 2.2. Treatment of (71) with rBuLi and Mel, gave only one
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stereoisomer. The alkaloids (67) and (72) were delivered by release of the formamidine







Scheme 2.2. The use of chiral formamidines affixed to tetrahydroisoquinolines to
generate an asymmetric C-C hond.
The first example of an asymmetric synthesis of 1,3-disubstituted
tetrahydroisoquinolines was reported as recently as 1996 by Husson.44 The
stereoselectivity was controlled by the appended phenylglycinol, and this was then
removed by hydrogenation to yield the 1,2,3,4-tetrahydroisoquinoline (73) with two










The same research group subsequently reported the first asymmetric synthesis of 1,4-
disubstituted tetrahydroisoquinolines based upon a Bischler-Napieralski reaction of (3-
substituted phenylethylamines.41 The Bischler-Napieralski reaction was conducted on
chiral amide (74) to generate the 3,4-dihydroisoquinoline, which was reduced in situ by
treatment with NaBkB to form (75). The stereogenic centre at C(4) controlled the
stereochemical course of the reduction. In the event, hydride approached C(l) to the
opposite face of C(4) as illustrated in scheme 2.4.




It was an objective to explore an asymmetric Bischler-Napieralski reaction using
substrate (76). The amide (76) has two diastereotopic aryl groups (3 to the
nitrogen, therefore cyclisation to one or other will generate diastereoisomeric products
(77 and 78). The latio of 77:78 is a measure of the stereoselectivity of the BN reaction.
Furthermore, asymmetric reduction of the 1,3,4-trisubsituted 3,4-dihydroisoquinolines
products, is anticipated to generate 1,2,3,4-tetrahydroisoquinoline carrying three
stereogenic centres at C(l), C(3) and C(4) (79-82). These reactions were also
investigated (scheme 2.5).
79 80 81 82






2.3 The asymmetric Bischler-Napieralski reaction
The availability of a series of (S)-l-alkyl-2,2-diphenylethylamine, including (83) and
(84) opened up an opportunity to explore the asymmetric BN reaction. These amines are
available in enantiomerically pure form from their corresponding amino acids (S)-
alanine and (5)-valine 45 as shown in scheme 2.6.
R Ph
\__L-Ph ... R Ph





Scheme 2.6. Reagents and conditions, (i). PhMgBr,Et20, 40-50%. (ii). Triphosgene,
Et3N, 80-90%, (iii). H2 Pd-C, 70%.
Amines (83) and (84), which are commercially available, were converted into their




The acetamides (85) and (86) were prepared in a straightforward manner23 by treatment
of amines (83) or (84) with acetyl chloride in presence of triethylamine (scheme 2.7).
R= Me 83
R=iPr 84 R=Me 85R=;Pr 86
Scheme 2.7. Reagents and conditions, (i and ii) AcCl, TEA, CH2CI2,12 h, RT, 94 % for
both amides (85) and (86).
2.3.2 Synthesis of benzamide (87)
Benzamide (87) was prepared by coupling benzoyl chloride and amine (84) in the
presence of triethylamine (TEA) as a base. The reaction provided the product as
crystalline material and in excellent yield (scheme 2.8).
Scheme 2.8. Reagents and conditions, (i) benzoylchloride, TEA, CH2CI2, 12 h, RT, 94
%
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2.3.3 Preparation 3,4-dihydroisoquinoline (88) and (89) via the asymmetric BN
reaction
Amide (85) was treated with a mixture of POCI3-P2O5 (10 eq: lOeq) under classical
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Bischler-Napieralski conditions in dry toluene. This generated the 3,4-
dihydroisoquinoline as a diastereomeric mixture (88) and (89). Scheme 2.9 shows
clearly the two possible modes of cyclisations. Cyclisation involving the red phenyl
group, represented in the image of intermediate (90), leads to the formation of (88). On
the other hand reaction involving the blue phenyl group gives the diasteromeric product
(89).
90
Scheme 2.9. Reagents and conditions, (i) POCI3, P2O5, toluene at reflux 12 h, 29%.
'ti NMR of the crude reaction product indicated the presence of two diastereoisomers
(88) and (89) by two sets of signals for the protons at C(4) and methyl group at C(l), as
shown in the spectrum in figure 2.1. It was clear that the two 3,4- dihydroisoquinoline
(88 and 89) were generated in the ratio of 9:1. The coupling constants between the
protons at C(3) and C(4) were measured. The major diasteroisomer had the larger
vicinal H(3)-H(4) coupling constant (11.0 Hz) and was assigned structure (88). The
minor isomer had a smaller vicinal coupling constant (6.0 Hz) consistent with structure
(89). Therefore it was deduced that the preferred reaction route was cyclisation to the
red phenyl group which led to the formation of the 3,4-dihydroisoquinolines with Me at
C(3) and Ph at C(4) trans to each other.
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Figure 2.1. ]H NMR of,the BN reaction mixture product performed on amide (85).
2.3.4 Preparation of 3,4-dihydroisoquinoline (91) and (92)
Amide (86) was also treated under Bischler-Napieralski conditions as shown in scheme
2.10. This generated a mixture of two diastereoisomers, which were again analysed by
'if NMR spectroscopy.
Scheme 2.10. Reagents and conditions, (i) POCI3, P2O5, toluene at reflux 12 h, 60%.
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From this analysis it was deduced that the product ratio was 21:1 figure 2.2. The major
diastereoisomer was assigned structure 91 based on the value of H (3) H (4) coupling
constant (9.7 Hz). The minor isomer had a smaller value (5.6 Hz) consistent with
structure 92. Recrystallisation of the reaction mixture from petrol and acetone afforded




Figure 2.2. !H NMR of the BN reaction product performed on amide (86)
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The X-ray derived structure of (91) in Figure 2.3 confirmed the absolute
stereochemistry at C(3) and C(4) as 3S and 4S. This trans relative configuration for the
major diastereoisomer is consistent with the larger coupling constant observed by 'H
NMR.
Figure 2.3. Ball and stick drawing of the molecular structure of 91 in the solid state
showing the trans relative configuration between substituents at C(3) and C(4).
2.3.5 Preparation of 3,4-dihydroisoquinoline (93) and (94)
Treatment of amide (87) with P2O5 and POCI3 again gave a mixture of two
diastereoisomers as Bischler-Napieralski products (scheme 2.11). 'H NMR analysis of
the crude reaction product, revealed a diastereomeric ratio of 13:1 as shown in figure
2.4. The coupling constants for the two diastereoisomers were also very different (major
8.7 Hz vs minor 5.3 Hz and the major was assigned structure (93) consistent with a
transoid relationship between the hydrogens in C(3) and C(4).
Scheme 2.11. Reagents and conditions, (i) POCI3, P2O5, toluene at reflux 12 h, 32%.
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8.0 7.3 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.3 3.0 2.5 2.0 1.3 1.0 0.5
Figure 2.4. *H NMR of the BN reaction product with diasteroisomers (93 and 94)
Recrystallisation from petrol-ethyl acetate provided crystals of (93) suitable for X-Ray
analysis. Inspection of the X-ray crystal structure (figure 2.5) clearly showed the trans
diaxial relation between PR and H4 reinforcing the assumption made from the 'H NMR
coupling constants values.
Figure 2.5. Ball and stick drawing of the molecular structure of 93 in the solid state
showing the trans relative configuration between substituents at C(3) and C(4).
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2.4 Bischler-Napieralski reactions on a (3-fluoroamide
There is a desire to develop synthetic methods for the preparation of fluorine containing
analogues of amino acids, nucleosides, and sugars. Such building blocks contribute to
the arsenal of molecules available for the synthesis of fluorinated drugs and agricultural
chemicals.
Recently our research group reported the synthesis of a series of fluorine containing
chiral amines. For example, the chiral amine (95), shown in scheme 2.12, was a




















Scheme 2.12. Reagents and conditions, (i). PhMgBr, Et20, 40-50%. (ii). triphosgene,
Et3N, 80-90%, (iii) HF-pyridine, 77% 45
2.4.1 p-Fluoroacetamide (96)
The synthesis of the fluorinated acetamide (96) follows the general method of amide
preparation discussed in the previous section. Therefore, acetyl chloride was added to a




Scheme 2.13. Reagents and conditions, (i). AcCl, TEA, 12 h, 97%.
2.4.2 Attempted synthesis of 4-fluoro-3,4-dihydro-isoquinoline (97).
Following the previous BN preparations, amide (96) was treated with P2O5 and POCI3
in anhydrous toluene. The reaction mixture was stirred at room temperature and aliquots
were taken every 5 min. Each aliquot was then analysed by 19F NMR to monitor the
progress of the reaction (figure 2.6). 19F NMR of the first aliquot showed a doublet at -
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Figure 2.6. 19F NMR spectra of the crude reaction mixture of a BN reaction with (96)
taken (a) after 5 min, (b) 10 min and (c) 30 min.
After 10 minutes the spectrum showed the presence of two new 19F NMR peaks; a
singlet at -160 ppm and a doublet at -10 ppm (J=l 190 Hz), which was clearly due to P-
F coupling. A third aliquot was taken at 30 minutes and the spectrum showed only the
presence of the peak at -10 ppm. The anticipated 4-fluoro-l,3-dimethyl-4-phenyl-3,4-
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dihydroisoquinoline (97) was not detected. Instead the major product was the fully
aromatised isoquinoline (98) which was identified in the product mixture. The
formation of (98) suggested the reaction course shown in (scheme 2.14). After 10 min
all of the organic fluorine was converted to a new entity, which appeared as a singlet at
-160 ppm in the 19F NMR. This is consistent with structure (99) or isomeric product of
(99).46Additionally a P-F intermediate was clearly detectable (doublet J=1190 Hz), most
likely attributable to a structure (100), derived from fluoride elimination and addition to
phosporus to generate amide (101). In fact (101) instantly cyclises to form the fully
aromatised structure (98). The presence of P-F species in the reaction mixture is
consistent with previous reports that HF in the presence of phosphorous pentoxide can
generate fluorophosporic acids and anhydrides.47 Perhaps this is structure (100),
although the literature chemical shift values ranges between -30 ppm for
48




Scheme 2.14. Proposed mechanism for the Bischler-Napieralski reaction on substrate
(96)
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2.5 Asymmetric reduction of the Bischler-Napieralski products
The BN reaction generated a series of novel 3,4-dihydroisoquinoline products. With the
3,4-dihydroisoquinoline products in hand, their reduction with LÌAIH4 was explored to
assess stereospecificity in the formation of 1,2,3,4- tetrahydroisoquinoline products. In
this study the reduction of substrates 91 and 92 and 93 and 94 with LÌAIH449 in diethyl
ether or THF was explored.
2.5.1 Synthesis 1,2,3,4-tetrahydroisoquinoline (102) and (103)
The 3,4-dihydroisoquinolines (91 and 92), which were prepared as 21:1
diastereoisomeric mixtures, were treated with LÌAIH4 In the event the reduced product
had formed in a similar diastereomeric ratio of (20:1) scheme 2.15, consistent with





Scheme 2.15. Reagents and conditions, (i) LÌAIH4, reflux, 69%.
This outcome suggested that the reduction was highly stereoselective and generated
products with a trans C(l)-C(3) relative stereochemistry. The major stereoisomer in this
reaction was assigned to structure (102). It retained the larger coupling constant
between H3 and H4 (J=7.1 Hz) relative to that of J=2.4 Hz for the minor product. A 'H
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NMR difference NOE analysis was also carried out to establish the relative
stereochemistry at C(l). In particular, there was a strong perturbation at H(3) when the
C(l) methyl hydrogen signal was irradiated and vice versa. There was also a strong and
reciprocated NOE response between H(l) and H(4) indicating that these hydrogens are
on the same face of the ring system in accordance with structure (103).
2.5.2 Synthesis 1,2,3,4-tetrahydroisoquinolines (104), (105) and (106)
The stereoselective reduction of (93) and (94) with LÌAIH4 was observably solvent
dependant (scheme 2.16). When the reaction was carried out in ether at reflux the
products (104) and (105) where formed in a 9:1 ratio. Their structures were assigned by









Scheme 2.16. Reagents and conditions, (i) LÌAIH4, ether or THF at reflux 24 h, 65%
(THF) or 67% (ether).
It is not clear why this ratio had changed from that found in the staring material (13:1).
It is possible that an isomerisation at C(3) has occurred, prior to hydride reduction and
thus isomer (105), which is the mirror image of 106, emerged as a minor component in
the product mixture. This isomer is clearly not resolvable from its enantiomer 105 by 'H
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NMR (figure 2.7 a) and therefore the change in bias from 13:1 to 9:1, may reflect the
formation of 106 as a minor component.
When the reduction was carried out in THF under reflux, then a new diastereoisomer
was observed by !H NMR (figure 2.7 b) as a significant product in addition to (104-
106).
i ■ ■ 1 ■ i ■ ' ' ■ i ' ' 1 ■ i ' ' ' ' i ' ' '' i ' ' 1 1 i 1 1 1 1 i 1 1 1 i i ' 1 i 1
Figure 2.7 a and b. (a) 'H NMR of reaction mixture after LÌAIH4 reduction in ether, (b)
'id NMR of reaction mixture after LÌAIH4 reduction in THF. Please note the signals
refers to HI H4 and H3 from left to right.
This new isomer was assigned structure (107) on basis of a Jh3-h4 coupling constant of
10. 6 Hz and *H NMR NOE difference analysis. The structure represents hydride
delivery to the Si face of imine (92). The stereochemical outcome of these reactions in
ether indicates that hydride exclusively attacks the Re face of both imines (92) and (93)
in a pseudoequatorial fashion, suggesting that the stereochemical course of the
reduction is controlled by the substituent in C(4). Lithium co-ordinates to the nitrogen
in anti manner to the C(3) isopropyl group covering the lower Re face of the imine.
Therefore, hydride is more easily presented the top (Re) face of the imine. Perhaps in
THF, lithium is sequestered by the solvent, promoting an increased accessibility of the
hydride to the Si face of (93) and thus (106) emerges as significant product. (Figure
2.8)
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R = Me, iPr
Figure 2.8. Pseudoaxial or pseudoequatorial hydride attacks on C(l) atoms of (92-93)
Similar results41'51 have been obtained with NaBHU in place of LÌAIH4 Julian et al.
have shown that NaBH* reduction at C(l) of 4-substituted 3,4 dihydroisoquinolines
(108,) gave (109) with a 90% diastereomeric excess in favour of the isomer carrying the
1, 4 substituents cis to each other, scheme 2.13. Also Vecchietti et al. demonstrated a
similar stereochemical course for the transformation of 110 to 111, although in this case









Scheme 2.17. Stereoselective reduction of 4 substituted 3,4-dihydroisoquinolines.
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2.6 Summary of Chapter 2
In summary, amides of the amines 83-84 and 95 have been prepared to explore the
asymmetric Bischler-Napieralski reaction. The cyclisation of 85-87 occurred in highly
stereoselective manner to deliver 3,4-dihydroisoquinoline (88-89 and 91-94) (80-91%
diastereomeric excess) in favour of the isomers carrying the substituents at C(3) and
C(4) in trans relationship. The stereochemistry was deduced from the H3-H4 coupling
constants in !H NMR. Additionally recrystallisation of the major diastereoisomer 91
and 93 gave crystals suitable for X-ray analysis which confirmed the stereochemistry
deduced by 'H NMR.
The amide (96) carrying a fluorine atom in (3 to the nitrogen was also used as substrate
for studying the BN reaction. The cyclisation occurred to deliver the fully aromatised
isoquinoline (98) instead of the anticipated 3,4-dihydroisoquinoline (97). However 19F
NMR analysis of the intermediates of the reaction suggested the existence of an imidoyl
pyrophosphate (99) intermediate, which undergoes rearrangements to produce an a,(3
amide (101). This intermediate cyclises to form the aromatised product.
Reduction of the 3,4-dihydroisoquinolines (91-94) BN products, was also investigated.
Reduction by LÌAIH4 at C(l), was completely stereoselective yielding 1,2,3,4-
tetrahydroisoquinolines with a trans geometry between the substituent at C(l) and C(3)
and a cis geometry between C(l) and C(4).
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Fluorine in organic chemistry
Part A
3.1 Introduction
Fluorine from the Latin and French words for flow, fluere, is the most reactive and
electronegative of all the elements. It forms compounds with most other elements,
including the noble gases xenon and radon and for this reason, fluorine does not occur free
in nature and proved extremely difficult to isolate.
Fluorine occurs principally as fluorospar (CaF2) and cryolite (Na2AlFe), (figure 3.1) but it
is rather widely distributed in other minerals.
Figure 3.1. Fluorospar or fluorite (CaF2),on the left and cryolite (Na2AlF6), on the right.
The first recorded use of a fluorine compound dates to around 1529 when Georigius
Agricola used fluorospar as a flux in metallurgical processes. It was only in 1886, when
Ferdinand Frederic Henri Moissan, a French chemist, isolated elemental fluorine as a gas
(F2). He accomplished this by the electrolysis of potassium fluoride (KF) and hydrofluoric
acid (HF)1. Today, fluorine gas, is still produced by this process as well as by the
electrolysis of molten potassium hydrogen fluoride (KHF2).
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Fluorine forms the strongest covalent bond to carbon and fluorocarbon compounds are
generally stable. Several fluorocarbon compounds are widely used in everyday products.
Freon (CF2CI2) was used universally in home refrigerators and automobile air conditioning
systems until their damaging impact on the ozone layer was established. These products
have been replaced by hydrofluorocarbons (CHF).
Poly tetrafluoroethylene or Teflon™, is another well known and globally utilised
fluorocarbon polymer having the repeat structure of (CF2CF2)n.
3.2 Chemical and physical properties of Fluorine
3.2.1 Electronic effects
The electronic properties of the fluorine atom relative to hydrogen and chlorine are
represented in Table 3.1.
H F CI
Electronic configuration Is1 -2sJ2p5 ~3ss3p53d°
Electronegativity (Pauling) 2.1 4.0 3.0
lonisation energy (kcal/g atom)" 315.0 403.3 300.3
Electron affinity (kcal/g atom)6 17.8 83.5 87.3
Bond energies of C-X (kcal/mole)c 99.5 116 -V78
Bond lengths of C-X (A)d 1.091 1.317 1.766
Preference as a leaving group H* F~ cr
»X*+e' X.
bX + e" — X".
cFor CX4.
dCovalent radii in CX4.
2Table 3.1 . Electronic properties of fluorine
The large ionisation energy of fluorine renders the fluoronium ion (F+) very high in energy
and it is very rare. On the other hand the high electron affinity of fluorine makes F" stable
and in organic chemistry is a good leaving group, particularly in elimination reactions.
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3.2.2 Fluorine's ability to stabilize charge
Fluorine is the most electronegative element in the periodic table (4.0 in the Pauling scale)
and as consequence, when covalently bonded to another atom the bond becomes polarised.
For example the C-F bond is the strongest and shortest C-X bond due to a significant ionic
character, and the bond can be represented to some extent as C+ F. This explains the
resistance of the C-F bond, towards nucleophilic substitution. The strong inductive effect of
fluorine (-1) can stabilise carbanions (3 to the fluorine atom (a) figure 3.2. Also the large











Figure 3.2. Inductive and mesomeric effects of fluorine in C-F bond.
By contrast fluorine destabilises a carbanions by n-7t repulsion (b) figure 3.2. However
fluorine stabilises a carbocations by a n-7t conjugation (c).
In summary, fluorine is always electron withdrawing by the inductive effect and electron
donating by the mesomeric or resonance effect.
When fluorine is succesively substituted for hydrogen in mono-, di- and trifluoroacetic acid






Table 3.2. Apka of mono di-tri fluorinated acetic acids relative to the parent compounds
from Schlosser7
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The acidity increases regularly as the number of fluorine atoms are substituted at the a C.
The strong mesomeric effect is predictable from the ar Hammett value of -0.348 for
fluorine. Consequently it is an ortho-para director in the electrophilic aromatic substitution
which is consistent with the ability of fluorine to donate electrons by the mesomeric effect
(+R).
Although there are still little controversies about the ability of fluorine to act as hydrogen
bond acceptor, theoretical calculations estimate9 the strength of a, F H-X bond to be
between 2 to 3.2 kcal mol,'1 compared to 5-10 kcal mol -1 of a O H-X hydrogen bond.10
This difference in strength reflects the lower polarisability of fluorine over oxygen.
Interestingly, it has been found that the C(sp3)-F H interaction is stronger then C(sp2)-
F H. For example the interaction between water and fluoromethane (112) gave a
stabilisation energy of -2.38 kcalmol'and an equilibrium distance of 1.9 À whereas a value







2.38 kcalmol"1 1.48 kcalmol"1
112 113
Figure 3.3. Calculated strengths of hydrogen bond for fluoromethane and fluoroethene in
water
Organic bound fluorine can coordinate metals. Such interactions have been detected by 19F
NMR. For example, fluorinated crown ether derivative (114 and 115)12 shown in figure 3.4
form 1:1 complexes with alkaline earth metals, and a remarkable chemical shift change was
observed, in the !9F NMR when sodium or barium was added. The barium complex was
crystallised and showed a clean interaction between Ba2+ and the fluorine atom, with a






Figure 3.4. Fluorine containing crown ethers
The ability of organic fluorine to participate in C-F "M interaction has been exploited in
1 o
chiral enolate chemistry. It has been demonstrated, that enolates of the type (116) shown
in figure 3.5, react with various electrophiles to the Re face. The high stereoselectivity
(90% de) (117) was attributed to chelation of the lithium with the a-oxygen and the
fluorine atom as illustrated in enolate (118).







Li+ up to 90% de
118
Figure 3.5. Reaction involving chelation of lithium to fluorine
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3.2.3 The steric influence of fluorine
Fluorine is the smallest substituent after hydrogen in the periodic table as measured by
covalent radius.14 The Van der Waals radii shown in table 3.3 suggest that fluorine has a
closer isosteric relationship to oxygen rather than hydrogen.






Table 3.3. Van der waals radii in À
Despite the larger Van der Waals radius of fluorine over hydrogen, substitution of fluorine
for hydrogen generally produces only a minimum steric perturbation. For example
monofluorinated analogues of biological substrates often follow the metabolic pathway of
their parent compound. The enzymes are deceived by the substitution and cannot make a
steric distinction between H and F. For example, very little distortion was observed in the
two-dimensional packing of 2-fluorostearic acid (119) on a graphite surface compared to
the unsubstituted acid (120)15(figure 3.6). This study reinforced the similarity in size
between fluorine and hydrogen.
Figure 3.6. Fluorostearic and stearic acids
The replacement of a methylene (CH2) group, for a difluoromethylene (CF2) group is much
less compatible. For example, the stability of monolayers on water of the corresponding
12,12-difluoro stearic acid (121) was investigated by Langmuir pressure/area isotherms.16
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The analysis indicated that the monolayer of the difluoromethyl stearic acid, was unstable
and vulnerable to collapse and reorganisation, indicative of significant conformational
disorder as shown in figure 3.7.
The origin of these anomalies in the 12-difluoro series can be related to the differences
between the C-CH2-C and C-CF2-C bond angles. Crystallographic17 and theoretical
evidence18'19 support a widening of the C-CF2-C angle from the classical 109.5 0 to 115-
119.° Therefore the extended zig-zag conformation is favoured in a long chain hydrocarbon
(120) or (122) since the gauche conformation brings the 1 and 4 hydrogens into close
contact. On the other hand, the gauche conformations is energetically more favoured for the
12,12-difluoro substituted chain (121), as the 1,4 hydrogen interactions are now minimised
by the angle widening.
Figure 3.7. Schematic representation of selectively fluorinated stearic acids on the surface
of water
A comparison of the molar volumes* of the trifluoromethyl group with various substituents
indicates that the CF3 is comparable to an isopropyl group l2' 14rather then a methyl group.
*
The van der Waals volume is defined as the volume that is impenetrable to thermal
collision.
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Similar results were obtained by comparison of the van der Walls hemispheres.
Interestingly, the trifluoromethyl group was found to be almost three times larger than the
methyl group.12
3.2.4 Stereolectronic effects
The reactivity of most organic molecules depends upon stereoelectronic effects.
The concerted displacement of a leaving group by a nucleophile in aliphatic (SN2 reaction)
substitution reactions was one of the first reactions recognised to take place with
transition state, resulting in an inversion of configuration. The nucleophile (Y ) must
approach the substrate from a 180° angle opposite to the leaving group (X) as shown in
figure 3.8. The stereochemistry of the resulting transition state is governed by the transition
state (123) where the central carbon, can be considered to be sp hybridised carbon. The
remaining p-orbital, not hybridised, has one lobe overlapping the nucleophile and the other
overlapping the leaving group (124). Therefore the mechanism of this reaction is controlled
by electronic effects which impose a specific stereochemistry at the transition state level.










Figure 3.8. Stereoelectronic effects in Sn2 reactions.
** The van der Waals radius is the distance at which the repulsion between two atoms just
balances the attraction forces between the two atoms
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3.2.4.1 Gauche effect
The most widely described stereoelectronic effect associated with organic fluorine
compounds is perhaps the gauche effect. The gauche effect was originally described by
Wolfe and acknowledges the tendency for a molecule to assume a gauche conformation
21between adjacent electron pairs and/or polar bonds .
For butane there are five possible conformers (A, B, C, D, E) at energy maxima or minima,
which are represented by the Newman projections in figure 3.9. The fully staggered
conformation or anti, trans, (D) is the lower in energy than the two staggered anticlinal
conformers (B, E). The energy barrier between is about 0.9 kcal mol"1 The three potential
energy maxima correspond to the eclipsed conformers with the highest the fully eclipsed or
syn-periplanar (A) conformers. The methyl-methyl eclipsed (A) conformer is about 6.0
kcal mol"1 higher in energy than the anti conformation (D).
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A Eclipsed B Gauche C Eclipsed
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Degrees of Rotation 0
Figure 3.9. Rotational energy diagram for butane showing maximum and minum
conformers.
These conformational preferences are fully understood in terms of steric repulsion between
bonding orbitals. Therefore these repulsive interactions are largest in the eclipsed and
minimised for the staggered conformations. At energies up to about 30 kcal mol,"1 enough
energy is present to surpass the energetic barriers between the different conformers.
The gauche effect recognises that there are some cases in which the gauche conformer is
lower in energy than the ariti conformer. For example in certain 1,2-diheterosubstituted
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ethanes, where the C-H or C-F bonds are replaced with more electronegative atoms X and
Y, the population of gauche conformers was found to be larger than the ariti. This
preference is contra intuitive since the dipole repulsion and steric effects are anticipated to
favour the anti conformers. For example theoretical and experimental evidence
demonstrates that 1,2-dimethoxyethane22 (125) and 1,2 dicyanoethane23 (126) in figure






Figure 3.10. Gauche and anti conformers for 1,2-di substituted ethanes
An established example of the gauche effect is the relationship between the rotamers of 1,2-
difluorobutane (125) where the gauche conformer has an energy 0.5-1 kcal mol" , lower
than the anti conformer.24'25
Theoretical and experimental calculations, using 19F NMR and *H NMR spectroscopy have
demonstrated that the fluorine gauche effect influences the relative energies of
conformations of both (±)-erythro (125a) and (±)-?/ireo-2,3-difluorobutane (125b).26 The
two staggered (±) erythro conformers (125a' and 125a") were very similar in energy
suggesting that the instability derived by bringing the two methyl group gauche to each
other is compensated for the energy gained by having the two fluorine atoms also gauche.
For the (±)-threo isomers, the most stable conformer (125b') had the two methyl groups























methyl groups in anti
fluorines in gauche
Figure 3.11. The fluorine gauche effect in 2,3-difluorobutane
The influence of the fluorine gauche effect has been investigated also on the long chain
fatty acids (±)-erythro and (±)-threo-9,10-difluorostearic acids27 (126 and 127) as shown in
figure 3.12. The extended zig-zag conformation for the (±)-erythro isomers (126a) has the
alkyl groups and the two fluorine atoms anti to each other. Thus, the system does not
benefit from the fluorine gauche effect. On the other hand, the (±)-threo isomer (127a) has
the fluorine atoms gauche and the two alkyl chains (R' and R") anti to each other and
therefore is the most energetically favoured conformer. There is a large difference in
melting points between the two series (erythro= 67-69 °C against 86-88 0 C for the threo)




















Figure 3.12. Staggered rotamers of (±)-erythro and threo-9,10- difluorostearic acids
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In order to explore the conformational stability in these systems further, each of the isomers
(126) and (127) was deposited on water in a Langmuir trough (figure 3.13). The
hydrophilic head groups oriented towards the water subphase and the hydrophobic fatty
acid chains towards the air. When a few molecules are spread on the water surface they
diffuse freely and do not interact with each other (see I). However as the barriers are moved
together, reducing the area, there is a transition at which the pressure suddenly starts to
increase as the molecules touch each other (II).
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Figure3.13. Representation of Langmuir trough (from
http://www.inapg.inra.fr/ens_rech/siab/asteq/elba/lb_tech.htm), and Langmuir isotherm for
threo a and erythro b (from ref. 31).
The shape of the Langmuir isotherm, for the (±)-e/*y//?ro-9,l O-difluorostearic acids (a) is
extremely expanded indicating a significant level of conformation disorder. On the other
hand, the isotherm (b) for the threo isomer is similar to stearic acid suggesting that the
molecules are conformationally more ordered {zig-zag). In conformer (127) the fluorine
gauche effect reinforces the classical anti zig-zag conformation, stabilising this system
relative to (126).
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3.2.4.2 The fluorine amide gauche effect
In 1965 theoretical calculations predicted the gauche conformation of N-acetyl-(3-
fluoroethylamide28 (128) to be 1.8 kcal mol"1 lower in energy than the anti conformation.
This difference was initially attributed to dipolar relaxation between the C=0 and C-F
bonds. However more recently it has been shown that the C-N bond of an amide is
29 30








Figure 3.14. The fluorine amide gauche effect
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3.2.4.3 Explanation of the gauche effect
There are currently two accepted and perhaps reinforcing explanations to account for
gauche effect: These have been attributed to bent bonds theory and o-hyperconjugation
theory.
3.2.4.3.1 Bent bonds theory
The bonds in organic compounds are usually taken as a linear path between the two atomic
nuclei. However experimental X- ray data indicated that in most cases the bond path is not
collinear with a line between the atoms. The most commonly recognised bent bonds are
those found in small ring compounds, such as cyclopropane (129) (figure 3.15) and
cyclobutane derivatives. Theoretical calculations have shown that the electron density in
cyclopropanes is directed away from the ring31' 32 as illustrated in figure 3.15. For
cyclopropane the 8 angle is 21,° and the bonds have an intermediate character between ct
and 7t, and cyclopropanes behave in some respects like double-bonded compounds.32 Bent
bonds are also found in small linear molecules. For example, theoretical calculations have
demonstrated that the bond path in methylfluoride (112) can be represented (exaggerated)




Figure 3.15. Bent bonds in cyclopropane (129)
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Theoretical calculations34 of the bond paths in 1,2-difluoroethane (130) indicated a certain
angular deviations (cci and (*2) from the conventional linear bond path as shown in figure
3.16. This goes some way to explain the fluorine gauche effect. In the case of the anti
conformer (130a) the two C-F bonds are bent in opposite directions, whereas in the gauche









Figure 3.16. Bent bond rationale for the gauche preference in 1,2-difluoroethane
Another case in which these considerations may apply is in 1,2-difluoroethene where the
cis (131a) isomer is more stable than the trans35 (131b) by 1 kcal mol."1
Charge density difference maps were used to explore this and they confirmed a greater
overlap of the orbitals in the cis isomer than the trans isomer. Figure 3.17 shows that in the
case of the cis, there is a clear "bent" bond between the fluorine bound carbons promoting








Figure 3.17. Difference between the charge density maps for trans 1,2 difluoroethene (left
side) (131a) and for cis 1,2-difluoroethene (right side) (131b). 35
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3.2.4.3.2 a-Hyperconjugation
The anomeric effect20' 36refers to the tendency of an alkoxy group at C(l) of a pyranose ring
(132) to assume an axial rather than an equatorial orientation despite unfavourable steric
interactions. The molecular orbital explanation suggests an n-a* overlap between a filled
37
non bonding electron pair on oxygen and the vacant a* orbital of C-0 bond' . This





Figure 3.18. The anomeric effect.
The gauche effect has also been explained by o-hyperconjugation, a stabilising interaction
arising from the overlap of an occupied a orbital with an adjacent unoccupied a* orbital.38
(figure 3.19).
F
Figure 3.19. Representation of a hyperconjugation
The hyperconjugative electron donation into C-F a* plays a dominant role in stabilising
conformations of 2-substituted-l-fluoroethanes. For example, the C-F bonds in 1,2
difluoroethane (130) are much weaker donors than the C-H bonds. Therefore the C(2)-H a
bond donates more strongly than the C(2)-F o* C(l)-F.
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In the gauche conformer (130b) the C(2)-H posses the correct geometry (antiperiplanar) in
respect of the a* C-F, whereas in the anti conformer (130a) only the C(l)-F a bonds can
act as electron donors39 (figure 3.20). Hence, the gauche unlike the anti conformer of 1,2-














Figure 3.20. a-Hyperconjugation for 1,2-difluoroethane (130)
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Part B
3.3 Preparation of Organo-fluorine compounds
3.3.1 Introduction
There is a wide distribution of fluoride in nature and it is estimated that, among the
elements, fluorine is the thirteenth in abundance. However, natural organo-fluorine
compounds are very rare because much of the fluorine exists in an insoluble form which is
biologically unavailable. The first organo-fluorine natural product to be identified, the
extremely toxic compound fluoroacetate (133), was isolated in 1943 from the Southern
African plant, Dichapetalum cymosum. 40
The synthesis of organo-fluorine compounds commenced between the 19th and the first
decades of the 20th century after the pioneering work of the Belgian chemist Frederic
Swarts. He prepared a range of aliphatic organo-fluorine compounds using the reaction40
between alkyl chlorides and SbF3 and it was on this foundation that Midgley and Henne41 in
1930 were able to apply fluoromethanes and ethanes as refrigerants.
Since then, the number of methods and compounds has increased dramatically and today
we are surrounded by organic fluorine compounds as refrigerants, thermally resistant
surface coatings, liquid crystals, agrochemicals, and pharmaceutical products.
The metabolites, fluoroacetate (133) and 4-fluorothreonine (134) are produced by the
bacterium Streptomyces cattleya, and the carbon-fluorine bond formation that occurs in the
micro organism was recently found to be catalysed by afluorinase enzyme. 42 The enzyme
catalyses the reaction of fluoride ion and S-adenosyl-L-methionine (SAM) to produce into
5'-fluoro-5'-deoxyadenosine (5'FDA). After a number of undefined steps, 5'FDA is
converted to fluoroacetaldehyde (135), which is the common precursor to both 4-





Scheme 3.1. The fluorinase in S. cattleya converts SAM to 5'FDA
The possibility of producing complex organic compounds containing fluorine by using this
enzyme is still a long way off and the preparation of organo-fluorine compounds is still
dominated by chemical methods.
The ultimate source of fluorine is CaF2 (fluorspar) from which anhydrous hydrogen
fluoride can be made by distilling it from a mixture of the mineral and concentrated
sulphuric acid. Hydrogen fluoride can be used directly as a reagent for the synthesis of
organic-fluorine compounds or can be converted into elemental fluorine or metallic









metal fluorides transition metal
complexes
Scheme 3.2. Sources of fluorine and fluorinating reagents
3.3.2 Fluorinating reagents43
3.3.2.1 Direct fluorination using elemental F2
Elemental fluorine is a diatomic molecule existing as a pale yellow gas. It is produced by
the electrolysis of solutions of KF in anhydrous HF, as originally demonstrated by Moissan.
Fluorine readily reacts with almost all organic and inorganic materials. The transformation
of a carbon-hydrogen to a carbon-fluorine bond using fluorine is a very exothermic
process43 (AH = -99 kcal mol-1) and there has been much discussion in the literature
concerning whether the mechanism follows a free radical44 or an electrophilic pathway45
(scheme 3.3). Experimental results seems to confirm the latter.46
Because of the heat evolved during such reactions, elemental fluorine is generally diluted in

























Scheme 3.3. Radical or electrophilic process involved in the fluorination of methane using
F2
3.3.2.2 Fluorination using transition metal fluorides
Fluorination with metal fluorides involves a change of higher valence metal fluorides to
lower valence species where the metal acts as a fluorine carrier. The reaction mediates the






Scheme 3.4. Overall reaction involving fluorination with a transition metal fluoride
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The most important member of this group, is cobalt trifluoride, which is prepared by
9 9
passage of fluorine (F2) over cobalt difluoride . Fluorination of benzene (136) for example
is one of the reactions which is accomplished using C0F3. The mechanism in scheme 3.5
shows that the Co (III) is reduced to Co (II) transferring the fluorine atom to the organic
substrate.
F F F
Scheme 3.5. Fluorination of benzene with C0F3
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3.3.2.3 Fluorinations using Hydrogen Fluoride
These reactions generally involve the nucleophilic displacement of a halogen (chlorine)
using hydrogen fluoride in combination with a metal fluoride. The metal fluoride acts as a
Lewis acid to assist the displacement of the halogen. Antimony fluorides are the most
common Lewis acids used in these reactions.
SbFs in combination with HF, is widely utilised for industrial purposes. For example, Freon
12 (137) is still produced from tetrachloromethane (138) using this reaction (Scheme 3.6),
Scheme 3.6. Industrial production of Freon
3.3.2.4 Alkali metal fluorides
This group of reactions generally involves the nucleophilic displacement of a halide ion
mediated by a fluoride ion as shown in scheme 3.7.
Scheme 3.7. Fluorination involving a Sn2 process
Fluoride ion in protic solvents is a poor nucleophile but it is a very strong nucleophile in
polar aprotic solvents such as DMF, DMSO, etc. Fluoride ion is a small hard anion and
susceptible to hydrogen bonding interactions which mask the charge in protic solvents. In
contrast, in aprotic solvents, fluoride becomes a very strong nucleophile, more nucleophilic
than the other halide ions.
HF, SbF5
CCI4
100 oc" CCI3F +cci2F2+CCIF3
9% 90% 0.5%
137 138
F + —(J—x F-C— + X-
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Potassium fluoride (KF), potassium bifluoride (KHF2) and cesium fluoride (CsF2) are the
most common fluoride reagents, and the fluorination reactions are carried out in high
boiling solvent or anhydrous solvents. Under these conditions the hydrogen bonds between
F" and the solvent are minimised and this encourages the formation of "naked fluoride."47
Solvation of metal cations using crown ethers or with solvents such as glycols and
glymes48, have also been successfully exploited, for example, in monofluorination reactions
with potassium fluoride at modest temperature as shown in scheme 3.8.
KF/polyethyleneglycol 400
27 h, 50-55 °C
59%
Scheme 3.8. Fluorination using KF and glycols
3.3.2.5 Other sources of fluoride ion
Silver (I) fluoride is a good alternative to the alkali metal reagents, because of its high
selectivity and its low basicity which generally gives more selective reactions. It is mainly
used in halogen exchange processes. Interestingly, an increase in the yield of AgF reactions
has been reported in presence of wet rather then anhydrous solvents.
Tetralkylammoniumfluorides are another class of reagents capable of generating fluoride
ions. They were developed to overcome the problems associated with the alkali metal
fluorides. The M+ ion is replaced with a bulky organic cation which reduces the interaction
between the solvent and F" and thus increases its nucleophilicity. Hydrated49 TBAF
(tetrabutylammonium fluoride) is the most widely used of this category and it is
particularly effective in displacement of OTs, OMs and OTf groups and in ring opening50










n-Ci5H31 COOMe 15 31 i
2. H30+ f
63% yield
Scheme 3.9. Fluorination involving TBAF
Anhydrous hydrogen fluoride is one of the cheapest fluorinating agents available but due to
its corrosive nature it is usually complexed with suitable solvents. For example
polypyridinium hydrogen fluoride, known as Olah's reagent,51 is one of the most common
HF reagents, where HF is complexed with pyridine in a 1:9 ratio. The reagent is
commercially available as a stable liquid (30% py: 70% HF). It has been used to fluorinate
5? CO CO
secondary and tertiary alcohols, alkenes, and in ring opening epoxide reactions in a
regiospecific manner as shown in scheme 3.10. Epoxide (139) when treated with Olah's
reagent gave the two possible regio isomers in a 9:1 (140)/(141) ratio depending on the








Scheme 3.10. Epoxide ring opening with HF*pyridine complex
Et3N*HF originally introduced by Franz,54 is a popular source of F" and it is less corrosive
than the HF*Py complex. It has been used successfully for the halofluorinations reactions





Scheme 3.11. Halofluorination with Et3NH 3HF
Et3N*3HF has also been used in the regioselective ring opening of epoxides55.
Sulfur tetrafluoride (SF4) is used in combination with HF and is best known for its
fluorodeoxygenation ability as shown in scheme 3.12. However there are some drawbacks
to using this reagent, SF4 is highly toxic and on exposure to moisture (air, skin) liberates








Scheme 3.12. Reactions promoted by SF4/HF
Recently, DAST (diethylaminosulfur trifluoride) has become one of the more friendlier
alternatives to SF4 in fluorodeoxygenation reactions56. DAST is a commercially available
liquid which can be stored in plastic bottles, and is stable in dry conditions at room




















Scheme 3.13. Example of fluorination reactions using DAST
Other reagents capable of generating F" are illustrated in figure 3.21. For example aromatic
hypervalent iodine fluorides (142) have been applied to the fluorination of steroids in
conjunction with an electron-transfer agent.57 Bromine trifluoride (143) and Mercury (II)
fluoride (144) have all been used for replacing bromine with fluorine43 whereas XeF2 (143)
is one of the most stable fluorinating agents and it has been used in the fluorination of, a




Figure 3.21. Other sources of fluoride ions
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3.3.2.6 Electrophilic sources of fluorine
Intuitively, chemists think of using fluorine as F, however ingenious ways have been
developed for generating fluorine as F+ for electrophilic fluorinations.
As discussed in section 3.3.2.1, elemental fluorine (F2) can behave as a free radical source
and as an electrophile. This is deduced because substitution of tertiary hydrogens by
fluorine proceeds with retention of configuration (scheme 3.14) and involves the formation
of a carbonium ion intermediate.
Scheme 3.14. Electrophilic fluorination with F2/N2
However, the most efficient reagents able to generate F,+ are the N-F reagents.58'59 The first
fluorination reaction involving a F+ carrier was reported by Banks and Williamson60 they
discovered that perfluoro-N-fluoropiperidine (146) converted the sodium salt of 2-
nitropropane (147) to the corresponding 2-fluoroderivative (148). This conversion was
rationalised on the basis of a nucleophilic displacement on the fluorine by the carbanion as
shown in scheme 3.15 (a). However, a different mechanism, involving an electron-transfer
process, was later, proposed61 scheme 3.15 (b).
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147 146
Scheme 3.15. Fluorination with perfluoro-N-fluoropiperidine: (a) nucleophilic mechanism
and (b) a single electron transfer.
Although perfluoro-N-fluoropiperidine (146) was found to be a powerful fluorinating
reagent, it has never been widely applied, perhaps as it generally provides low yielding
products. In the early 1980's more successful N-F reagents were developed (figure 3.22).
The first was Purrington's reagent,62 dihydro-N-fluoro-2-pyridone (149), followed by the
Barnette's reagent, 63 (150), Umemoto's N-fluoropyridinium 64' 65 (151),
fluoroquiniclidinium salts66 (152) and then the most powerful reagent of this class, the N-
fluorobis (trifluoromethylsulfonyl) imide67 (153). The discovery of N-fluoroquinuclidinium
fluoride as a fluorinating reagent (152) inspired chemists to develop cheaper and more
stable alternatives. In fact, the commercial l,4-diazabicyclo[2.2.1] octane known in the
polyurethane industry as TEDA, was used in place of the quinuclidinium ring, but the first
bis (NF) salts (154) proved difficult to isolate68and were found to deliver only one half of
the theoretical F+ available due to self-defluorination reactions. 69 These problems were
circumvented by using BF4" as a counter ion and by placing an alkyl group on one of the
two nitrogens. It emerged that (155) (so called F-TEDA-BF4) which has been
commercialised under the name of Selectfluor,™ is one of the most potent electrophilic
fluorinating agent.70
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Figure 3.22. Electrophilic N-F fluorinating reagents
F-TEDA-BF4 (155) has been used successfully in the preparation of a variety of different
organo-fluorine compounds from a different range of electron-rich substrates. Reactions
generally proceed under mild condition and these are summarised in scheme 3.16.
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Scheme 3.16. Some of the reactions of F-TEDA-BF4
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Activated aromatic substrates undergo fluorination and in some cases difluorination
(pathway a in scheme 3.16). Perhaps the most common reaction employing F-TEDA-BF4
*7 TJ TX
as a reagent is the fluorination of P-dicarbonyl compounds (via b). ' ' This involves the
reaction of the stabilised carbanion with the reagent. Fluorodemetallation of
vinylstannanes74 and fluorination of alkenes (via d) in the presence of nucleophiles75 are
examples of other processes which can be achieved using F-TEDA-BF4.
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3.3.3 Asymmetric fluorination
Many stereoselective syntheses of organo-fluorine compounds have been reported, however
they can be classified into four general categories according to the strategy employed to
form the stereogenic C-F bond.
3.3.3.1 Asymmetric fluorination using chiral fluorinating reagents
Asymmetric fluorinations require a chiral reagent capable of delivering the fluorine F atom
in a stereoselective manner. N-Fluorocamphorsultams76' 77(156 and 157) were the first
examples of these reagents and they have been used for the asymmetric fluorination of
metal enolates as shown in scheme 3.17. Flowever the yield and the ee's for the asymmetric
fluorinations were very poor and this has limited their use.
156 y 35 % ee, <5 % yield
157 S 67 %ee, 41% yield
Scheme 3.17. Asymmetric fluorination of metal enolates with chiral camphorsultams
The selectivities were improved later by of Takeuchi and Shibata78 who were able to
prepare N-fluoro sultams (158) and successfully applied these to the electrophilic
fluorination of enolates as shown in scheme 3.18
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74% ee, 67% yield
Scheme 3.18. New generation of sultams for asymmetric fluorination reactions.
A significant step forward on asymmetric fluorination methodology was reported
simultaneously by Shibata and Cahard.79' 80 They noticed that a combination of
Selectfluor™ and the cinchona alkaloid generates a chiral N-fluoroquinuclidinium species
capable of selective F+ delivery. Furthermore it was observed that the choice of the
cinchona alkaloid had a substantial influence on the stereoselectivity of the reaction. Enol
silane (159) was used as a model for investigating the selectivity of the reaction with
different combinations of cinchona alkaloids and Selectfluor. Quinine and Selectfluor gave
only a 40% ee in favour in of R the enantiomer at C(2) (160), whereas with
DHQB/Selectfluor improved the stereoselectivity to 81 ee % in favour of the S isomer,
(scheme 3.19). The most effective combinations, including the ones obtained with
DHQDA, were used for other aryl enol silanes and in some cases the selectivity (ee) was














Scheme 3.19. Asymmetric fluorination with Selectfluor/cinchona alkaloids
The asymmetric fluorinations hitherto described require the use of stoichiometric amounts
of the chiral reagents. However, the first catalytic fluorination were recently reported by
Togni.81 These use only catalytic amounts of Ti (IV) complexes generated by reactions of
[TiCl2(/?,.R-TADDOLato)] with DME or acetonitrile to form stable adducts (161) and
(162). These adducts have the ability to catalyze enantioselective fluorination reactions.
The reaction presumably proceeds via coordination of the Lewis acid (Ti) to the carbonyl
oxygen of the (3-ketoester (163) to form a stable enolate capable of attacking the F+ reagent
to generate the fluorinated product (164) see scheme 3.20. The reactions were conducted at
room temperature with a slight excess of a saturated F-TEDA solution in acetonitrile on
different substrates and in all cases the yields ranged between 80 - 95% and the best
enantioselectivities were obtained by using catalyst (162).
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161 R=1 -Naphtyl 1(j2
161 > 59% ee
162 => 82% ee
Scheme 3.20. Catalytic enantioselective fluorination using chiral Lewis acids.
The enantioselective introduction of fluorine via nucleophilic attack of an asymmetric F "
source remained unexplored. Until recently the only example82 of such as asymmetric
fluoride attack occurred in only 16% ee using a (5) proline-based DAST analogue scheme




Scheme 3.21. First example of stereoselective nucleophilic fluorination
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The most representative example of stereoselective nucleophilic fluorination was reported
by Haufe.83 The reaction involves epoxide ring opening using Cr (salen) complexes. When
cyclohexene oxide (165) was treated with potassium hydrogen difluoride in the presence of
18 crown-6 and a stoichiometric amount of Jacobsen's chiral chromium salen complex
(166) the two products (167) and (168) were generated in an 89:11 ratio and 92% combined
yield. The desired fluorohydrin product (167) was formed with an 55% ee. (scheme 3.22)
Scheme 3.22. Enantioselective ring opening of a meso epoxide
3.3.3.2 Asymmetric fluorination controlled by chiral auxiliaries
An alternative approach to direct stereoselective fluorinations involves the use of
covalently linked chiral auxiliaries. Davis et al. have used Evans' oxazolidinones as chiral
auxiliaries in asymmetric fluorinations.
Fluorination of oxazolidinone (169) with the stable fluorinating reagent N-fluoro-o-
benzedisulfonimide (170, NFOBS)84' 85 has produced a-fluorocarboxiimides (171) in
excellent yield (86-95 %) and excellent de (90-99%). The products can then be converted
into various functionalities without significant racemization. As shown in scheme 3.23,
compound (171) can be converted into the corresponding alcohols (172) by a simple
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reduction with LiBEU Alternatively, conversion into the a-fluoro N-methoxy-N-
methylamides (173) via the transamination procedure developed by Weinreb86 followed by
treatment with the appropriate Grignard reagent (RMgBr,) afforded ketones (174) in high

























>80% yield >96% ee
O
174
Scheme 3.23. Davis asymmetric fluorination controlled by Evans' oxazolidinones
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3.3.3.3 Asymmetric fluorination controlled by substrates
The stereoselectivity for this type of reaction is controlled by the presence of a covalently
modified chiral fragment that is retained in the target molecule. One of the most
representative examples of this type is the hydrofluorination of optically active terminal
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epoxides . 1,2-Epoxyoctane (175) and glycidyl hexyl ether (176) gave the corresponding
2-fluoro-l-alkanol (175a and 176a) derivatives when treated with a HF*amine complex,
suggesting a configurational inversion of the asymmetric centre (ee 90%), while during the
hydrofluorination of pentafluorostyrene oxide (177) and 2-methyl-l,2-epoxyhexane (178),
partial racemization occurred.
The high stereoselectivity for the first two reactions can be rationalised by assuming the
formation of an intermediate state, in which the positive charge is delocalised on three
atoms and the fluoride attacks in a Sn2 fashion to the carbon centre leading to the product
with inverted stereochemistry. On the other hand, the low selectivity for (177) and (178) is
presumably caused by formation of a stable carbocation (tertiary and benzylic) with two








Scheme 3.24. Epoxide ring opening with an HF-amine complex
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Part C
3.4 Applications of Organo-fluorine compounds
3.4.1 Fluorine containing drugs
Many fluorinated compounds are currently used in the treatment of disease. These include
the antidepressant fluoxetine (179), which is the most significant anti-depressant drug by
88volume and sales. Other major products include the anti-inflammatory agent diflunisal
(180), the antibacterial ciprofloxacin (181) and chemotherapic agents such as 5-fluorouracil







Figure 3.23. Example of commercially significant fluorinated drugs
85
The inclusion of fluorine in a drug, can influence both the metabolism or the interaction of
the drug with the target protein. The replacement of an hydroxyl group or a hydrogen atom
by fluorine is an important strategy in medicinal chemistry. Although, fluorine is a little
bigger in size than hydrogen, it has already been discussed that the substitution of fluorine
over hydrogen causes minimal steric effects at receptor sites and it can be considered as an
hydrogen mimic.89 However it also can act as an isostere of the hydroxyl group. F and OH
are both hydrogen bond acceptors although the CF HX bond is weaker than the
corresponding CO HX.11
Fluorine generally acts to increase the lipophilicity of an organic molecule and the effect is
pronounced with the CF3 group. This feature has been used in medicinal chemistry as a
general strategy to increase the lipophilicity of drugs. Drugs acting on the central nervous
system (CNS) must pass through the blood brain barrier and many of these drugs contain
either a CF3 or a fluoro/phenyl group which contributes to the pharmacological activity of
the biologically active compound.
Fluorination can also increase the metabolic stability of a pharmaceutical formulation and
replacement of different groups with fluorine has been used to increase the biological half-
life of endogenous or synthetic compounds. For example, fluorinated analogues of
prostacyclin, which is an inhibitor of platelet aggregation, contain an acidic labile enol-
ether responsible for its short half-life. A fluorine atom placed alpha to the enol ether as is






Figure 3.24. Examples of fluorinated analogues of endogenous compound
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Fluorinated nucleosides and nucleotides are a very important class of anticancer or anti-
AIDS drugs. 5-Fluorouracil (182) is one of the major drugs used to treat solid cancers. It is
converted into the active metabolite 5-fluoro-2'-deoxyuridine 5'-phosphate (FdUMP) which
inhibits thymidylate synthase and its cofactor, a tetrahydrofolate derivative, responsible for
the trasformation of dUMP into dTMP (figure 3.25 A). The FdUMP acts as suicide
inhibitor, binding covalently to the enzyme co-factor resulting in the inactivation of the
enzyme, as shown in figure 3.25 B, and interfering with the synthesis of the DNA.90'91
Dead-end
Formation of a covalent complex
Figure 3.25. Conversion of dUMP to dTMP and its inhibition by FdUMP
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3.4.2 Fluorine-containing chiral liquid crystals
Fluorine also has a major role to play in material science. Some solid materials exhibit a
long-range order even after they melt giving rise to liquid crystalline behaviour where the
molecules do not exhibit any positional order, but only a certain degree of orientational
order is maintained. Liquid crystals are anisotropic materials, where the properties of the
material differ depending on the direction they are measured. Liquid crystals behave
differently depending on what direction electric or magnetic fields are applied relative to
the director and this property forms the basis of their use as data displays in calculators,
watches and flat screens.
There are many kinds of liquid crystal. Nematic liquid crystals have a tendency to organize
themselves in a parallel fashion as shown in figure 3.26. In Smectic liquid crystal the
molecules align themselves in layers figure 3.26. In smectic A (SmA) liquid crystals the
molecular orientation is perpendicular to the layers, whereas the director is tilted in the
SmC phase. Both show no positional order within the layers and therefore are often
considered as two-dimensional liquids. The SmC phase of chiral molecules form a helical
structure to form the phase known as smectic SmC*.
smectic C smectic A nematic Chiral Smectic Phase Sc*
Figure 3.26. Representation of liquid crystal phases
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Liquid crystals which contain chiral molecules and show the SC* phase are known as
ferroelectric liquid crystals (FLC). The (FLCs) posses a spontaneous ferroelectric
polarisation (Ps) or macroscopic dipole moment. Appropriate application of an external
electric field results in alignment of the chiral molecules by 0 degrees from the normal line
of the layer. When the sign of the applied field is reversed a realignment or switching of
FLC molecules occurs92. This response or switching time (x) falls in the order of a ps. This
property of the FLC's can be useful in high-speed, high-resolution electro-optic devices,
such as flat panel displays and the research in the field of chiral smectic material has greatly
expanded. Ever faster switching speeds are required nowadays and small t are associated
with FLCs which posses high polarisation density (Ps) and low viscosity.
Chiral organo-fluorine molecules are typical examples of ferroelectric-liquid crystal. The
C-F bond possesses a dipole moment of 1.79 D and since fluorine has a relative small
atomic radius it induces an appropriate Ps and generally a low viscosity.
Fluoroalkyl ethers such as the one shown (184) in figure 3.27 are currently used in Canon
displays. An additional fluorine atom may induce a larger Ps such as difluoro ethers (185a
and 185b) prepared by Walba.93' 94 The syn-isomer 185a induced a large Ps whereas the
anti- isomer 185b showed a smaller value. The difference can be explained in terms of the
dipole moment induced by the two fluorine groups. The syn-isomer possesses two fluorines
in parallel, which increase the Ps, whereas the dipole moments in the anri-isomers










Figure 3.27. Fluorine containing liquid crystals.
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4 ™..ro s_, .
New Class of Fluorinated Compounds
4.1 Aims
There is clear evidence that the C-F bond can be exploited as a tool for influencing the
conformation of organic molecules, particularly when it is used as a replacement for
hydrogen. This is most easily illustrated by the well known gauche effect which recognises
that 1,2-difluoroethane prefers a gauche over an ariti conformation. The gauche preference
of vicinal fluorines influences the conformation of hydrocarbon chains for example in 2,3-
difluorobutane. It extends also to longer chain systems (see difluorostearic acids) as
previously discussed in section 3.2.3.2, This is attributed to the vicinal C-F bonds
preferring to align gauche to each other in both systems, the former stabilising and the latter
destabilising the classical anti-zig-zag conformation of the hydrocarbon chain. With the
fluorine gauche effect reasonably well understood for vicinal difluorohydrocarbons, it
appeared desirable to investigate the behaviour of a hydrocarbon system with a third vicinal
fluorine. This chapter explores the synthesis of such vicinal trifluoro systems in a
diastereoselective manner.
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4.2 Stereoselective synthesis of trifluorononanes
4.2.1 Synthetic strategy for the synthesis of a vicinal trifluoro system
A synthesis of trifluoro derivatives 186- 189 (figure 4.1) was explored.
186 and 188 R=(CH2)4-CH3, R'=-CH3
187 and 189 R=(CH2)6-CH3, R'=Ph-(CH2)5
Figure 4.1. Novel structures of trifluoroalkanes
The synthesis of trifluoro derivatives 186 and 187 was explored as illustrated in scheme
4.1. Two different approaches (a, b) were taken having a common intermediate 190a (or
190b) which can be easily synthesised from the allylic alcohol (191). Approach a, requires
direct fluorination of substrate (190a or 190b) via a nucleophilic replacement of two
hydroxy groups with DAST. Alternatively approach (b) introduces the two remaining
fluorine atoms in step wise manner. It was envisaged that the fluorodiols 190a (or 190b)
could be converted in to either an epoxide (192a or 192b) or into cyclic sulfates (193a or
193b). The sulfates would then be substrates for the second fluorination via a HF-pyridine
reaction or TBAF respectively. The final fluorine could be placed by simple activation of




Scheme 4.1. Retrosynthetic analysis for trifluorononanes 186 (or 187)
4.2.2 Direct fluorination approach (a)
4.2.2.1 Preparation of fluorodiols (190a) and (190b)
The required fluorodiols 190a and 190b were synthesised from the commercially available
o^P-trans-unsaturated-ketone via a three step protocol. The route is illustrated in scheme
4.2. The sequence starts with the reduction of enone (195) using NaBPU in the presence of
CeCl3*7H20. This reaction proceeded in almost quantitative yield to give alcohol (191).
The alcohol was then converted into the two diastereotopic epoxides 196a and 196b as a
2:1 mixture. It proved more efficient to separate the diastereomers after the next step
following treatment with HF*Pyridine. This reaction resulted in a regio- and stereo-
specific ring opening generating the fluorodiols 190a and 190b retaining the ratio 2:1.
Diastereoisomers 190a and 190b were readily separated by silica gel chromatography and






















+ C5H11 ; Me
ÒH
1 190b
Scheme 4.2. Reagents and conditions: (i) NaBEL, CeCh 7H20 in MeOH, 0 °C 15 min 90%;
(ii) mCPBA in DCM, 0 °C 2 h, 85%; (iii) HF* Pyridine in DCM, -10 °C 4 h, 62%.
4.2.2.2 Attempted to the synthesis of trifluorononane (185) via the DAST reaction of the
fluorodiol (190a)
With the fluorodiol 190a in hand, the direct fluorination approach discussed in the previous
section was explored. However simultaneous replacement of the two OH groups by
fluorine using classical DAST conditions scheme 4.3 was unsuccessful. In fact, the reaction
which could be followed by TLC, instantly showed the formation of several by-products.
Spectroscopic analysis of the reaction mixture after work-up, confirmed the existence of
four or five products with proton signals in the olefinic region of the *H NMR spectrum (5-
6 ppm ) and with fluorine signals in the aliphatic region of the I9F NMR spectrum (-180 - -
190 ppm). Clearly, a number of elimination reactions competed with the nucleophilic
displacement, generating different olefins in place of the desired trifluoroalkane.
Scheme 4.3. Conversion of 190a to 186 was unsuccessful with DAST.
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4.2.2.3 Attempted synthesis of fluoroepoxide (192a) from 190a
The preparation of the desired epoxide (192a) required a two step protocol. The first step
required the activation of only one OH group of the fluorodiol (190a) and this was achieved
using one equivalent of tosyl chloride, which generated the tosyl derivative (197) in a
regioselective manner. It was envisaged that the second step would involve a deprotonation
of the remaining OH with a base (DBU).95 This was unsuccessful, even when LiBr was
added, and the expected epoxide was not formed, (scheme 4.4.)
190a Y)i
Scheme 4.4. Reagents and conditions: (i) Tosyl chloride, pyridine, DMAP, DCM, rt 24 h,
70%; (ii) DBU, LiBr, THF RT.
4.2.2.4 Stepwise fluorination by ring opening of a cyclic sulphate
Sharpless has shown that cyclic sulfates can be ring opened with fluoride ion. This strategy
was now explored as a method for the stereospecific introduction of fluoride. The vicinal
diols of both diastereoisomeric series (190a and 190b) were efficiently converted to their
cyclic sulfates 198a and 198b using the Sharpless protocol.96'97The reaction was performed
with SOCI2 and pyridine generating a cyclic sulfite in less than 1 hour. This intermediate
was then oxidised with Ru04 (NaI04 and catalytic amount of RuCb) in MeCN-H20 to











Scheme 4.5. Reagents and conditions, (i) Thionyl chloride, pyridine, DCM, 0 °C 45 min.
(ii) NaKV RuC13 in CH3CN/H2O, 0 °C.
The sulfates (198a and 198b) were subsequently treated with TBAF 98 in acetonitrile and
after 30 min all of the starting material was consumed (TLC). The reaction mixture was
then hydrolysed in situ in a biphasic system (H2SO4 20% and ether) at room temperature.
Spectroscopic analysis showed that the difluoro alcohols 199a and 199b were formed in a
highly regio- and stereo- specific manner. Fluoride ion attacked the less hindered position
of the sulfate ring in a SN2 manner generating exclusively a single diastereoisomer of the























Scheme 4.6. Reagents and conditions, (i) TBAF in acetone, 0 °C 2 h; (ii) Et20/H2S04 20%
RT 24 hours.
4.2.2.5 Introduction of the third fluorine
The third fluorine atom was introduced via fluorination with TBAF on the triflates 200a
and 200b. These materials were easily prepared from their corresponding alcohols (199a
and 199b) after reaction with triflic anhydride and pyridine in DCM at -40 °C. The
nucleophilic displacement of the OTf group led to the desired vicinal trifluoroproducts as
shown in scheme 4.7, although the desired products were accompanied by elimination
products. These fluoroolefins could not be isolated due to their volatility. However the
desired products 186 and 187 could be secured in a straightforward manner after
chromatography.
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Scheme 4.7. Reagents and conditions, (i) Tf20, pyridine in DCM, -40°C 1 h; (ii) TBAF in
acetonitrile, 0 °C 30 min.
4.2.3 Synthesis of enantiomerically pure difluoroalcohol (199b) via a Sharpless
epoxidation of allylic alcohol (191)
Although all of the vicinal trifluoro products in this study were prepared as racemates, the
enantiomerically pure products can be accessed by initiating the synthetic protocol with a
Sharpless asymmetric epoxidation/kinetic resolution.99'100 This was explored to confirm the
stereochemical course of the first two fluorination reactions in schemes 4.7 and 4.8.
Compound (196b) was prepared by the Sharpless kinetic resolution of racemic 3-nonen-2-
ol 189 as a substrate using (+)-DIPT and a limiting (0.5 equiv) amount of 'BuOOH. This
generated the allylic epoxide 196b, of known configuration101 in 95% de and 80% ee.
scheme 4.8.
With enantiomerically enriched epoxide 196b in hand it was possible to explore the
stereochemical course of the two fluorination reactions. Therefore the sequence described
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above was applied again to the synthesis of enantiomerically enriched 198b as shown in
scheme 4.8. The difluroro alcohol (198b) was a crystalline material and proved suitable for








80%ee by chiral GCMS














Scheme 4.8. The preparation of enantiomerically pure 199b
The resultant X-ray structure of 199b is shown in figure 4.2. This revealed a
stereochemistry consistent with two configurational inversions at C(4) and at C(2) for each
C-F bond forming reactions. The final trifluoro product, which results from fluoride ion
displacement of a triflate is assumed to proceed with an inversion of configuration. These
trifluoroalkanes were not crystalline materials and were not amenable to crystallisation,
however with this latter assumption, the relative (and in this case the absolute)




Figure 4.2. The X-Ray structure of 199b confirmed the relative stereochemistry after two
fluorinations reactions
4.3 Stereoselective synthesis of a second trifluoroalkane series
4.3.1 Retrosynthetic analysis
The methodology developed in the last section for placing three vicinal fluorines along an
alkyl chain was then applied to the synthesis of a second system. The aryl alkanes, 188 and
189 as shown in figure 4.1, contain a longer chain hydrocarbon system (15 carbons).
Retrosynthetic analysis reveals an allylic alcohol as the starting point for the synthesis of
these trifluoro alkyl; systems (188 and 189). The required allylic alcohol 201 was readily
accessible from a condensation of 6-phenyhexanaldehyde 202 and non-l-yne 203 followed
by a LAH reduction as illustrated in scheme 4.9.
4.3.2 Preparation of allylic alcohol (201)
The methodology developed for the synthesis of trifluorononanes (186 and 187) required
allylic alcohol (191) as the starting material. It can be generalised that the synthesis of any
such trifluoro derivative by our method requires an allylic alcohol as a starting point.
Therefore the synthesis of the desired trifluoro compounds commenced with the allylic










Scheme 4.10 Reagents and conditions, (i) PCC, 2 h; DCM. (ii) HC=C-C7Hi5 (203), BuLi in
THF, -78 °C, 3 h. (iii) LÌAIH4 in THF, reflux.
The method started with the oxidation of alcohol (204) with PCC in DCM105 to afford 6-
phenylhexaldehyde (202) in 86% yield. The acetylide derived from (203) was generated in
situ with BuLi. Treatment of this with aldehyde (202)102 gave propargyl alcohol derivative
(205) in good yield. Finally, the trans-allylic alcohol (201) was secured after LiALH4
reduction of 205.103
4.3.3 Synthesis of trifluoro derivatives 188 and 189
4.3.3.1 HF ring opening of epoxides (206a and 206b)
In the trifluorononane series the first fluorination reaction required the allylic epoxides
(196a and 196b) as substrates for HF ring opening. Similarly, epoxides 206a and 206b
were prepared by transformation of the allylic alcohol (201) to their corresponding
diastereoisomeric pairs by reaction with mCPBA. The two distereoisomers were again
generated as a 2:1 mixture in favour of isomer 206a. These diastereoisomers could be
separated by chromatography and the resulting epoxides were used individually for the
subsequent steps. Olah's reagent (HF*py) was then used again for opening of the epoxides
of 206a or 206b to yield the fluorodiols 207a or 207b in a completely regio-and stereo-
specific manner scheme 4.11. The high stereospecificity suggests that F" attacks
101
























Scheme 4.11. R.-C7H15 and R'=(CH2)5Ph. Reagents and conditions, (i) mCPBA, DCM, 0
°C, 75%; (ii) HF-Pyridine, 0 °C, DCM.
4.3.4 TBAF ring opening of cyclic sufates (208a and 208b)
The second C-F bond was introduced once more via reaction of TBAF with the appropriate
cyclic sulfate. The cyclic sulfates were prepared via the two step procedure discussed in
section 4.2.3.2. This consists of the initial formation of a cyclic sulfite by treatment of the
corresponding vicinal diols (207a and 207b) with thionyl chloride, followed by a





























Scheme 4.12. R=C7Hi5 and R'=(CH2)5Ph. Reagents and conditions, (i) Thionyl chloride,
pyridine in DCM, 0 °C 45 min then NaICV RuC13 in CH3CN/H20, 0 °C 1 h; (ii) TBAF in
acetonitrile, 0 °C 1 h; THF/H2S04 conc RT 2 h.
Cyclic sulfates 208a and 208b were then reacted with TBAF in acetonitrile and the
resultant difluorinated sulfates were obtained. Hydrolysis using conc. H2S04 in THF gave
the difluoro alcohols 209a and 209b in a good yield. Nucleophilic attack by fluoride ion
resulted again in a totally regio- and stereo- specific reaction with the nucleophile attacking
exclusively at the C(3) of the cyclic sulfates (scheme 4.13). The high selectivity is perhaps
attributed to the preference of fluoride ion to attack the less hindered position of the sulfate


































Scheme 4.13. Reagents and conditions, (i). TBAF in acetonitrile, 0 °C 1 h; (ii). THF/H2SO4
cone RT 2 h.
4.3.4.1 Introduction of the third fluorine
The third fluorine atom was introduced again by a fluoride substitution reaction. The
remaining OH of 209a or 209b was first transformed into a good leaving group and then
reacted with a F" source. As shown in scheme 4.14, the alcohol functionality (209a or
209b) was straightforwardly converted to the corresponding triflates (210a or 210b) by
treatment with triflic anydride and pyridine at -50 °C. The displacement of the triflate
group was then successfully achieved with 2 equivalents of TBAF to produce the desired
trifluoro alkanes (188 and 189). This reaction was also accompanied by elimination
products visible by spectroscopic methods. However the mixture was found to be difificult











Scheme 4.14. Reagents and conditions. R=CvHi5 and R'=(CH2)5Ph. (i) Tf20, DCM -40 °C;
(ii) TBAF, acetonitrile, 0°C 15 min.
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4.4 19F NMR analysis of trifluoroalkanes
Both series of the vicinal trifluoroalkanes were analysed by 19F ^H} NMR spectroscopy.
The three fluorine atoms displayed very different chemical shifts as shown in figure 4.3.
The difference is comprehensible for compounds 186 and 187 where each fluorine atom is
positioned in a very different chemical environment. Whereas the large difference in
chemical shifts of F(l) and F(3) is less understandable for compound 189, where the two
fluorines mentioned above are in a much similar chemical environment. Perhaps such large
difference in chemical shifts is derived from the fluorine gauche effect.
187
JUL JL JÉ,
Figure 4.3. 19F {1H} NMR spectra of trifluroalkanes 184-187
Compound (188) possesses a certain symmetry derived from the fact that all the three
fluorine atoms are syn to each other. On the other hand (189) possesses both an anti
relationship between F(l) and F(2) and a syn relationship between F(2) and F(3).
Additionally, the two sets of diastereoisomers displayed similar NMR characteristics.
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magnitudes of the fluorine-fluorine coupling constants and chemicals shifts are similar
within each diastereomeric series and they are clearly characteristic of that stereochemistry,
as shown in Table 4.1. There is a clear analogy between compounds 186 and 187 and 188
and 189. The 186 and 188 isomers which have the three fluorine all in gauche have both
Jfi-f2 and J f2-f3 around 12 Hz on the other hand compound 187, 189 have Jfi-f2 value


















































4.5 Conclusion and Future work
In summary the first synthetic method has been developed for the stereospecific synthesis
of vicinal trifluoroalkanes, and provides access to this novel class of molecules. The
structural motif of this new class of organo-fluorine compounds hold some future promise
in the design of performance materials. For example the synthesis of building block (211)
could give access to the synthesis of the novel ferroelectric liquid crystal (FLC) (212)
analogues of the well known FLC's such as (185). The potential synthetic route would start
from a readily available (figure 4.4) starting material and using the chemistry already
evaluated in the St. Andrews laboratories and as discussed in this thesis. These compounds
are required to be prepared in optically pure forms, a prerequisite of the ferroelectric











Figure 4.4. Trifluoroderivative compound as potential FLC.
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This Chapter introduces the concept of the Fluorous Phase, a new technique and strategy
for reaction and separation in organic chemistry. This concept was first proposed in a Ph.D
thesis by Vogt1 in 1991 and later independently brought to the scientific community by the
seminal work of Horvàth and Rabai, who also coined the term of Fluorous for
perfluorinated solvents, in analogous way to "aqueous" for water-based system. However,
unlike water the miscibility of fluorous molecules with organic solvents is strongly
temperature dependent. This characteristic has been crucial for the success of fluorous
chemistry and its applications, particularly in catalysis.
5.1.1 Perfluorinated solvents
Perfluorocarbons (PFCs) are defined as those saturated fluids such as alkanes, alkenes,
ethers or amines in which all hydrogen atoms have been replaced by fluorine atoms.
Perfluorinated solvents are liquids of high density, colourless, non toxic and they are
remarkably hydrophobic. Unlike the volatile halofluorocarbons, PFCs are not ozone-
depleting compounds although their high stability expressed by their long atmospheric
lifetime (>2000 years) makes them potent greenhouse gases. It emerges that PFCs are
excellent solvents for gaseous substances, being able to dissolve significant quantities of
oxygen (twice as much as the corresponding hydrocarbon4), nitrogen and carbon dioxide,
but they are poor miscible with organic solvents. The miscibility with the organic media is
thermo-and pressure-dependent. The phase diagram in figure 5.1 shows the miscibility and
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the critical temperature (Tc)* of two liquids (benzene and pefluoromethylcyclohexane
(PFMCH)). For example equal volumes of benzene and perfluoromethylcyclohexane are
completely miscible (forming one phase) at temperatures above 75 °C.
Figure 5.1. Phase diagram of
perfluoromethylcyclohexane and benzene; x=
mole fraction of benzene (redrawn from data in
ref5)
The thermo controlled miscibility of
perfluorocarbons with organic solvents is the basis
of a Fluorous Biphase Chemistry6 and its resulting
applications particularly in catalysis. A typical Fluorous Biphase System consists of a
fluorous soluble reagent or catalyst (RF-Cat) in a fluorous solvent (e.g. perfluorodecalin)
and a second phase which is generally a typical organic solvent (e.g. hexane) containing the
organophilic reagents. On warming, the two phases become completely miscible (in our
case at ca. 50-55 °C) providing a homogeneous phase which allows catalysis to occur. On
cooling, the system returns to a genuine biphasic system, with the fluorous catalyst



















Scheme 5.1. The Fluorous Biphase System (FBS) strategy
Thus, a fluorous biphase system can combine the advantages of homogeneous catalysis
with the liquid-liquid separation technique. The availability of fluorous solvents within a
wide range of boiling points, ranging from 56°C for perfluorohexane to 220 °C for
90
°0 0.1 02 03 0.4 0.5 0:6 07 08 0.9 1
*
Tc is the temperature above which two liquids are miscible in all ratios.
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perfluorotripentylamine, allows a variety of reactions to be performed under various
conditions.
5.2 "Fluorophilic" Molecules
A suitable catalyst or reagent for a FBS reaction must partition preferentially in the fluorous
phase. This is obtained by attaching appropriate perfluorinated group or "ponytails" to the
active site of the molecule as shown in figure 5.2. To quantify the extent of the fluorous
phase preference for a compound Rabai7 et al have introduced the concept of specific
fluorophilicity (fi) expressed by the equation 5.1:
fi= In Pi- In
Ci(CFiCóFn)
ci(CHjCóHs)
, T= 25 °C
According to this equation, the fluorophilicity of a generic compound "i," is a function of
the partition coefficient (Pi) between two solvents (e.g. perfluoromethylcyclohexane
CF3C6F11 and toluene CH3C6H5) at 25 °C, and a compound is fluorophilic when the value
of fi is positive. However the fluororphilicity of a substance can be predicted by some
empirical rules derived from experimental data:
Fluorine content. The total fluorine content of a fluorous compatible molecule
should be at least above 60%.
S Leneth of fluorous ponytails. Generally, longer fluorous ponytails increase the
fluorophilicity of a molecule, but in contrast decrease the absolute solubility.
S Number of fluorous ponytails. Usually, increasing the number of perfluoro ponytails
results in higher Pi.
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•S The structure. Functional groups which are responsible of intermolecular
interactions have a negative effect on the fluorophilicity and should be limited (e.g.
H-bonding interactions).
Therefore, the design of fluorophilic molecule should also consider the strong electron-
withdrawing properties of the fluoro ponytails. This can be controlled by the insertion of
i 8
"spacci" usually two 01 Linee CH2 groups capable of insulating the reactive centre of the
molecule as shown in figure 5.2.
Figure. 5.2 An example of fluorophilic molecule where the reactive centre is represented
with the solid sphere and is separated from the fluorous ponytail by two methylenes groups.
5.2.1 Fluorous Catalysts
The special physical properties of peifluorinated compounds are ideally suited for catalysis
and it is not surprising that the main field of application for fluorous phase chemistry is in
fluorous biphasic catalysis (FBC). Generally the catalyst is modified with a fluorous tag
such that the catalyst can be removed from the product by washing with a perfluorous
solvent. The reaction can proceed either in a heterogeneous biphasic fashion or under
homogeneous conditions, if the temperature is raised such that the biphasic solvent
becomes homogeneous. However in the latter situation, the phases are separated at the end
of the process by cooling the system again and the products can be recovered free of
catalyst contamination. This avoids purification piocedures such as chromatography 01
distillation. One of the most studied and widely applied methods in FBC has focussed on
the development of monodentate florous phosphines as suitable ligands for various metals.
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In 1994, Horvàth and Ràbai first reported the hydroformylation of 1-octene (213) in 85%
conversion to the corresponding aldehyde (214) catalysed by rhodium complex (215) at














n= 6 or 8
216
Scheme 5.2. Hydroformylation of terminal olefins with an in situ generated fluorous
rhodium catalyst. ((PFMCH) perfluoromethylcyclohexane)
215 has also been employed in hydroboration9 and hydrosylation10'11 and the analogue of
12Wilkinson's catalyst (216) has been also used as catalyst for hydrogenation in fluorous
biphasic systems.
Palladium-catalysed C-C bond forming reactions have been also performed in the fluorous
phase system and these have included the Heck13, Negishi14, Stille15, Suzuki16 and
Sonogashira17 reactions. The fluorous media are especially suitable for oxidation reactions
since the solubility of the oxygen is very high in fluorous solvents.18' 19 For example
Betzemeier et al. have demonstrated that the catalyst generated in situ from the
119
perfluoroalkylbipyridine 217 together with CuBrMe2S (2 mol%) and 2,2,6,6-
tetramethylpiperidine-N-Oxide (TEMPO) (3.5 mol%) in a fluorous biphasic system is
excellent for the aerobic oxidation of alcohol (218) to aldehyde (219).20 The catalyst could




Scheme 5.3. Oxidation of 4-methyl-benzylalcohol with fluorous bipyridine
There are several examples of epoxidation reactions on olefins performed by fluorous
compatible catalysts. The greater challenge has been in developing fluorous compatible
asymmetric epoxidation catalysts. For example, Pozzi et al. have synthesised the optically
active (salen) manganese(III) complexes of (220) (Jacobsen-Katsuki type analogue) in
figure 5.3 which catalyses the aerobic epoxidation of alkenes in presence of various oxygen
donors in FBS21. Surprisingly, many advantages with respect to the classic homogenous
system were observed including an increased stability towards bleaching, and the activity
22
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220
Figure. 5.3. Chiral Mn(III) complex soluble in Fluorous Phase
The same fluorous-salen ligand (220) and closely related analogues were also used by
Maillard et al. in the iridium catalysed asymmetric reduction of ketones, using an
isopropanol/perfluorooctane biphase system. Enantiomeric excesses of up to 60% were
observed.
5.2.2 Fluorous Reagents
Fluorous reagents can be used to separate the by-products or excess reagents from the
products of a reaction. This can be achieved by extraction with an appropriate fluorous
solvent or by filtration over Fluorous Phase Silica Gel (FPSG).
There are examples of fluorocarbon bonded silica gel (fluorous reverse phase silica gel)
that can be used to purify fluorous from organic molecules using this solid-liquid process.
In such cases a reaction mixture is charged on the column. The silica is eluted first with an
organic solvent to remove the organic reagents and then with a fluorophilic solvent to
clearly collect the fluorous reagents as shown in figure 5.4.
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1) Charge reacton mixture 2) eiute organic 3) eiute fiuorcus
























Figure 5.4. Fluorous phase silica gel.
This approach is especially attractive for those reactions which require the use of toxic,
expensive or difficult to remove compounds. The toxicity of trialkyl tin reagents and
selenium compounds is well known. Notably Curran24 and co-workers have developed






Figure 5.5. Perfluorinated analogue of tin hydride
In the presence of AIBN (10%) these catalysts can reduce various functional groups (e.g.
R-Br). The reactions are carried out in the homogeneous phase and at the end the solvent
benzotrifluoride (C6H5CF3) is evaporated. The products are isolated by extraction in a
biphasic mixture (DCM/PFMCH).24 Fluorous tin reagents have been used also in the
allylation of aldehydes. The allyl stannane (222) reacts with the aldehyde in the absence of
solvent to generate allylic alcohols (223). The reaction mixture is purified by extraction of
9 S
the tin treagents with a fluorous solvent or by FPSGC . Cross coupling reactions (e.g.
Stille coupling) have also been performed using fluorous stannanes (224) to yield the
122
before26 (scheme 5.4).














Scheme 5.4. Fluorous tin reagents
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5.3 Recent developments in Fluorous chemistry
Although perfluorocarbon media are believed to play no significant contribution to ozone
depletion they are coming under scrutiny because of their difficulty of disposal. Therefore
there is an increasing requirement to develop alternative reaction methods which reduce the
amount of fluorous media. Recently, several modifications of the classical FBS protocol
have been provided. For example, Gladysz et al. have used FBS catalysis without any
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fluorous medium . They noticed that the same factors that give temperature-dependent
miscibility between fluorous media and organic media can also be valid for a highly solid
fluorous catalyst in organic media. A fluorous catalyst, which normally has a low melting
point, when heated at T near the melting point, forms a homogenous phase with the organic
media allowing homogeneous catalysis (figure 5.6) in the organic medium. At the end of
the process, the mixture is cooled and the catalyst separates again from the organic products













Figure 5.6. Fluorous catalyst recycling based on liquid/solid phase separation
The high affinity of fluorocarbons for gases led to the opportunity of replacing the fluorous
media with supercritical fluids (SCFs). The supercritical state is the state in which the
distinction between gas and liquids disappears and the physical properties of the SCF are
intermediate between those of a liquid and a gas. The critical point represents the highest
pressure (pc) and temperature (Tc) at which the vapour and the liquid of a substance can
exist in equilibrium. The properties of the SCFs such as polarity, viscosity and solubility
properties vary with the temperature and the pressure. In principle, by adjusting the T and P
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of SCF it is possible to change the reaction conditions and selectivity. Another important
feature of SCFs is their total miscibility with gases, a characteristic which makes the SFCs
an ideal medium for reactions as hydrogenation, hydroformylation and oxidation. Among
these are different SCFs, carbon dioxide is the most widely used as it becomes supercritical
(scC02) at Tc=31.1 °C and pc= 73.8 bar allowing reactions to be performed under mild
conditions. scC02 is finding many applications as a solvent in clean synthesis because it is
non toxic and can be completely removed from the reaction just by releasing the pressure
from the reactor. Therefore, ^cC02 is a clean alternative to fluorous media. In fact, Ojima
and coworkers28 have prepared a fluorous BINAPHOS iigand (226) in Figure 5.7 for
rhodium-catalysed asymmetric hydroformylation and the catalysis was performed
successfully in scC02.
R, R'= H or Rf(CH2)n
Figure 5.7. Fluorous catalyst for utilization in supercritical C02
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Part B
5.4 Synthesis and potential application of fluorinated amine reagents
5.4.1 Aims of the project
This aspect of the project was part of a collaboration between members of a EU Research
Training Network (RTN Fluorous Phase) which involves several laboratories throughout
Europe (UK, Italy, Hungary, France and Germany). The aim of the Network was to develop
new reagents and catalysts for reaction in the Fluorous Phase. The aim of the St. Andrews
laboratories was to develop a new class of perfluorinated amines to employ them in
catalytic and stoichiometric reactions performed in the fluorous phase.
The amines synthesised are illustrated in figure 5.8. Initially, the work has focused on the
synthesis of amines such as the morpholine analogue (227) in which the nitrogen atom is
linked to a long perfluorinated ponytail through one CH2 spacer. This reagent exhibits basic
properties and had the potential to be used in reactions in a fluorous phase which require
the use of an organic base. Assuming the successful synthesis of the fluorous amine (227),
it was anticipated that the corresponding N-oxides (228) could also be prepared and used in
a variety of applications. For example, the parent, A-methylmorpholine A-oxide (NMO), is
a strong oxidizing agent and is used in organic synthesis to regenerate osmium tetroxide.
The reaction of an olefin with osmium tetroxide is the most reliable method for cis-
dihydroxylation of a double bond, particularly for preparation of cA-diols on the least
hindered side of the molecule. However, osmium tetroxide is volatile and toxic, resulting in
handling problems and catalytic osmylation to regenerate osmium tetroxide avoids some of
these problems.29'30
The most challenging aspect of the research programme was the synthesis and use of
fluorous chiral amines. Mono branched chiral amines (229, 230) were designed, starting
from commercially available (S)-phenylethylamine, with the intention to apply them in the
fluorous phase. Assuming the successful synthesis of the fluorous amines (229-230), the
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work was aimed at the synthesis of di-branched chiral amines (230-232) with the aim to
convert them to their quaternary ammonium salts, and employ them as chiral phase transfer
catalysts in reactions performed in biphasic fluorous/organic systems. The C2-symmetric




5.4.2 Synthesis of morpholine analogue (227)
The alkylation reaction, shown in scheme 5.5, was attempted in order to prepare the
corresponding fluorous morpholine derivative (227).Amine (227) is designed with two CH2
spacers between the N atom and the perfluorinated chain, to insulate the fluorines from




















Scheme 5.5. Attempted synthesis of fluorous morpholine derivative
It is a classical example of N-alkylation31 in which potassium carbonate is used to
neutralize the hydrogen iodide formed during the reaction. Direct alkylation of morpholine
(235) was attempted, however this proved unsuccessful. This failure is attributed to an
elimination reaction that competes with the required nucleophilic substitution reaction.
Morpholine is a strong base (pKb=5.7) and the elimination reaction is much more favoured
than the N-alkylation. This is also facilitated by the increased acidity of the proton alpha to
the perfluorinated chain. Therefore a different approach to the synthesis of the fluorous
morpholine derivative was taken and shown in scheme 5.6. The commercially available,
pentadecafluoro-octanoyl chloride (237) was reacted with morpholine (235) to generate
first the amide (238) which was subsequently reduced to fluorous morpholine (227).
Generally amide formation is carried out using an excess of acyl chloride and TEA as a
catalyst in DCM. It was decided however to carry out the reaction with an excess of
morpholine (227) but in the absence of triethylamine (TEA). The amide (238) was obtained
in excellent yield and was subsequently reduced using a solution of borane in
tetrahydrofuran (THF) according to Brown's protocol to generate the mono branched




Scheme 5.6. Reagents and conditions, (i) CH2CI2, 2h, 25°C, (96%); (ii) BH3 / THF reflux,
lh (70%).
5.4.3 The synthesis and application of N-oxide derivative (228)
Alkyl and aryl tertiary amines are readily converted to their corresponding stable N-oxides
under a variety of conditions such as treatment with mCPBA. Some supported polymer-
bound amine N-oxides (239, 240) (figure 5.9) have been synthesised and their use in
organometallic cluster chemistry demonstrated 34.
239 240
Figure 5.9. Polymer supported N-oxides
It was decided to use fluorous phase technology to the same effect in place of solid phase
chemistry. For this reason N-oxide N-perfluorinated morpholine was synthesised as shown
in scheme 5.7. Morpholine derivative (227) was stirred at 0 °C for 12 hours with mCPBA.
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This generated the N-oxide derivative as a crystalline material suitable for X-ray structure
analysis.
Scheme 5.7. Reagents and conditions, (i) mCPBA, CH2CI2, 12h, 0°C, (80%).
The resultant structure is shown in figure 5.10. The ring is in the chair conformation with
the N-0 oxygen axial and the long perfluorinated chain lying zig-zag and equatorial.
Figure 5.10. X-Ray structure of N-oxide (228)
The reactivity of the N-oxide (228) was tested in the conversion of primary aliphatic
halides into aldehydes.35"37 The reaction involves nucleophilic displacement of the halide by
N-0 oxygen, followed by a base-induced elimination via cleavage of the heteroatom-













Scheme 5.8. Oxidation of halides into aldehydes employing N-Oxides
The reactions were carried following Chandrasekhar's protocol,37 and cinnamyl bromide
(241) was stirred together with N-oxide (2) in acetonitrile. The formation of cinnamyl
aldehyde (242) was monitored by *H NMR and after 30 h reflux the conversion reached
50%. The low conversion is probably due to the poor solubility of the N-oxide reagent in
the organic solvent. The same reaction was also carried out under fluorous biphase
(hexane:perfluorodecalin), but the reaction was unsuccessful due to the very poor solubility













Scheme 5.9. Reagents and conditions, (i) Acetonitrile, 30h, 50 °C, (50%); (ii)
perfluorodecalin/hexane 30h, 50 °C.
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5.5 Synthesis and application of chiral fluorous amines
The main objective of the fluorous phase RTN project was to develop a new class of chiral
amines soluble in fluorous media and to demonstrate their use as reagents or catalyst for
straightforward organic reactions performed in fluorous phase.
The first chiral amine designed (229) was accessed by reaction of the (S)-alpha
phenylethylamine (243) with the perfluoroalkyl iodide derivative (236). The best yields
(54%) were achieved using an excess of amine (2.5 equivalent) rather then an excess of the





Scheme 5.10. Reagents and conditions, (i). Acetonitrile, K2CO3, 24h, reflux (54%).
Amine (229) was then used as catalyst for the asymmetric epoxidation of olefins. There are
00 -iq
a few examples in the literature ' where chiral oxaziridinium salts catalyse the
asymmetric epoxidation of olefins. For example, trans-stilbene (244) is converted to trans-









yield 99% ee up to 30%
Scheme 5.11. Asymmetric epoxidation of rrans-stilbene with amine (246)
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Scheme 5.12 shows a mechanism for the reaction. The iminium salts which can be formed
in situ is oxidised by oxone to an oxaziridinium species which catalyses the epoxidation of
the olefin
Scheme 5.12. Mechanism of the epoxidation of olefin catalysed by an oxaziridinium
species.
The reaction conditions used previously scheme 5.11 were followed for the chiral amine
(229) but catalysis was not observed even after 36 hours.
We conclude that the nitrogen atom is a poor nucleophile due to the electron withdrawing
property of the perfluorinated chain. Amine (229) carrying one perfluorinated tail, had the
partition ratio of 37:63 (perfluorodecalin/hexane) and therefore was not suitable for
reaction in the fluorous phase. As previously discussed the "fluorophilicity" of a molecule
can be increased by adding extra perfluorinated chains. The original plan to introduce an
extra perfluorinated branch, involved reaction of amine (229) with an excess of (236) as
illustrated in scheme 5.13. However, no reaction was observed after 24 hours reflux in
acetonitrile, suggesting that the lone pair on nitrogen was significantly less nucleophilic due









Scheme 5.13. Reagents and conditions. Acetonitrile, K2CO3, 24h, reflux.
In order to circumvent this problem a different approach to the synthesis of a di-branched
chiral amine was taken and is shown in scheme 5.14. The idea was to react the amine (229)
with a more reactive electrophile, such as the perfluorinated acyl chloride (236), to generate




Scheme 5.14. Reagents and conditions, (i). DCM, TEA, 12h, RT. (97%). (ii). THF, BH3-
THF, 24 h RT (55%).
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Amine (229) was converted in a straightforward manner to tertiary amide (249) by
treatment with acylchloride (236). The reduction of the amide was first attempted with
LiAlH4 but no product was observed and only the starting amine (229) was recovered.
However succesfull reduction was achieved using BH3-THF as the reducing agent. After 24
hours the amine was recovered in 55% yield.
Amine (230) was found to be very "fluorophilic" with a partition ratio of 97:3.This material
is clearly attractive for fluorous phase chemistry. Tertiary amines can be converted to their
quaternary ammonium salts and these are extensively used in organic chemistry as phase
transfer catalysts. Due to the high solubility of 230 in fluorous media the idea was to
convert amine (230) into the corresponding quaternary ammonium salt (250) and this
would be explored as a chiral phase transfer catalyst across the fluorous-organic interface


















Figure 5.11. Chiral Phase transfer catalyst in Fluorous Phase
In the event the reaction of the tertiary amine (230) with HCl-Et20 to form the
hydrochloride salt was unsuccessful. This confirms the poor basicity of this N when
attached to the perfluorinated chains. Therefore the idea to generate the quaternary salt of
(230) was abandoned. A different molecule (232) was then designed. The new target
carried three spacer CH2's between the perfluorinated chains and the nitrogen to insulate
the lone pair from the strong electron withdrawal fluorine atoms. The synthesis, shown in
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scheme 5.15 followed the same protocol seen for the synthesis of 230 with minor




Scheme 5.15 Reagents and conditions, (i). C8Fn(CH2)3I (251), TEBA, Acetonitrile,
K2C03, 24h, reflux (70%). (ii). Rf8CH2CH2COCl (253) DCM, TEA, 12h, RT. (84%). (iii).
THF, BH3-THF, 24 h. RT. (51%)
Perfluoroalkyl iodide 251 was reacted with one molar equivalent of (R)-1-
phenylethylamine (252) in the presence of a catalytic amount of triethylbenzylammonium
chloride (TEBA) and solid K2C03 as a base40. Under these conditions, the enantiomerically
pure primary amine was A-alkylated selectively, affording the chiral secondary amine 231
(yield = 70%) as the only products. HI elimination has little effect on the iodide 251
featuring an extra methylene spacer inserted between the perfluoroalkyl chain and the
iodine atom. Indeed, unreacted 251 could be recovered from the mixture at the end of the
reaction. Amide formation (254) by reaction with acyl chloride (253) followed by BH3
reduction delivered the desired di-branched amine (232). Preliminary results confirmed a
certain reactivity of the N lone pair towards acids. However the reactivity versus
electrophile to generate quaternary ammonium salts has not been explored.
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5.6 Synthesis and application of fluorous chiral diamines
5.6.1 Chiral diamines in asymmetric synthesis.
Chiral C2 symmetrical 1,2-diamines (255) have recently emerged as versatile auxiliaries or
ligands in many asymmetric reactions. The key features of these 1,2 -diamines is their
ability to coordinate metals such as Cu, Ni, Zn to generate metal complexes which are
capable of catalysing numerous organic reactions.41 In particular such chiral 1,2-diamines
have been used as ligands employed in asymmetric olefination, 1,2-nucleophilic addition







Scheme 5.16. Asymmetric olefination.
Several N, N'-dimethyl and P-alkyl bicyclic phosponamides have been prepared and their
reactivity as asymmetric olefination reagents has been evaluated.42"44 For example,
treatment of chiral phosphonamide (256) with KDA at low temperature followed by the
addition of a symmetrical ketone such as 4-fórt-butylcyclohexanone (257) and gave (258)
as a single enantiomer (scheme 5.16).
1,2-Nucleophilic addition reactions to aldehydes and ketones are important and well-
documented method for functionalising organic molecules. An example of the asymmetric
version of this reaction was reported by Kobayashi and co-workers43 using the chiral
diamine (259) by addition of the organozinc (260) reagent as shown in scheme 5.17. The
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resultant Lewis acid, derived from the coordination of the zinc metal to the amino group,
was found to be very efficient in mediating an asymmetric reaction. The strong electron
withdrawing group increases the acidity of the Lewis acid and the reaction gave good yields





Scheme 5.17. Asymmetric 1,2-nucleophilic addition.
54% ee
Enantioselective cyclopropanation has been the focus of much research since the seminal
work of Nozaki46 which represents the first example of the use of chiral metal complexes to
catalyse the conversion of a prochiral substrate into a chiral product with an excess of one
enantiomer. Presently, highly efficient enantioselective cyclopropanation is obtained using
the bisoxazoline copper complex (261)47. In scheme 5.18, styrene (262) is converted to the
cyclopropane in 99% ee in favour of (R) enantiomer (263a) and with a 263/264 ratio of
94:6. Chiral binapthyldiimines48 and bis(ferrocenyll)diamines49 have been also employed in


















Scheme 5.18. Asymmetric cyclopropanation using chiral bisoxazolidines as ligand for
Cu(I).
139
One of the limitations of the complexes discussed above is the difficulty to remove them
from the reaction mixture and to reuse them. However, bisoxazolines and other ligand have
been linked to inorganic and organic supports to allow filtration and thus recovery of the
catalyst. Although the selectivity remains analogous to the "unlinked" system, a drop in
activity has been noticed50. Chiral bisoxazolidines have been also linked to a soluble
support such as PEG. The reaction could be run in a homogeneous phase without loosing
the selectivity and the activity of the catalyst.51
Clearly another immobilisation strategy could be to link the catalyst to perfluoro ponytails
to generate "fluorophilic molecules" soluble in FBS. To this end, fluorous carboxylates
have been used with rhodium as a catalyst for achiral cyclopropanations and the complex
could be recovered by fluorous liquid/liquid extractions.
Fluorous bisoxazoline have been also prepared and employed in asymmetric
52
cyclopropanation reactions however the recycling of the catalyst was unsuccessful .
5.6.2 Synthesis of novel perfluorinated chiral diamines
With perfluorinated amines (229) and (231) in hand the synthesis of C2 symmetry chiral
amines (265) and (266). Proved straightforward. Only two synthetic steps synthesis were
necessary to prepare perfluorinated diamine (233) and (234). As shown in scheme 5.19,
(229) or (231) were converted first into diamides (265 or 266) in a good yield and these
diamides were readily reduced to (233) or (234) by treatment with LiAlH4.
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266 234
Scheme 5.19. Rfg= CF3(CF2)7-. Reagents and conditions, (i). DCM, oxalyl chloride, TEA,
6h 0 °C-RT. (ii). THF (233) or ether (234), LÌAIH4, 12 h. RT.
Due to their poor solubility of (233) and (234). in fluorous solvent (P% 50:50) the catalysis
(scheme 5.20) was performed in DCM using copper acetonitrile hexafluorophospate salt as
metal catalyst.
Preliminary results have shown that the diamines (233 or 234) are encouraging ligands for
asymmetric cyclopropanation. The yield of the conversion is reasonably good (around
60%). However the selectivity and the enantiomeric excess were found to be low. It is
interesting to note the different reaction time for the two ligands. The reaction with (233)
took 24 hours whereas that for (234) took only 90 mins. This may be a result of the
different conformational flexibility of the two systems. Diamine (234) carrying an extra
spacer is more flexible than (233) therefore the reaction maybe much faster for this reason.
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233 or 234 A^COOEt A
pt?' '''coo Et
261 267
IS, 2S IS, 2R










57% 58/42 11% IS, 2S
Scheme 5.20. Asymmetric cyclopropanation of styrene using 233 or 234 as ligand.
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6.1 General experimental procedures
This chapter documents the experimental procedures for Chapters: two, four and five.
All the work was undertaken at the University of St. Andrews except the work
concerning compounds (231, 232, 234, 254 and 266) which was undertaken during two
weeks at the CNR in Milan under the direction of Dr. Gianluca Pozzi as part of the EU
Research training Network.
6.2 Reagents and Solvents
All commercially available materials were purchased from Acros, Avocado, Fluka,
Fluorochem or Sigma-Aldrich unless otherwise stated and purified according to
literature procedures1. The solvents used in reactions were dried, distilled and stored
under nitrogen prior to use: Diethyl ether (sodium, benzophenone), dichloromethane
(calcium hydride), tetrahydrofuran (sodium, benzophenone), pyridine and triethylamine
(potassium hydroxide), perfluorodecalin (phosporous pentoxide, molecular sieves (4A).
Petrol refers to the 40 - 60 °C boiling fraction of petroleum ether and ether refers to
diethyl ether, perfluorodecalin was used as a mixture of cis and trans isomers.
6.3 Reaction conditions
Air- and moisture sensitive reactions were carried out under a positive pressure of
nitrogen/ argon in oven-dried (160°C) glassware. Room temperature (RT) refers to 20-
25°C. Reaction temperatures of -78 °C were obtained using solid CO2 pellets and
acetone and temperatures of 0 °C were obtained in an ice/water bath. Reaction reflux
condition were obtained using an oil bath equipped with a contact thermometer. Solvent
evaporations were carried out under reduced pressure on a Biichi rotary evaporator.
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6.4 Chromatography
Thin layer chromatography (TLC) was performed using Merck, Kieselgel 60 plates and
were visualised by the use of a UV lamp or by the use of cerium (IV) sulfate stain.
Liquid chromatograpy was performed using Merck, Kieselgel 60 (230-400) silica and
preparative TLC was performed using Merck, Kieselgel 60 plates (1000 pm thickness).
Gas chromatography/mass spectroscopy (GC/MS) analysis of synthetic samples was
conducted using an Agilent 5890 plus gas chromatograph equipped with a 5973N mass
selective detector (EI mode) and 7683 series injector/autosampler, . Chromatographic
separations were performed using a HP-5MS 5% Phenyl methyl siloxane capillary
column (30 m x 250 pm with a film thickness of 0.25 pm). Chiral analysis were
performed using a supelco 24304 Beta Dex 120 fused silica (30 m x 250 pm with a film
thickness of 0.30 pm). The carrier gas was helium, with a flow rate of 1.1 ml min."1 the
injection volume was lpl and the injection port temperature was 250 °C.
6.5 Instrumentation
Melting points were measured on a Gallenkamp Griffin MPA350BM2.5, Buchi SMP-
20 (Milan) melting point apparatus and are not corrected. Optical rotations were
determined with a A-1000 polarimeter (optical polarimeter Ltd.) using a 2 dm cell,
Perkin Elmer 241 polarimeter (Milan). Specific rotations are given in units of 10"1
deg.g"1 cm2. High-resolution CI and EI mass spectra were performed on a VG
AUTOSPEC spectrometer, Bruker APEX II ICR-FTMS. Source: nano ESI at 45°
(Milan). Carbon, hydrogen and nitrogen analyses were obtained using a CE Instrument
EA 1110 CHNS analyser, Departmental Service of Microanalysis (University of
Milano). Infrared spectra were recorded with Perkin Elmer 2000 FT-IR instrument as a
thin layer between NaCl disks. Solid materials were prepared with KBr pellets. Values
were rounded to 5 cm"1 upon manual assignment.
Nuclear magnetic resonance (NMR) spectra were measured for CDCI3 solutions on a
Bruker Av-300.06 (7.0T) operating at 299.98 MHz for 'H, 75.45 MHz for 13C and 282.4
for 19F, and Varian Unity Plus 300 MHz operating at 299.98 MHz for ]H, 75.43 MHz
for 13C and Bruker AC 300 spectrometer operating as above stated (Milan). The
assignments of the signals in the 'H NMR spectra are based on the first-order analysis of
the spin systems and when required were confirmed by 'H{'H} decoupling and two-
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dimensional (2-D) ("H, 'H) homonuclear chemical shift correlation (COSY)
experiments. 'H-NMR NOE experiments was conducted in a Varian Unity Plus 500
MHz (!H at 500.08 MHz) spectrometer. All chemical shifts 8 are reported in parts per
million (ppm) and quoted relative to the residual proton and/or fluorine peak CDCI3 (SH
7.24 or 8c 77.0 ppm, for 'H and 13C, respectively), CFCI3 (0.0 ppm) for 19F. Proton-
proton coupling constants (J) are given in Hertz. Spectral coupling patterns are
designated as follows: s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet, br: broad..
6.6 Partition coefficient measurement
The partitioni coefficient is reported as P % and measured according to Gladysz
procedure. In a typical experiment a vial was charged with the compound in exam (0.03
3 3
mmol), perfluorodecalin (0.500 cm ), and hexane (0.500 cm ), capped, vigorously
shaken (2 min), and immersed (cap-level) in a 55 °C bath. After 2 h, the bath was
removed. After 1 h (at RT), 0.010 cm3 aliquots of each layer were added to stock
solutions of 1-hexadecene in hexane (0.0022 M in 2 cm3 hexane) and from this solution,
aliquots of 50 pi were injected in GCMS.
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6.7 Preparation of (S)-N-(l- methyl- 2,2-diphenyl-ethyl)-acetamide (85)
Triethylamine (0.34 cm3, 2.41 mmol) and acetyl chloride (0.13 cm3, 1.77 mmol) were
added drop wise to a solution of amine 83 (0.3 g, 1.61 mmol) in DCM (15 cm3) at 0°C.
The reaction was stirred at RT for 12 h and was then worked up by washing with water
(3 x 20 cm ). The organic layer was dried (MgS04), filtered and evaporated under
reduced pressure. The residue was purified by recrystallisation (petrol: acetone 90:10) to
give amide 85 (0.3 g, 94%) as a white crystalline salt. Mp= 104 - 106 °C. [cc]d20 = -67.2
(c— 0.64, CHC13). HRMS (C17H20NO requires, 254.1551. Found M+l, 254.1545). IR
(Kbr), v : 3445, 3305, 1640, 1545, 700. !H NMR (300 MHz, CDC13), 5 : 1.10 (3H, d, J=
6.4, CHCH3), 1.73 (3H, s, COCH3), 3.80 (1H, d, J= 9.8, Ph2CH), 4.80 (1H, m,
CH3CHNH), 5.18 (IH, d broad, J= 8.3, NH, D20 exchangeable), 7.10-7.22 (10H, m,
aromatics). 13C NMR (75 MHz, CDC13), 5 : 20.4 (s, CHCH3), 23.4 (s, C=0, CH3), 47.5
(s, Ph2CH), 58.1 (s, CHNH), 126.6 (s, aromatic), 128.1 (s, aromatic), 128.2 (s, aromatic),
128.5 (s, aromatic), 128.6 (s, aromatic), 141.7 (s, aromatic), 142.2 (s, aromatic), 168.9 (s,
C=0). MS m/z (rei. int. %), (Cl-isobutane): 254 (M+l, 100), 86 (C4H8NO+, 5).
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6.8 Preparation of (S)-N-(l-benzhydryl-2-methyl-propyl)acetamide (86)
3 3
Triethylamine (0.88 cm , 6.27 mmol.) and acetyl chloride (0.30 cm , 4.60 mmol) were
added dropwise to a solution of amine 84 (1.00 g, 4.18 mmol) in DCM (40 cm3) at 0 °C
and the mixture was then heated under reflux for 4h. The reaction was washed with
■j
water (3 x 30 cm ) and the organic layer was dried (MgS04) and evaporated under
reduced pressure to leave a white amorphous powder. This material was recrystallised
from hexane:EtOAc (85:15) to obtain the title amide 86 as a white crystalline solid (1.10
g, 94%). Mp= 130 - 132 °C. [oc]20D = -35.3 (c=0.56, CHC13). HRMS (C19H24NO requires,
282.1850. Found M+l, 282.1858). IR (Kbr), v : 3405, 2960, 1645, 1555, 1515, 1495,
1450, 755, 705. ]H NMR (300 MHz, CDC13), 5 : 0.99 (3H, d, J= 6.7, CH5CHCH3), 1.10
(3H, d, CH3CHC//3), 1.80 (3H+1H, m, CH3C//CH3 and COCH3), 4.01 (1H, d, J= 10.6,
Ph2C/7), 4.99 (1H, m, (Ph)2CHC77NH), 5.18 (IH, d broad, J= 9.1, NH, D20
exchangeable), 7.20-7.50 (10H, m, aromatics ). I3C NMR (75 MHz, CDCI3), 8 : 15.5 (s,
CH3CHCH3), 21.2 (s, CH3CHCH3), 23.6 (s, COCH3), 29.3 (s, CH3CHCH3), 55.6 (s,
CHNH), 55.7 (s, Ph2CH), 126.8 (s, aromatic), 126.9 (s, aromatic), 128.2 (s, aromatic),
128.5 (s, aromatic), 128.8 (s, aromatic), 129.2 (s, aromatic), 142.7 (s, aromatic), 143.0 (s,
aromatic), 170.4 (s, C=0). MS m/z (rei. int. %), (CI-isobutane): 282 (M+l, 100), 114
(C6H12NO+, 20).
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6.9 Preparation of (S)-N-(l-Benzhydryl-2-methyl-propyl) benzamide (87)
Triethylamine (0.4 cm , 2.19 mmol) and benzoyl chloride (0.2 cm , 1.61 mmol) was
added to a solution of amine 84 (0. 350 g, 1.46 mmol) in DCM (20 cm3) at 0 °C. The
reaction was stirred for 12 h at RT. The reaction mixture was washed with water (3 x 20
cm3) and the organic layer was dried (MgS04), filtered and evaporated under reduced
pressure. The product was recrystillised from ethanohwater (80:20) to obtain the title
amide 87 (0.410 g, 94%) as a white crystalline solid . Mp= 221 - 223 °C. [cc]2°d= -29.5
(c= 0.59, CHCI3). HRMS (C24H26NO requires, 344.2014. Found M+l, 344.2009). IR
(Kbr), v : 3340, 2950, 1635, 1530, 1490, 1450, 700. ]H NMR (300 MHz, CDC13), 8 :
1.00 (3H, d, J= 6.7, C//3CHCH3), 1.10 (3H, d, J= 6.7, CH3CHCH3), 1.95 (1H, m,
CH3C//CH3), 4.20 (1H, d, J= 11.1, Ph2CH), 5.20 (1H, m, (Ph)2CHC//NH), 5.80 (IH, d
broad, J= 10.1, NH, D20 exchangeable), 7.10-7.60 (15H, m, aromatics). 13C NMR (75
MHz, CDCI3), 8 : 15.5 (s, CH3CHCH3), 20.9 (s, CH3CHCH3), 29.3 (s, CH3CHCH3),
55.3 (s, (Ph)2CHCHNH), 55.9 (s, Ph2CH), 126.5 (s, aromatic), 126.6 (s, aromatic),
127.8 (s, aromatic), 128.0 (s, aromatic), 128.3 (s, aromatic), 128.6 (s, aromatic), 130.9
(s, aromatic), 142.3 (s, aromatic), 142.5 (s, aromatic), 168 (s, C-O). MS m/z (rei. int.
%), (CI-isobutane): 344 (M+l, 100), 176 (CnH14NO+, 15), 77 (Ph+, 26).
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6.10 Preparation of (3S, 4S)- l,3-dimethyl-4-phenyl-3,4-dihydroisoquinoline (88)
and (3S, 4R)- l,3-dimethyl-4-phenyl-3,4-dihydroisoquinoline (89)
Phosphoryl chloride (1.35 g, 9.40 mmol) was added dropwise to a suspension of
phosphorous pentoxide (0.86 cm3, 9.40 mmol) in a solution of amide 85 (0.200 g, 0.94
mmol) in anhydrous toluene (25 cm ). After complete addition the reaction mixture was
heated under reflux for 12 h. After cooling, crushed ice (25 cm ) was added. The
organic layer was separated and the aqueous residue was made basic with sodium
hydroxide (15% w/v) solution and the product was then extracted into chloroform (3 x
25 cm3). The chloroform extract was dried (MgS04), evaporated under reduce pressure
and the product purified over silica (1:1 hexane: EtOAc) to give 88 and 89 as a mixture
in 9:1 ratio of yellow oils (0.047 g, 29%). HRMS (Ci7H18N requires, 236.1431. Found
M+l, 236.1444). IR (neat), v : 2965, 2925, 2865, 1630, 1570, 1490, 1450, 1140, 765.
'H NMR (300 MHz, CDC13), 5 : 1.40 (3H, d, J= 6.7, CHCH3), 2.59 (3H, d, J= 1.9,
N=CCH3), 3.80 (1H, d, J= 11.1, PhC/7), 6.90-6.95 (1H, m, aromatic), 7.20-7.50 (7H, m,
aromatics H), 7.60-7.65 (1H, m, aromatic). 13C NMR (75 MHz, CDC13), 8 : 21.8 (s,
CHCH3), 23.4 (s, N=CCH3), 49.5 (s, PhCH), 57.7 (s, CHN); 126.5 (s, aromatic), 125.2
(s, aromatic), 126.8 (s, aromatic), 127.7 (s, aromatic), 128.6 (s, aromatic), 129.0 (s,
aromatic) 140.2 (s, aromatic), 141.9 (s, aromatic), 163.3 (s, C=N). MS m/z (rei. int. %),
(Cl-isobutane): 236 (M+l, 100).
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6.11 Preparation of (3S, 4S)-3-isopropyl-l-methyl-4-phenyl-3,4-dihydro-
isoquinoline (91 ) and (3S, 4R)-isopropyl-l-methyl-4-plienyl-3,4-diliydro-
isoquinoline (92)
Phosphoryl chloride (3.25 cm3, 35.00 mmol) was added dropwise to a suspension of
phosphorous pentoxide (5.00 g, 35.00 mmol) in a solution of amide 86 (1.00 g, 3.54
mmol) in anhydrous toluene (60 cm3). After complete addition the reaction mixture was
heated under reflux for 12 h. After cooling, crushed ice (60 cm3) was added. The
organic layer was separated, the aqueous residue was washed with basic sodium
hydroxide (15% w/v) solution, and the product was then extracted into chloroform (3 x
25 cm ). The chloroform extract was dried (MgSO/O, evaporated under reduce pressure
and the product purified over silica gel (2:1 hexane: EtOAc) to give a mixture of 91 and
92 in 21:1 ratio as a white amorphous solid (0.558 g, 60%). The product was
recrystallised from (95:5 petrol: acetone) to give 91 (94% de). Mp= 65 - 67 °C. HRMS
(Ci9H21N requires, 263.1674. Found M, 263.1666). IR (Kbr), v : 2955, 1625, 1425,
1370, 1295, 770. *H NMR (300 MHz, CDC13), 5 : 1.05 (3H, d, J= 6.7, C//5CHCH3),
1.20 (3H, d, J= 6.7, CH3CHCH3), 1.85 (IH, m , CH3C//CH3), 2.60 (3H, d, J= 1.5,
N=CCH3), 4.00 (1H, dd, J= 8.7, J= 4.8, CHN=C), 4.20 (1H, d, J= 9.7, PhCfl), 6.85-6.90
(1H, m, aromatic), 7.15-7.35 (7H, m, aromatics H), 7.58-7.60 (1H, m, aromatic). 13C
NMR (75 MHz, CDC13), 5 : 17.8 (s, CH3CHCH3), 20.9 (CH3CHCH3), 23.8 (N=CCH3),
30.9 (CH3CHCH3), 45.3 (PhCH), 67.8 (CHN=C), 125.2 (s, aromatic), 126.9 (s,
aromatic), 127.2 (s, aromatic), 128.4 (s, aromatic), 128.9 (s, aromatic), 129.1 (s,
aromatic), 129.5 (s, aromatic), 131.0 (s, aromatic) 140.5 (s, aromatic), 143.2 (s,
aromatic), 162.9 (s, C=N). MS m/z (rei. int. %), (EI): 263 (M, 44), 248 (M- Me+, 100),
220 (Ci6HI4N+, 20).
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6.12 Preparation of (3S, 4S)- 3-isopropyl-l,4-diphenyl-3,4-dihydroisoquinoline (93)
and (3S, 4R) - 3-isopropyl-l,4-diphenyl-3,4-dihydroisoquinoline (94)
Phosphoryl chloride (1.24 g, 8.90 mmol) was added dropwise to a suspension of
phosphorus pentoxide (0.80 cm3, 8.90 mmol) in a solution of amide 87 (0.303 g, 0.88
mmol) in anhydrous toluene (25 cm ). After complete addition the reaction mixture was
heated under reflux for 12 h and was then quenched by the addition of crushed ice (25
cm3). The aqueous residue was made basic by the addition of sodium hydroxide (15%
w/v) solution and the product was then extracted into chloroform (3 x 25 cm3). The
chloroform extract was dried (MgS04), evaporated under reduced pressure and the
product purified over silica (90:10 hexane: ethyl acetate) to give 93 and 94 as a mixture
inl3:l ratio and as white crystalline solid (0.091 g, 32%) which was recrystallised from
(95:5 petrol: acetone) to give 93 in 88 de%. Mp = 119 - 121 °C. HRMS (C24H23N
requires, 326.1908. Found M+l, 326.1915). IR (Kbr), v : 3060, 3025, 2955, 2925, 1610,
1540, 1450, 695. ]H NMR (300 MHz, CDCI3), 5 : 1.06 (3H, d, J= 6.7, CT/3CHCH3), 1.20
(3H, d, J= 6.7, CH3CHCH3), 1.82-1.85 (IH, m, CH3C//CH3), 3.84 (1H, dd, J= 8.7, J=
4.5, PhCHCT/N), 4.00 (1H, d, J= 8.7, PhCH), 6.85 -7.63 (14H, m, aromatic). 13C NMR
(75 MHz, CDCI3), 6 : 17.9 (s, CH3CHCH3), 20.5 (s, CH3CHCH3), 30.2 (s, CH3CHCH3),
44.9 (s, PhCH), 67.9 (PhCHCHN), 126.5 (s, aromatic), 128.1 (s, aromatic), 128.2 (s,
aromatic), 128.3 (s, aromatic), 128.6 (s, aromatic), 128.7 (s, aromatic), 128.9 (s,
aromatic), 128.9 (s, aromatic), 129.1 (s, aromatic), 141.2 (s, aromatic), 142.3 (s,
aromatic), 165.4 (s, C=N). MS m/z (rei. int. %), (Cl-isobutane): 326 (M+l, 100).
154
6.13 Preparation of (N-(2-fluoro-l-methyl-2,2-diphenyl-ethyl)-acetamide (96)
Triethylamine (0.18 cm , 1.32 mmol) and acetyl chloride (0.062 cm , 0.97 mmol) were
added dropwise to a solution of amine 95 (0.200 g, 0.88 mmol) in DCM (15 cm3) at
0°C. The reaction was stirred at RT for 12 h and was then worked up by washing with
water (3 x 20 cm3). The organic layer was dried (MgS04), filtered and evaporated under
reduced pressure. The residue was purified by recrystallisation (petrol: acetone 90:10) to
give the product amide 96 as white crystalline solid (0.230 g, 97%). Mp= 120 - 122 °C.
[a]20D=-+12.37 (c= 0.49, DCM). HRMS (C17H,8FNO requires 271.1372. Found M,
271.1367). IR (Kbr), v : 3290, 1645, 1540. 'H NMR (300 MHz, CDC13), 5 : 1.10 (d, 3H,
J= 6.7, CHC//.0, 1.89 (s, 3H, COCH3), 5.32 (1H, ddq, J= 16.0, J= 9.6, J= 6.7,
(Ph)2CFC//CH3), 6.06 (IH, d broad, J= 9.6, NH, D20 exchangeable), 7.10-7.22 (m,
10H, aromatics). 13C NMR (75 MHz, CDC13), 5 : 15.7 (CHCH3), 23.1 (COCH3), 47.5
(d, J= 20.5, FCCHNH), 100.1 (d, J= 181.9, FCH), 124.1 (s, aromatic), 124.2 (s,
aromatic), 124.8 (s, aromatic), 124.9 (s, aromatic), 127.4 (s, aromatic), 127.6 (s,
aromatic), 128.2 (s, aromatic), 128.3 (s, aromatic), 141. 3 (d, J= 23.0, aromatic), 141.6
(d, J= 23.0, aromatic), 169.1 (s, C=0). 19F NMR (282 MHz, CDC13), 5 : -170.1 (d, J=
16, ). MS m/z (rei. int. %), (EI): 271 (M, 5), 213 (Ci5H14F+, 10), 185 (Ci3Hi0F+, 15),
165 (17), 86 (C4H8NO+, 90), 44 (C2HF+, 100).
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6.14 Preparation of l,3-dimethyl-4-phenyl-isoquinoline (98)
Phosphoryl chloride (0.930 g 6.6 mmol) was added dropwise to a suspension of
phosphorous pentoxide (0.60 cm , 6.6 mmol) in a solution of amide 96 (0.18 g, 0.66
mmol) in anhydrous toluene (15 cm3). After complete addition the reaction mixture was
heated under reflux for 12 h and was then quenched by the addition of crushed ice (25
cm ). The aqueous residue was made basic by the addition of sodium hydroxide (15%
w/v) solution and the product was then extracted into chloroform (3 x 15 cm ). The
chloroform extract was dried (MgS04) and evaporated under reduced pressure to give 98
as a orange crystalline solid (0.090 g, 59%). Mp= 106 - 108 °C. HRMS (C24H23N
requires, 234.1283. Found M+l, 234.1293). !H NMR (300 MHz, CDC13), 5 : 2.57 (3H,
s, Ci/?), 3.12 (3H, s, Ci/?), 7.38-7.61 (8H, m, aromatic), 8.23 (1H, m, aromatic). 13C
NMR (75 MHz, CDC13), 5 : 22.4 (CH3), 23.0 (CH3), 125.3 (s, aromatic), 125.4 (s,
aromatic), 125.5 (s, aromatic), 125.6 (s, aromatic), 127.3 (s, aromatic), 128.5 (s,
aromatic), 129.5 (s, aromatic), 130.2 (s, aromatic), 135.8 (s, aromatic), 137.9 (s,
aromatic), 147.4 (s, aromatic), 156.4 (C=N). MS m/z (rei. int. %), (CI-isobutane): 234
(M+l, 100).
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6.15 Preparation of (IS, 3S, 4S)-l-methyl-3-isopropyl-4-phenyl-l,2,3,4-
tetrahydroisoquinoline (1025) and (IS, 3S, 4R)-l-methyl-3-isopropyl-4-phenyl-
1,2,3,4-tetrahydroisoquinoline (103).
A solution of 91 and 92 (0.350 g, 1.33 mmole) in ether (30 cm3) was added dropwise to
a suspension of LiAlH4 (0.500 g, 13.3 mmole) in ether (10 cm3) at 0 °C and then the
reaction was heated under refluxed for 24 h. The reaction was then quenched with 5%
HC1 solution. The aqueous layer was made basic with 15% NaOH and the products were
extracted into ether (3 x 30 cm3). The organic extract was dried (MgS04) and evaporated
under reduce pressure to give 102 and 103 as colourless oil and in 21:1 ratio (0.242 g,
69%). HRMS (Ci9H24N requires, 266.1908. Found M+l, 266.1901). "H NMR (300
MHz, CDC13), 5 : 0.98 (3H, d, J= 7.1, CH3CHC//3), 1.01 (3H, d, J= 7.1, C//?CHCH3),
1.56 (3H, d, J= 6.6, NHCHCH3), 1.70 (IH, m, (CH3)2CH), 2.97 (1H, t, J= 6.2,
PhCHCT/NH), 4.00 (1H, d, J= 7.1, PhC/7), 4.30 (1H, q, J= 6.6, NHC/7CH3), 6.80-7.30
(9H, m, aromatics). 13C NMR (75 MHz, CDC13), 8 : 16.7 (CH3CHCH3), 20.8
(CH3CHCH3), 23.4 (NHCHCH3), 27.7 (CH3CHCH3), 47.9 (PhCH), 49.4 (NHCHMe),
61.1 (PHCHCHNH), 125.7 (s, aromatic), 128.2 (s, aromatic), 129.0 (s, aromatic), 130.4
(s, aromatic), 137.3 (s, aromatic), 140.7 (s, aromatic), 145.1 (s, aromatic). MS m/z (rei.
int. %), (CI-isobutane): 266 (M+l, 100), 222 (M-iPr+, 22).
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6.16 Preparation of (IS, 3S, 4S)- 3-Isopropyl-l,4-diphenyl-l,2,3,4-
tetrahydroisoquinoline (104) and (1R, 3R, 4S) 3-isopropyl-l,4-diplienyl-l,2,3,4-
tetrahydroisoquinoline (105) and (IS, 3S, 4R) -3-isopropyl-l,4-diphenyl-l,2,3,4-
tetrahydroisoquinoline (106)




A solution of 93 and 94 (0.048 g, 0.147 niniol) in cilici (5 cm ) was added dropwise at
0 ^
0 C to a suspension of LÌAIH4 (0.056 g, 1.47 mmol) in ether (5 cm ) and then the
reaction was heated under reflux for 24 h. The reaction was then quenched with % HC1.
The aqueous layer was made basic with 1% NaOH and the products were extracted into
ether (3x10 cm ). The organic extract was dried (MgSO^) and evaporated under reduce
pressure to give 104 (and 105 and 106) as a colourless oil and in 9:0.7:0.3 ratio. (0.025
g, 52%). HRMS (C24H26N requires, 328.2065. Found M+l, 328.2058). 'H NMR (300
MHz, CDCI3), 6 : 0.80 (3H, d, J= 6.8, C//3CHCH3), 1.01 (3H, d, J= 6.8, C//3CHCH3),
1.67 (IH, m, CH3C//CH3), 2.84 (1H dd, J= 7.9, J= 4.9, PhCHC/TNH), 4.10 (1H, d, J=
7.9, PhC//CHNH), 5.30 (1H, s, NHCT/Ph), 6.90-7.45 (14 H, m, aromatic). 13C NMR
(75 MHz, CDCI3), 8 : 16.3 (CH3CHCH3), 20.6 (CH3CHCH3), 27.7 (CH3CHCH3), 47.9
(PhCHCHNH) , 58.9 (NHCHPh), 61.1 (PhCHCHNH), 125.6 (s, aromatic), 126.7 (s,
aromatic), 126.9 (s, aromatic), 127.5 (s, aromatic), 127.9 (s, aromatic), 128.2 (s,
aromatic), 128.7 (s, aromatic), 129.3 (s, aromatic), 129.8 (s, aromatic), 130.4 (s,
aromatic), 130.8 (s, aromatic), 137.2 (s, aromatic), 139.2 (s, aromatic), 144.9 (s,
aromatic), 145.2 (s, aromatic). MS m/z (rei. int. %), (Cl-isobutane): 328 (M+l, 100).
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6.17 Preparation of (E)-non-3-en-2-ol (191).
Sodium borohydride (2.7 g, 71.4 mmol) was added to a solution of 195 (10 g, 71.4
mmol) and cerium (III) chloride heptahydrate (27 g, 71.4 mmol) in methanol (100 cm )
at 0 °C. The resulting suspension was stirred for 15 min. The reaction was concentrated
by rotary evaporation and diluted with water (100 cm ) and a 1 N HC1 solution (30
cm ). The aqueous phase was extracted into ether (3 x 100 cm ) and the combined
organics were washed with brine (100 cm3), dried over magnesium sulfate, filtered and
concentrated to yield 191 (9.0 g, 89%) as clear oil. This material was used without
further purification. IR (neat), v : 3360, 2960, 2930, 2855, 1465, 1370, 1060, 965. !H
NMR (300 MHz, CDC13), 5 : 0.87 (t, 3H, J= 6.6, CH3CH2), 1.21 (d, 3H, J= 6.4,
CHOHCtfj), 1.24-1.41 (m, 6H), 1.98 (q, 2H, J= 6.6, C//2CH=CH), 4.23 (p, 1H, J= 6.4,
CHOHCH3), 5.42-5.66 (m, 2H, CH=CH). 13C NMR (75 MHz, CDC13), 5 : 13.9 (s,
CH3CH2), 22.4 (s, CH3CH2), 23.3 (s, CHOHCH3), 28.8 (s, CH3CH2CH2), 31.3 (s,
CH2CH2CH=CH), 32.0 (s, CH2CH2CH=CH), 68.9 (s, C//OH), 131.1 (s,
CH=CHCHOH), 134.0 (s, CH=CHCHOH). MS m/z (rei. int. %), (EI): 142 (M, 15), 124
(M- H20, 20), 109 (M- H20-Me 25), 99 (20), 82 (60).
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A solution of 191 (9.4 g, 63.4 mmol) and mCPBA (ca. 70% purity, 15.6 g, 63.4 mmol)
in DCM (70 cm3) was stirred at 0 °C for 2 h. The reaction mixture was then stirred at
0°C with 10% aqueous Na2S03, (50 cm3) and was then washed with sat. NaHC03 (50
cm3) and sat. NaCl (75 cm3), dried over anhydrous MgS04, and concentrated in vacuo
to yield a mixture of 196a and 196b (2:1 ratio) (8.5 g, 85%) as a colourless oil which
was used without further purification.
IR (neat), v : 3450, 2960, 2930, 2860, 1460, 1260, 1150, 1090, 940. "H NMR (300
MHz, CDCI3), 8 : 0.86-0.94 (m, 3H, CH3CH2), 1.25 (d, 3H, J= 6.1, CHOHCH3), 1.28-
1.64 (m, 8H), 2.76 (dd, 1H, J= 3.0, J= 2.5, CHOCHCHOH), 2.96 (m, IH, CHOH), 3.91-
4.01 (m, 1H, CHOCHCHOH). 13C NMR (75 MHz, CDC13), 5 : 13.9 (s, CH3CH2), 19.6
(s, CHOHCH3), 22.5 (s, CH3CH2), 25.5 (s, CH3CH2CH2), 31.5 (s, CH2CH2CHO), 31.5
(s, CH2 ), 55.1 (s, CHOCHCHOH), 62.7 (s, CHOCHCHOH), 64.8 (s, CHOH). MS m/z
(rei. int. %), (EI): 125 (C9Hi7+,2), 83 (60), 71 (20).
IR (neat), v : 3450, 2960, 2930, 2860, 1460, 1260, 1150, 1090, 940. ]H NMR (300
MHz, CDCI3), 8 : 0.86-0.94 (m, 3H, CH3CB.2), 1-25 (d, 3H, J= 6.4, CHOHCH3), 1.28-
1.64 (m, 8H), 2.71 (dd, 1H, J= 5.1, J= 2.3, CHOC//CHOH), 2.90 (td, 1H, J= 5.6, 2.3,
C//OHCH3), 3.60-3.69 (m, IH, OCHCHOH). 13C NMR (75 MHz, CDC13), 8 : 13.9 (s,
CH3CH2), 18.7 (s, CHOHCH3), 22.5 (s, CH3CH2), 25.6 (s, CH3CH2CH2), 31.4 (s,
OCHCH2CH2), 56.8 (s, CHOCHCHOH), 61.7 (s, CHOCHCHOH), 67.7 (s, CHOH).




6.19 Preparation of 4-fluoro-nonane-2,3-diol (190a) and (190b)
A solution of 196a and 196b (7.20 g, 36.0 mmol), in DCM (50 cm3) was treated with
pyridine polyhydrogenfluoride (13 cm3) at -5 °C for 4h. The reaction mixture was
poured into 5% aq. NaHCCF (30 cm3) and the organic layer was washed with sat.
NH4CI (20 cm3), was dried and, was evaporated to yield a mixture of 190a and 190b in
2:1 ratio as a white solid (4.0 g, 62%). The diastereoisomers were separated by column
chromatography (hexane:EtOAc: 3:1) to obtain 190a as white solid (2.1 g , Mp= 60 -
62 °C) and 190b as amorphous solid (0.70 g, Mp= 45 - 47 °C) and a mixture of 190a
and 190b (1.2 g) not resolvable.
(190a).
Anal. Calcd: C, 60.65; 77; 10.74. Found: C; 61.28; 77, 11.15. HRMS (C9H20O2F requires,
179.1447. Found M+l, 179.1449). IR (Kbr), v : 3400, 2925, 2855, 1460, 1380, 1065. 'H
NMR (300 MHz, CDC13), 5: 0.85-0.92 (m, 3H, C77?CH2), 1.26 (d, 3H, J= 6.7,
CHOHCTT?), 1.28-1.77 (m, 8H), 3.31-3.39 (m IH, CHFC770HCHOH), 3.89-3.99 (m,
1H, CHOHC770HCH3), 4.40 (dq, 1H, J= 48.4, J= 5.9, C77F). 13C NMR (75 MHz,
CDCI3), 5 : 14.0 (s, CH3CH2), 19.6 (d, J= 1.1, CH3), 22.5 (s, CH3CH2), 24.6 (s,
CH3CH2CH2), 31.0 (d, J= 20.4, CH2CHF), 31.6 (s, CH2CH2CHF), 66.2 (d, J= 4.4,
CHOHCH3), 75.8 (d, J= 22.7, CHFCHOH), 94.3 (d, J= 169.7, CHF). 19F NMR (282
MHz, CDCI3), 5 : [-192.2] - [-191.6] (m, CUF). MS m/z (rei. int. %), (Cl-isobutane):
179 (M+l, 95), 161 (M+1-H20, 100), 141 (C9H170+, 40), 123 (C9H16+, 18).
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(190b).
Anal. Calcd: C, 60.65; H\ 10.74. Found: C; 61.30; H; 11.13. HRMS (C9H20O2F
requires, 179.1447. Found M+l, 179.1442). IR (Kbr), v : 3340, 2925, 2855, 1460, 1380,
1065. 'H NMR (300 MHz, CDCI3), 6 : 0.83-0.96 (m, 3H, CF,CH2), 1.23 (dd, 3H, J=
6.6, J= 1.0, CHOHCH3), 1.27-1.87 (m, 8H), 3.62-3.73 (m, IH, C//OHCHOHCH3),
3.92-4.03 (m, IH, CHOHC//OHCH3), 4.32-4.57 (dm, 1H, J= 48.4, CHF). 13C NMR (75
MHz, CDCI3), 5 : 13.9 (s, CH3CH2), 17.2 (d, J= 1.7, CHOHCH3), 22.5 (s, CH3CH2),
24.6 (d, J= 2.7, CH3CH2CH2), 31.3 (d, J= 20.5, CH2CHF), 31.6 (s, CH2CH2CHF), 67.9
(d, J= 4.4, CHOHCH3), 75.3 (d, J= 23.7, CHOHCHF), 93.9 (d, J= 168.1, CHF). 19F
NMR (282 MHz, CDC13), 6 : [-194.5] - [-194.0] (m, CHF). MS m/z (rei. int. %), (CI-
isobutane): 179 (M+l, 85), 161 (M+1-H20, 100), 141 (C9H170+, 93), 123 (C9H16+, 45),
114 (C7H140+, 10), 96 (C7H13+, 7), 81(C6H10+, 5).
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6 20 Preparation of toluene-4-sulfonic acid 3-fluoro-2-hydroxy1mcthyl-octyl ester
(197)
To a solution of 190a (0.178 g, 1.00 mmol), pyridine (0.098 cm3, 1.2 mmol), and
DMAP (2.0 mg, 0.02 mmol) in DCM (20 cm3) was added TsCl (0.226 g, 1.1 mmol) at
RT. After being stirred for 24 h at reflux, the reaction mixture was diluted with DCM,
washed with water and brine, dried, and concentrated to dryness. Chromatography of
the residue with hexane-AcOEt (3 : 1) gave (197) (0,232 g, 70%) as a colourless oil.
HRMS (Ci6H2604FS requires, 333.1531. Found M+l, 333.1536. !H NMR (300 MHz,
CDCI3), 8 : 0.80-0.91 (m, 3H, CH3CU2), 1.17-1.88 (m, 8H + 3H), 2.44 (s, 3H, TsCH3),
4.14 (ddt, 1H, J= 48.1, J= 8.7, J= 2.5, CHF), 4.82-4.92 (dm, 1H, CFOTs), 7.30-7.37 (m,
2H, aromatic), 7.77-7.83 (m, 2H, aromatic). 13C NMR (75 MHz, CDC13), 5 : 13.9 (s,
CH3CH2), 17.8 (d, J= 1.1, CHOTsCH3), 21.6 (s, TsCH3), 22.5 (s, CH3CH2), 24.2 (d, J=
2.7, CH3CH2CH2), 31.1 (d, J= 20.4, CH2CHF), 31.4 (s, CH2CH2CHF), 74.7 (d, J= 26.0,
CHOTsCH3), 91.6 (d, J= 173.1, CHF). 19F NMR (282 MHz, CDC13), 5 : [-191.6] - [-
191.0] (m, CHF). MS m/z (rei. int. %), (Cl-isobutane): 333 (M+l, 95), 161 (C9H]8FO+,




6.21 Two step protocol procedure for the preparation of cyclic sulfates (198a) and
(198b)





Pyridine (1.26 cm3, 15.50 mmol) was injected at room temperature to a solution of 190a
(1.80 g, 10.34 mmol) in DCM (50 cm3). After the mixture was stirred and chilled at 0
°C, SOCI2 (0.91 cm3, 12.40 mmol) was added. The reaction was stirred at 0 °C for 30
min and then sat. Q1SO4 (50 cm ) was added. The organic layer dried with MgSCE,
concentrated on a rotary evaporator and used in the subsequent oxidation without
isolation.
Cyclic Sulfate.
NaI04 (5.53 g, 25.85 mmol) was added to a solution of the crude cyclic sulfite in MeCN
(20 cm ) followed by the addition of a catalytic amount of R.UCI3-3H2O (1 mol%) and
H20 (18 cm3). The heterogeneous mixture was stirred vigorously at 0 °C until full
consumption of the starting material (30 min). Ether (20 cm3) was then added and the
organic layer was separated, washed with NaHCCE 5% solution, dried, filtered through
a pad of silica gel and concentrated under reduced pressure. The residue was purified
over silica gel (elution with hexane:EtOAc 6:1) to obtain 198a (1.95 g, 78%) as
colourless oil.
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HRMS (C9Hi804FS requires, 241.0909. Found M+l, 241.090). IR (neat), v : 2960,
2860, 1460, 1390, 1210. 'H NMR (300 MHz, CDC13), 5 : 0.87-1.00 (m, 3H, CH3CH2),
1.29-1.63 (m, 6H), 1.66 (dd, 3H J= 6.4, J= 1.02, SOCHCH?), 1.69-1.89 (m, 2H) 4.34 (q,
1H, J= 7.1, CHFC//OS), 4.71 (dm, IH, CHF), 5.01 (p, 1H, J= 7.1, C//OSCH3). 13C
NMR (75 MHz, CDC13), § : 13.9 (s, CH3CH2), 18.9 (d, J= 1.6, CH3), 22.4 (s, CH3CH2),
24.0 (d, J= 2.7, CH3CH2CH2), 31.2 (s, CH2CH2CHF), 31.6 (d, J= 19.9, CH2CHF), 81.1
(s, SOCHCH3), 85.4 (d, J= 30.4, CHFCHOS), 91.21 (d, J= 174.1, CHF). 19F NMR (275
MHz, CDCI3), 5 : [-196.0] - [-195.5] (m, CHF). MS m/z (rei. int. %), (Cl-isobutane):
241 (M+l, 100), 143 (C9Hi6F+, 7), 123 (C9HI5+, 32).
6.21.2 Preparation of4-(1 -fluoro-hexyl)-5-methyl-[1,3,2]dioxathiolane 2,2-dioxide
(198b).
In a similar manner to the method described above, cyclic sulfate (198b) was prepared
as colourless oil (0.80 g, 3.3 mmol, 85%) starting from 190b (0.70 g, 3.93 mmol).
HRMS (C9Hi804FS requires, 241.0894. Found M+l, 241.0901). IR (neat), v : 2960,
2865, 1460, 1390, 1215. *H NMR (300 MHz, CDC13), 5 : 0.87-0.96 (m, 3H, CH3CH2),
1.29-1.60 (m, 6H), 1.64 (dd, 3H, J= 6.6, J= 2.5, OSCHCF3), 1.69-1.89 (m, 2H) 4.66-
4.91 (m 2H, CHFC//OS and CHF), 5.21 (dq, 1H, J= 6.6, J= 5.6, SOCHCH3). 13C NMR
(75 MHz, CDCI3), 6 : 13.9 (s, CH3CH2), 14.4 (d, J= 3.8, SOCHCH3), 22.4 (s, CH3CH2),
23.6 (d, J= 2.7, CH3CH2CH2), 31.3 (s, CH2CH2CHF), 31.9 (d, J= 20.5, CH2CHF), 81.6
(s, SOCHCH3), 82.1 (d, J= 5.5, CHFCHOS), 88.5 (d, J= 170.3, CHF). 19F NMR (282
MHz, CDCI3), 5 : [-194.9] - [-194.4] (m, CHF). MS m/z (rei. int. %), (Cl-isobutane):
241 (M+l, 100), 143 (C9Hi6F+, 7), 123 (C9H15+, 32).
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To a solution of 198a (1.80 g, 10.11 mmol) in dry acetone (30 cm3) was added 1 M
TBAF solution in THF (14.8 cm3, 14.8 mmol). The reaction mixture was stirred at 0° C
until 198a was fully consumed (TLC, hexane/EtOAc 4:1, 40 min). Most of the acetone
was removed on a rotary evaporator, and the residue was dried by high vacuum for 6-10
min (0.8 Torr). Ether (20 cm3) and 20% aqueous H2S04 (20 cm3) were added, and the
heterogeneous mixture was stirred vigorously at ambient temperature until hydrolysis
was complete (48 h). The two phases were separated and the organic layer was washed
with sat. NaHC03 (25 cm3), evaporated, dried and the residue was purified over silica
gel (7:1 hexane/ethyl acetate) to yield 199a as a colourless oil (0.70 g, 52%). HRMS
(C9H19OF2 requires, 181.1404. Found M+l, 181.1411). IR (neat), v : 3440, 2960, 2865,
1460, 1395, 1060, 995. 'H NMR (300 MHz, CDCI3), 5 : 0.84-0.98 (m, 3H, CH3CR2),
1.27-1.34 (m, 6H), 1.41 (ddd, 3H, J= 25.3, J= 6.4, J= 0.8, CHFC//3), 1.50-1.82 (m, 2H),
3.83-3.96 (m IH, CHFCHOH), 4.47 (dm, 1H, CH2C77F, J= 47.4), 4.77 (dm, 1H, J=
46.6, C//FCH3). 13C NMR (75 MHz, CDC13), 5 : 14.0 (s, CH3CH2), 15.4 (dd, J= 22.7,
J= 1.6, CHFCH3), 22.5 (s, CH3CH2), 24.6 (d, J=3.3, CH3CH2CH2), 30.6 (dd, J= 20.4, J=
1.1, CH2CH2CHF), 31.6 (s, CH2CH2CHF), 73.9 (dd, J= 23.7, J= 22.6,
CHFCHOHCHF), 90.1 (dd, J= 164.4, J= 5.5, CH2CHF), 93.24 (dd, J= 168.1, J= 6.1,
CHFCH3). 19F NMR (282 MHz, CDC13), 5 : [-195.6] - [-195.2] (m, CH2CHF), [-185.7]
- [-185.2] (m, CHFCH3). MS m/z (rei. int. %), (Cl-isobutane): 181 (M+l, 5), 161 (M+l
- HF, 90), 141 (M+l - 2HF, 20), 123 (CgH^lOO).
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6.23 Preparation of 2,4-difluoro-nonan-3-ol (199b).
In a similar manner to the method described above (199b) was prepared as colourless
oil (0.250 g, 45%) from 198b (0.750 g, 3.12 mmol). HRMS (C9H20OF2 requires,
181.1404. Found M+l, 181.1402). IR (neat), v : 3405, 2960, 2865, 1460, 1380, 1060,
1000. 'H NMR (300 MHz, CDCI3), 6 : 0.85-0.93 (m, 3H, CH3CU2), 1.21-1.37 (m, 6H),
1.41 (ddd, 3H, J= 24.8, J= 6.6, J= 0.7, CHFC//3), 1.50-1.82 (m, 2H), 3.83-3.96 (m, 1H,
C//OH), 4.45 (dm, 1H, J= 47.9, CH2C//F), 4.90 (dm, 1H, J= 47.4, C//FCH3). 13C NMR
(75 MHz, CDCI3), 5 : 14.0 (s, CH3CH2), 17.1 (dd, J= 22.6, J= 1.1, CHFCH3), 22.5 (s,
CH3CH2), 24.4 (d, J= 2.7, CH3CH2CH2), 31.4 (dd, J= 20.4, J= 3.3, CH2CH2CHF), 31.6
(s, CH2CH2CHF), 73.9 (dd, J= 23.6, J= 22.8, CHFCHOHCHF), 88.9 (dd, J= 167.5, J=
□ □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□' □' □
'
□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□"□□
□ □□□□□□□□□□□□□□□JL □Jb □□□□□□□□□□□□□□□□□□□□□□□□□ □
□ □□/□JbnJLDDDn □□□□□□□□□□□□□□□□□□□□□□□£□□□ □CDDmDD
□ □□JLDJLD15), 123 (C9H15+, 30).
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Pyridine (0.22 cm3, 2.67 mmol) was added to a solution of 199a (0.3 g, 1.78 mmol) in
dry DCM (15 cm3) at ambient temperature. The solution then was cooled to -40° C and
triflic anidride (0.31 cm , 1.86 mmol) was added over a period of 5 min. The resulting
dark orange solution was stirred for 1 h at - 40 °C and then allowed to warm to ambient
temperature. Hexane (10 cm3) was added and the solution filtered. The filtrate obtained
was evaporated, dried and the residue passed over a silica gel pad (eluent 10:1,
hexane/ethyl acetate) to afford 200a (0.41 g, 74%) as a clear oil. HRMS (C9H17F2
requires, 163.1298. Found [M-SO3CF3+I] 163.1295); (C9Hi6F requires, 143.1236.
Found [M-SO3CF3-HF+I], 143.1230); (C9H,5 requires, 123.1173. Found [M-SO3CF3-
2HF+1], 123.1168). IR (neat), v : 2960, 2870, 1415, 1465, 1245, 1210, 1145, 950, 920.
*H NMR (300 MHz, CDC13), 5 : 0.82-0.96 (m, 3H, CH3CH2), 1.24-1.43 (m, 6H), 1.49
(ddd, 3H, J= 23.6, J= 6.4, J= 1.0, CHFC//3), 1.57-1.85 (m, 2H), 4.61-4.68 (m 1H,
CHFCHOTf), 4.76-5.09 (m, 2H,CT/FCHOTfCHF). 13C NMR (75 MHz, CDC13), 5 :
14.3 (s, CH3CH2), 16.4 (dd, J= 22.6, J= 2.8, CHFCH3), 22.7 (s, CH3CH2), 24.9 (d, J=
3.3 CH2CH2CH3), 30.8 (dd, = 21.0, J= 1.7, CH2CH2CHF), 31.6 (s, CH2CH2CHF), 87.3
(dd, J= 173.6, J= 5.5, CH2CHF) 87.35 (t, J= 23.8, CHFCHOTfCHF), 91.3 (dd, J= 176.9,
J= 6.1, CHFCHOTfCHF), 118.9 (q, J= 318.9, CF3). 19F NMR (282 MHz, CDC13), § : [-
193.3] - [-193.2] (m, CH2CHF), [-182.4] - [-182.3] (m, CHFCH3), -74.5 (dd, J= 4.8, J=
3.3, CF3). MS m/z (rei. int. %), (CI-isobutane): 163 (M+l-OTf, 10), 143 (C9Hi6F+, 30),
123 (C9H15+, 100).
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6.25 Preparation of trifluoro-methanesulfonic acid 2-fluoro-l-(l-fluoro-ethyl)-
heptyl ester (200b).
In a similar manner to the method described above, (200b) was prepared as colourless
oil (0.18 g, 70%) from 199b (0.60 g, 0.83 mmol). HRMS (C9H15 requires, 123.1173.
Found [M-S03CF3-2HF+1], 123.1167). IR (neat), v : 2960, 2865, 1465, 1415, 1245,
1215, 1145, 950, 920.'id NMR (300 MHz, CDC13), 5 : 0.87-0.99 (m, 3H, CH3CH2),
1.26-1.41 (m, 6H), 1.48 (dd, 3H, J= 24.2, J= 6.3, CHFC//3), 1.54-1.94 (m, 2H), 4.60-
4.68 (m 1H, CHFCT/OTfCHF), 4.76-5.06 (m, 2H, C//FCHOTfC/7F). 13C NMR (75
MHz, CDCI3), 5 : 13.9 (s, CH3CH2), 17.1 (d, J= 23.0, CHFCH3), 22.4 (s, CH3CH2), 24.9
(d, J= 3.3, CH3CH2CH2), 30.0 (d, = 20.7, CH2CH2CHF), 31.2 (s, CH2CH2CHF), 87.3
(dd, J= 177.2, J= 6.9, CH2CHF) 88.5 (dd, J= 23.0, J= 18.2, CHFCHOTfCHF), 90.4 (dd,
J= 170.3, J= 4.6, CHFCHOTFCHF), 114.3 (q, J= 319.1, CF3). 19F NMR (282 MHz,
CDCI3), 8 : [-189.1] - [-188.2] (m, CHFCH2), [-185.5] - [-184.6] (m, CHFCH3), -74.5
(dd, J= 4.83, J= 3.7, CF3). MS m/z (rei. int. %), (Cl-isobutane): 123 (C9H15+, 35), 80
(C6H8,+100)
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A solution of 1M TBAF in THF (1.2 cm3, 1.2 mmol) was added to a solution of the
triflate 200a (0.30 g, 0.96 mmol) in dry acetone (10 cm3). The reaction mixture was
stirred at 0 °C until the triflate was consumed (TLC, hexane/Ether 9:1, 10 min). The
O -3
residue was washed with water (10 cm ) and extracted into hexane (2 x 10 cm ). The
organic layer was evaporated, dried and the residue purified by preparative TLC
(elution with hexane/Ether 9:1) to obtain 186 (0.050 g, 28%) as a clear oil. HRMS
(C9H18F3 requires, 183.1361. Found M+l, 183.1356). 'H NMR (300 MHz, CDC13), 5 :
0.87-0.97 (m, 3H, CH3CH2), 1.23-1.37 (m, 6H), 1.44 (ddt, 3H, J= 24.1, J= 6.4, J= 0.8,
CHFC//3), 1.50-1.98 (m, 2H), 4.18-5.03 (m, 3H, CHFCHFCHF). 13C NMR (75 MHz,
CDC13), 8 : 13.9 (s, CH3CH2), 16.3 (dd, J= 23.0, J= 6.9, CHFCH3), 22.4 (d, J= 6.1,
CH3CH2), 24.4 (d, J= 4.6, CH3CH2CH2), 30.1 (dd, = 20.7, J= 4.0, CH2CH2CHF), 31.5
(s, CH2CH2CHF), 88.2-95.4 (m, CHFCHFCHF). 19F NMR (275 MHz, CDC13), 8 : [-
207.4] - [-206.9] (m, CHF-CHFCHF), [-199.4] - [-198.7] (m, CH2CHF), [-189.4] - [-
188.7] (m, CHFCH3). 19F NMR {'HI (282 MHz, CDC13), 8 : -207.1 (dd, J= 12.9, J=
11.2, CHFCHFCHF), -198.9 (d, J= 11.2, CH2CH/0 -189.1 (d, J= 12.9, CHFCH3). MS
m/z (rei. int. %), (Cl-isobutane): 183 (M+l, 5), 143 (M+1-2HF, 100), 123 (M+l -3HF,
20).
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6.27 Preparation of2,3,4-trifluoro-nonane (187).
A solution of 1M TBAF in THF (1.2 cm3, 1.2 mmol) was added to a solution of the
tri fiate 200b (0.150 g, 0.48 mmol) in dry acetone (5 cm3). The reaction mixture was
stirred at 0 °C until the triflate was consumed (TLC, hexane/Ether 9:1, 10 min). The
3 3
residue was washed with water (5 cm ) and extracted into hexane (2x5 cm ). The
organic layers were evaporated, dried and the residue purified by preparative TLC
(elution with hexane/Ether 9:1) to obtain 187 (0.021 g, 0.115 mmol, 24%) as colourless
oil. 'H NMR (300 MHz, CDC13), 8 : 0.81-0.96 (m, 3H, CH3CU2\ 1.22-1.41 (m, 6H),
1.48 (dddd, 3H, J= 25.4, J= 6.1, J= 2.3, J= 0.5, CHFCH3), 1.54-1.99 (m, 2H), 4.29 (dtdd
3H, J= 45.8, J= 26.4, J= 7.4, J= 1.8, C/7FCH3), 4.50-4.73 (m, IH, C/7FCHFCHF), 4.86
(dm, 1H, J= 48.1, CHFCFFCHF).,3C NMR (75 MHz, CDC13), 8 : 13.9 (s, CH3CH2),
17.1 (dd, J= 20.7, J= 2.1, CHFCH3), 22.4 (s, CH3CH2), 24.6 (d, J= 5.1, CH2CH2CH3),
27.8 (dd, = 21.7, J= 5.1, CH2CH2CHF), 32.5 (s, CH2CH2CHF), 86.4 (ddd J= 173.1,
29.3, 5.3, CHFCHFCHF), 90.1 (ddd J= 181.1, 29.3, 18.0, CHFCHFCHF), 92.9 (ddd J=
180.0, J= 18.4, J= 3.3, CHFCHFCHF). 19F NMR (282 MHz, CDC13), 8 : [-213.5] - [-
213.1] (m, CHFCHFCHF), [-201.2] - [-200.7] (m, CH2CHF), [-185.8] - [-185.2] (m,
CHFCH3). 19F NMR {'H] (282 MHz, CDC13), 8: 213.3 (dd, J= 14.4, J= 9.3,
CHFCHFCHF), -201.0 (dd, J= 9.3, J= 3.4, CH2CHF), -185.5 (dd, J= 14.4, J= 3.4,
CHFCH3). MS m/z (rei. int. %), (EI): 134 (2), 113 (5).
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6.28 Sharpless epoxidation of (E)-3-nonen-2-ol.
1.1.1 Preparation of (lS)-l-[(2S,3S)-3-pentyloxiranyl]ethanol (196b) and E-
(2R,)-3-nonen-2-ol (191)
Molecular sieves (4 À), DCM (30 cm3), 191 (1.10 g, 7.8 mmoles) and (L)-(+)-
diisopropyl tartrate (0.258 g, 1.11 mmoles), were mixed under nitrogen and the mixture
cooled at -23 °C. Ti(O'Pr) (0.218 g, 0.78 mmoles) was then added via syringe and the
mixture stirred at -23 °C for 30 min, before 'BuOOH (1.0 cm3 of an approximately 5-6
o
M solution in isooctane, pre-dried for 12 h over molecular sieves 4 A) was slowly
added. After 2 h the reaction was quenched by adding a solution obtained by dissolving
FeS04*7H20 (3.0 g) and citric acid (1.0 g) in 10 cm of water. The organic layer was
recovered and the aqueous solution extracted into DCM (2 x 30 cm3). The combined
organic phases were dried and evaporated. A pre-prepared aqueous solution (0.5 g of
NaCl, 3.3 g of NaOH, in 10 cm3 of H20) was then added to the organic residue whereby
an emulsion formed. After the emulsion (approx. 30 min) had disappeared the mixture
was worked up as described above. After evaporation of the solvent, column
chromatography (hexane:EtOAc 2:1) gave 191 (0.300 g [cc]d20= +9.203, c = 0.555,
DCM) and 196b (0.500 g, 40.5%, [a]D20= -6.87, c = 0.495, DCM, 90% de and 80% ee).
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In a similar manner to the method described in section 6.19, (190b) was prepared as
colourless oil (0.226 g, 55%, [a]D20= +19.17, c= 0.135, DCM) from 196b (0.400 g, 2.53
mmol).
6.30 Preparation of (4R,5R)-4-[(lS)-l-fluorohexyl]-5-metliyl-l,3,2-dioxathiolane
2,2-dioxide (198b)
In a similar manner to the method described in section 6.21, (198b) was prepared as
colourless oil (0.230, 87%, [a]D20= +15.27 c= 0.14 in DCM) from 190b (0.20 g, 1.10
mmol), to afford 198b (0.230, 87%).
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6.31 Preparation of (2S,3R,4S)-2,4-difluoro-3-nonanol (199b)
OH
199b
In a similar manner to the method described in section 6.22, (199b) was prepared as a
white crystalline solid (0.050 g, 66%, Mp = 41 - 43 °C , [a]D20= +11.99, c= 0.18, DCM)
from 198b (0.10 g, 0.42 mmol).
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6.32 Preparation of 6-phenyl-hexanal (204)
A solution of alcohol 202 (4.1 g, 23.00 mmol) in DCM (20 cm3) was added to a
suspension of PCC (7.4 g, 34.50 mmol) in dry DCM (50 cm3) in one portion and the
mixture was stirred at RT for 2 hours. Dry ether (25 cm3) was then added and the
residue passed through a short pad of silica gel. The organic phase was evaporated to
obtain 204 as a yellow oil (3.5 g, 86%). This material was used without further
purification. IR (neat), v : 2930, 2855, 1725, 1495, 1450, 745, 690. ]H NMR (300
MHz, CDC13), 8 : 1.30-1.44 (m, 2H), 1.58-1.75 (m, 2H, CH2\ 2.43 (dt, 2H, J= 7.2, J=
1.8, CH2C=O), 2.62 (t, 2H, J= 7.7, C/MPh), 7.14-7.32 (m, 5H, aromatics), 9.76 (d, 1H,
J= 1.8, CHO). 13C NMR (75 MHz, CDCI3), 5 : 21.9 (s, CH2), 28.7 (s, CH2), 31.2 (s,
CH2), 35.7 (s, CH2C=0), 43.8 (s, PhCH2), 125.7 (s, aromatic), 128.3 (s, aromatic),
128.4 (s, aromatic), 142.4 (s, aromatic), 202.8 (C=0). MS m/z (rei. int. %), (EI): 176
(M, 10), 130 (CiiH,4+, 20), 91 (PhCH2+,100).
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A solution of n-BuLi (2.5M in hexane, 6.8 cm , 17.0 mmol) was added to a THF (30
cm3) solution of alkyne 203 ( 2.1 g, 17.0 mmol) at -78°C, and the mixture was stirred
for 30 min. A solution of 202 (3.0 g, 17.0 mmol) in THF (30 cm3) was then added, and
the reaction mixture was warmed to 0 °C and stirred for 2 hr. A sat. NH4CI (25 cm3)
was then added and the mixture was extracted into ether (2 x 50 cm"). The organic layer
was dried over MgS04, evaporated and the organic residue purified over silica gel
(hexane:EtOAc, 6:1) to afford 205 as colourless oil (4. g, 82%). HRMS (C21H33O
requires, 301.2524. Found M+l, 301.2524). IR (neat), v : 3336, 2931, 2854, 1496,
1454, 1086, 1029, 745, 698. !H NMR (300 MHz, CDC13), 8 : 0.67-0.87 (m, 3H, CH3),
1.10-1.74 (m, 18H), 2.07 (dt, 2H, J= 6.9, J= 2.0, C//2CH2OH), 2.48 (t, 2H, J= 7.6,
CH2Ph), 4.16-4.26 (m, IH, CHOH) 7.00-7.19 (m, 5H, aromatics). ,3C NMR (75 MHz,
CDCI3), 8 : 14.1 (s, CH3), 18.6 (s, CH2CHOH), 22.6 (s, CH2), 25.0 (s, CH2), 28.6 (s,
CH2), 28.8 (s, CH2), 28.8 (s, CH2), 28.9 (s, CH2), 31.4 (s, CH2), 35.8 (s, CH2Ph), 38.1
(s, CH2C=C), 62.8 (s, CHOH), 81.2 (s, C=CCHOH), 85.5 (s, C^CCHOH), 125.7 (s,
aromatic), 128.2 (s, aromatic), 128.4 (s, aromatic), 142.7 (s, aromatic). MS m/z (rei. int.
%), (Cl-isobutane): 301 (M+l, 5), 283 (M+1-H20, 100), 193 (Ci4H25,+25).
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A solution of alkyne 205 (3.0 g, 10.0 mmol) in THF (20 cm ) was added to a suspension
of LiAlH4 (0.76 g, 20 mmol) in THF (30 cm3) at 0 °C. The reaction mixture was then
stirred under reflux for 12 hours, and the excess of LÌAIH4 was quenched by dropwise
addition of water (1 cm3). The mixture was filtered and the white precipitate washed
with ether. The combined organic filtrates were dried over MgS04 and evaporated to
afford 201 as colourless oil (2.7 g, 89%). This material was used without further
purification. HRMS (C21H35O requires, 303.2680. Found M+l, 303.2688). IR (neat), v :
3360, 2930, 2850, 1495, 1455, 1020, 970, 910, 730, 695. 'H NMR (300 MHz, CDC13),
5 : 0.79-0.95 (m, 3H, CH3), 1.18-1.75 (m, 18H), 2.01 (q, 2H, J= 6.6, C//2CHOH), 2.60
(t, 2H, J= 7.4, C/HPh), 4.02 (q, 1H, J= 6.4, CHOH), 5.43 (ddt, 1H, J= 15.3, J= 6.9, J=
1.2, C=CHCHOH), 5.62 (dt, 1H, J= 15.3, J= 6.6, C//=CHCHOH), 7.19-7.33 (m, 5H,
aromatics). i3C NMR (75 MHz, CDC13), 8 : 14.1 (s, CH3), 22.7 (s, CH2), 25.3 (s, CH2),
29.0 (s, CH2), 29.1 (s, CH2), 29.1 (s, CH2), 31.4 (s, CH2), 31.8 (s, CH2), 32.1 (s, CH2),
35.8 (s, CH2Ph), 37.1 (s, CH2C=C), 73.1 (s, CHOH), 125.5 (s, aromatic), 128.1 (s,
aromatic), 128.3 (s, aromatic), 132.2 (s, C=C), 132.8 (s, C=C), 142.7 (s, aromatic). MS
m/z (rei. int. %), (Cl-isobutane): 303 (M+l, 2), 285 (M+1-H20, 20), 203 (C14Hi90+,
20), 189 (C13H170+, 70) 175 (20).
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6.35 Preparation of l-(3-heptyl-oxiranyl)-6-phenyl-hexan-l-ol (206a) and (206b)
A solution of 201(1.85 g, 6.12 mmol) and mCPBA (ca. 70% purity, 1.51 g, 6.12 mmol)
in DCM (40 cm3) was stirred at 0 °C for 3 h. The reaction mixture was then stirred at 0
°C with 10% aqueous Na2S03, (40 cm3) and was then washed with sat. NaHCC>3 (40
-5 -2
cm ) and sat. NaCl (50 cm ), dried over anhydrous MgSC>4, and concentrated in vacuo
to yield a mixture 206a and 206b in 2:1 ratio (1.5 g, 77%) which was purified by
column chromatography (hexane:EtOAc 4:1) to yield 206a (0.80 g), 206b (0.4 g) as a
colourless oil and a mixture of 206a and 206b (0.2 g) .
(206a)
HRMS (C21H35O2 requires, 319.2637. Found M+l, 319.2646). IR (neat), v : 3430, 2930,
2860, 1490, 1455, 1040. 'H NMR (300 MHz, CDC13), 5 : 0.82-0.92 (m, 3H, CH3), 1.18-
1.73 (m, 20H), 2.61 (t, 2H, J= 7.7, CH2Ph), 2.71 (dd, 1H, J= 5.3, J= 2.3, OC//CHOH),
2.89 (td, 1H, J= 5.3, J= 2.6, CH2CHOCH), 3.35-3.48 (m, IH, CHOH), 7.14-7.21 (m,
3H, aromatics), 7.15-7.31 (m, 2H, aromatics). 13C NMR (75 MHz, CDC13), 5 : 14.0 (s,
CH3), 22.6 (s, CH2), 25.1 (s, CH2), 25.9 (s, CH2), 29.2 (s, CH2), 29.2 (s, CH2), 29.3 (s,
CH2), 31.3 (s, CH2), 31.6 (s, CH2), 31.7 (s, CH2), 34.2 (s, CH2Ph), 35.8 (s,
CH2CHOCH), 57.0 (s, CHOCHCHOH), 61.8 (s, CHOCHCHOH), 71.3 (s, CHOH),
125.6 (s, aromatic), 128.2 (s, aromatic), 128.4 (s, aromatic), 142.6 (s, aromatic). MS m/z




HRMS (C21H35O2 requires, 319.2637. Found M+l, 319.2651). IR (neat), v : 3340, 2930,
2855, 1495, 1455, 1015. *H NMR (300 MHz, CDC13), 5 : 0.85-0.95 (m, 3H, CH3), 1.21-
1.72 (m, 20H), 2.61 (t, 2H, J= 7.4, CH2Ph), 2.75 (dd, 1H, J= 2.6, J= 2.3,
CHOC//CHOH), 2.99 (td, 1H, J= 5.3, J= 2.3, CH2C//OCH), 3.75-3.48 (m, IH, CHOH),
7.14-7.21 (m, 3H, aromatics), 7.24-7.31 (m, 2H, aromatics). 13C NMR (75 MHz,
CDCI3), 5 : 14.1 (s, CH3), 22.5 (s, CH2), 25.1 (s, CH2), 26.0 (s, CH2), 29.1 (s, CH2), 29.2
(s, CH2), 29.3 (s, CH2), 31.3 (s, CH2), 31.6 (s, CH2), 31.7 (s, CH2), 33.4 (s, CH2Ph),
35.8 (s, CH2CHOCH), 54.8 (s, CHOCHCHOH), 60.9 (s, CHOCHCHOH), 68.4 (s,
CHOH), 125.6 (s, aromatic), 128.2 (s, aromatic), 128.3 (s, aromatic), 142.6 (s,
aromatic). MS m/z (rei. int. %), (Cl-isobutane): 301 (M+1-H20 ,100), 283 (M+l-
2H20, 25), 207 (5), 175 (10).
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6.36 Preparation of 8-fluoro-l-phenyl-pentadecane-6,7-diol (207a)
A solution of 206a (0.6 g, 3.12 mmol), in DCM (20 cm3) was treated with pyridine
polyhydrogenfluoride (4 cm3) at -5 °C for 4h. The reaction mixture was poured into 5%
aq. NaHC03 (20 cm3) and the organic layer was washed with sat. NH4CI (20 cm3), was
dried and, was evaporated to afford a residue which was purified over silica
(hexane:EtOAc 80/20) to yield 207a as a waxy solid (0.460 g, Mp= 87 - 89 °C, 72%).
HRMS (C2]H3602F requires, 339.2699. Found M+l, 339.2684). IR (neat), v : 3053,
2986, 2930, 2858, 1421, 1262, 835. 'H NMR (300 MHz, CDCI3), 5 : 0.82-0.93 (m, 3H,
CH3), 1.20-1.79 (m, 20H), 2.61 (t, 2H, J= 7.4, C//2Ph), 3.36-3.47 (m, 1H,
CHFC7/OHCHOH), 3.78-3.87 (m, IH, CHFCHOCMDH), 4.48 (dm, 1H, J= 48.13,
CHF), 7.13-7.21 (m, 3H, aromatics), 7.24-7.31 (m, 2H, aromatics). 13C NMR (75 MHz,
CDCI3), 5 : 14.1 (s, CH3), 22.6 (s, CH2), 25.0 (s, CH2), 25.1 (s, CH2), 25.5 (s, CH2), 29.1
(d, J= 1.1, CH2), 29.4 (s, CH2), 31.0 (s, CH2), 31.3 (s, CH2), 31.8 (s, CH2), 33.6 (s,
CH2Ph), 35.8 (s, CH2CHOCH), 69.7 (d, J= 3.8, CHFCHOHCHOH), 74.2 (d, J= 23.2,
CHFCHOHCHOH), 94.3 (d, J= 169.7, CHF), 125.6 (s, aromatic), 128.2 (s, aromatic),
128.4 (s, aromatic), 142.6 (s, aromatic). 19F NMR (282 MHz, CDC13), 5 : [-192.4] - [-
191.9] (m, CHF). ). MS m/z (rei. int. %), (CI-isobutane): 339 (40), 321 (M+l -H20,
100), 301 (M+l-HF, 25), 283 (C2iH3I+, 30), 176 (10).
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6.37 Preparation of 8-fluoro-l-phenyl-pentadecane-6,7-diol (207b)
In a similar manner to the method described in section 6.36, (207b) was prepared as
waxy solid (0.300 g, Mp= 66 - 68 °C, 71%) from 206b (0.40 g, 1.25 mmol). HRMS
(C2,H3602F requires, 339.2699. Found M+l, 339.2697). IR (Kbr), v : 3320, 2930, 2855,
1460, 1060, 700. 'H NMR (300 MHz, CDC13), 5 : 0.83-0.95 (m, 3H, CH3), 1.22-1.80
(m, 20H), 2.61 (t, 2H, J= 7.6, C//2Ph), 3.66-3.79 (m, 2H, CHFC//OHC//OH), 4.55 (dm,
1H, J= 47.8, CHF), 7.12-7.21 (m, 3H, aromatics), 7.22-7.32 (m, 2H, aromatics). 13C
NMR (75 MHz, CDC13), 5 : 14.0 (s, CH3), 22.6 (s, CH2), 25.0 (s, CH2), 25.1 (s, CH2),
25.5 (s, CH2), 29.2 (d, J= 1.6, CH2), 29.4 (s, CH2), 30.6 (s, CH2), 30.9 (s, CH2), 31.4 (s,
CH2), 31.7 (d, J= 1.6, CH2), 35.9 (s, CHOHCH2), 72.1 (d, J= 4.4, CHFCHOHCHOH),
75.1 (d, J= 23.2, CHFCHOHCHOH), 93.9 (d, J= 166.9, CHFCHOHCHOH), 125.6 (s,
aromatic), 128.2 (s, aromatic), 128.4 (s, aromatic), 142.6 (s, aromatic). 19F NMR (282
MHz), 5 : [-193.5] - [-193.0] (m, CHF). MS m/z (rei. int. %), (Cl-isobutane): 339
(M+l, 55), 321 (M+l -H20, 100), 303 (M+l-HF, 55), 283 (C2iH31+, 70), 193 (10).
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6.38 Preparation of 4-(l-fluoro-octyl)-5-(5-phenyl-pentyl)-[l,3,2]dioxathiolane 2,2-
dioxide (208a)
Cyclic Sulfite.
Pyridine (0.120 cm3, 1.33 mmol) was was injected at room temperature to a solution of
207a (0.33 g, 0.97 mmol) in DCM (20 cm3). After the mixture was stirred and chilled at
0 °C, SOCI2 (0.085 cm3, 1.0 mmol) was added. The reaction was stirred at 0 °C for 30
min and then sat. CuS04 (20 cm3) was added to the organic layer dried with MgS04,
concentrated on a rotary evaporator and used in the subsequent oxidation without
isolation.
Cyclic Sulfate.
NaI04 (0.48 g, 2.25 mmol) was added to a solution of the crude cyclic sulfite in MeCN
(7 cm3) followed by the addition of a catalytic amount of R.UCI3-3H2O (1 mol%) and
3 0
H2O (5 cm ). The heterogeneous mixture was stirred vigorously at 0 C until full
consumption of the starting material (45 min). Ether (10 cm3) was added and the
organic layer was separated, washed with NaHCCE 5% solution, dried, filtered through
a pad of silica gel and concentrated under reduced pressure. The residue was purified
over silica gel (elution with hexane:EtOAc 6:1) to obtain 208a (0.300 g, 77%) as
colourless oil.
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HRMS (C21H34O4FS requires, 401.2162. Found M+l, 401.2156). IR (neat), v : 2935,
2855, 1395, 1210, 965. *H NMR (300 MHz, CDC13), 8 : 0.79-0.93 (m, 3H, CH3), 1.17-
1.92 (m, 20H), 2.62 (t, 2H, J= 7.4, CH2?\\), 4.36-4.46 (m, IH, CHFC//OS), 4.67 (dm,
1H, J= 47.6, CHF), 4.80-4.89 (m, 1H, S0O7CH2), 7.13-7.22 (m, 3H, aromatics), 7.23-
7.30 (m, 2H, aromatics). 13C NMR (75 MHz, CDC13), 8 : 14.0 (s, CH3), 22.5 (s, CH2),
24.3 (s, CH2), 24.3 (s, CH2), 24.9 (s, CH2), 29.2 (d, J= 1.6, CH2), 29.4 (s, CH2), 30.6 (s,
CH2), 30.9 (s, CH2), 31.4 (s, CH2), 31.7 (d, J= 1.6, CH2), 35.9 (s, SOCHCH2), 72.1 (d,
J= 4.4, SOCHCH2), 75.1 (d, J= 23.2, CHFCHOS), 93.9 (d, J= 166.9, CHF), 125.6 (s,
aromatic), 128.2 (s, aromatic), 128.4 (s, aromatic), 142.6 (s, aromatic). I9F NMR (282
MHz, CDCI3), 8 : [-195.8] - [-195.3] (m, CHFO- MS m/z (rei. int. %), (Cl-isobutane):
401 (M+l, 50), 303 (70), 283 (C21H31+, 100) 131 (65).
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6.39 Preparation of 4-(1-fluoro-octyl)-5-(5-phenyl-pentyl)-[l,3,2]dioxathiolane 2,2-
dioxide (208b)
In a similar manner to the method described in section 6.38, (208b) was prepared as
colourless oil (0.220 g, 75%) starting from 207b (0.25 g, 0.74 mmol). HRMS
(C21H34O4FS requires, 401.2162. Found M+l, 401.2152). IR (neat), v : 2929, 2861,
1389, 1209, 992. ]H NMR (300 MHz, CDC13), 8 : 0.72-0.85 (m, 3H, CH3), 1.11-1.99
(m, 20H), 2.55 (t, 2H, J= 7.4, C//2Ph), 4.60-4.70 (m, IH, CHFC/70S), 4.67 (dtd, 1H, J=
48.6, J= 8.7, J= 2.8, CHF), 4.94 (ddd, 1H, J= 10.1, J= 5.2, J= 3.3, SOC/7CH2), 7.06-7.15
(m, 3H, aromatics), 7.16-7.25 (m, 2H, aromatics). 13C NMR (75 MHz, CDC13), 8 : 14.1
(s, CH3), 22.6 (s, CH2), 23.9 (s, CH2), 24.0 (s, CH2), 25.3 (s, CH2), 28.1 (d, J= 3.3,
CH2), 28.5 (s, CH2), 29.0 (s, CH2), 29.1 (s, CH2), 31.0 (s, CH2), 31.7 (d, J= 1.6, CH2),
35.6 (s, CH2CHOS), 82.1 (d, J= 34.8, CHFCHOS), 85.9 (s, SOCHCH2), 88.4 (d, J=
170.1, CHOHCHOHCHF), 125.7 (s, aromatic), 128.3 (s, aromatic), 128.4 (s, aromatic),
142.2 (s, aromatic). 19F NMR (282 MHz, CDC13), 8 : [-193.7] - [-193.2] (m, CHF). MS










To a solution of 208a (0.3 g, 0.75 mmol) in dry acetonitrile (15 cm ) was added 1 M
TBAF solution in THF (1.5 cm3, 1.5 mmol). The reaction mixture was stirred at 0° C
until 208a fully dissolved (TLC, hexane/EtOAc 4:1, 40 min). Most of the organic
solvent was removed on a rotary evaporator, and the residue was dried. THF (10 cm )
and H2S04 (catalytic amount 1%) were added, and the mixture was stirred vigorously at
ambient temperature until hydrolysis was complete (1 h). The organic layer was washed
with sat. NaHCC>3 (15 cm3), and extracted into ether (10 x 2), evaporated, dried and the
residue was purified over silica gel (hexane:EtOAc 10:1) 209a as an amorphous solid
(0.160 g, 63%, Mp= 59 - 61 °C). HRMS (C2,H340F2 requires, 341.2656. Found M+l,
341.2669). IR (neat), v : 3450, 2930, 2855, 1495, 1460, 1075, 1035. *H NMR (300
MHz, CDCI3), 8 : 0.83-0.95 (m, 3H, CH3), 1.21-1.82 (m, 20H), 2.62 (t, 2H, J= 7.4,
CH2Ph), 3.83-3.97 (m, IH, C7/OH), 4.53 (dm, 2H, J= 48.4, CFFCHOOCFF), 7.13-7.21
(m, 3H, aromatics), 7.23-7.31 (m, 2H, aromatics). 13C NMR (75 MHz, CDC13), 8 : 14.1
(s, CH3), 22.6 (s, CH2), 24.9 (s, CH2), 29.0 (s, CH2), 29.2 (s, CH2), 29.4 (s, CH2), 30.1
(dd, J= 21.1, J= 1.1, CHFCH2), 30.2 (d, J= 21.5, CH2CHF), 31.3 (s, CH2), 31.7 (s, CH2),
35.8 (s, CH2), 73.5 (t, J= 23.2, CHFC//OHCHF), 93.5 (dt, J= 168.1, J= 5.6
CHFCHOHCHF), 125.6 (s, aromatic), 128.2 (s, aromatic), 128.4 (s, aromatic), 142.6 (s,
aromatic). 19F NMR (282 MHz, CDC13), 8 : [-194.3] - [-193.9] (m, CHFCHOHCHF).
MS m/z (rei. int. %), (Cl-isobutane): 341 (M+l, 35), 321 (M+l-HF, 100), 303 (M+l-
HF-H2O, 35), 283 (C2iH3I+, 65), 131 (35).
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In a similar manner to the method described in section 6.40, (209b) was prepared as a
white solid (0.090 g, 59%, Mp= 66 - 68 °C,) starting from 208b (0.180 g, 0.45 mmol).
HRMS (C21H34OF2 requires, 341.2656. Found M+l, 341.2642). IR (Kbr), v : 3415,
2923, 1466, 1071. 'H NMR (300 MHz, CDC13), 5 : 0.84-0.93 (m, 3H, CH3), 1.21-1.86
(m, 20H), 2.62 (t, 2H, J= 7.4, CH2Ph), 3.47 (dt, 1H, J= 24.3, J= 7.9, CHOH), 4.45 (dtd,
1H, J= 48.1, J= 8.4, J= 2.6, CFFCHOHCHF), 4.70 (dm, 1H, J= 48.1, CHFCHOHCFF),
7.10-7.22 (m, 3H, aromatics), 7.23-7.32 (m, 2H, aromatics). I3C NMR (75 MHz,
CDCI3), 5 : 14.1 (s, CH3), 22.6 (s, CH2), 24.8 (s, CH2), 24.8 (s, CH2), 28.9 (s, CH2), 29.1
(s, CH2), 29.4 (s, CH2), 31.0 (d, J= 21.5, CHFCH2), 31.3 (s, CH2), 31.5 (d, J= 19.9,
CH2CHF), 31.8 (s, CH2), 35.8 (s, CH2), 73.4 (dd, J= 24.8, J= 17.7, C//OH), 92.0 (dd, J=
172.0, J= 16.0, CHFCHOHCHF), 92.0 (dd, J= 169.7, J= 9.4, CHFCHOHCHF), 125.7
(s, aromatic), 128.2 (s, aromatic), 128.3 (s, aromatic), 142.5 (s, aromatic). 19F NMR
(282 MHz, CDCI3), 8 : [-202.6] - [-202.4] (m, CHFCHOHCHF), [-191.3] - [-191.2]
(m, CHFCHOHCHF). MS m/z (rei. int. %), (Cl-isobutane): 341 (M+l, 75), 321 (M+l-
HF, 100), 303 (M+1-HF-H20, 35), 283 (C2,H3i+, 45), 171 (10).
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6.42 Preparation of trifluoro-methanesulfonic acid 2-fluoro-l-(l-fluoro-6-phenyl-
hexyl)-nonyl ester (210a)
Pyridine (0.048 cm3, 0.66 mmol) was added to a solution of 209a (0.15 g, 0.44mmol) in
dry DCM (10cm3) at ambient temperature. The solution then was cooled to -40° C and
triflic anhydride (0.030 cm3, 0.048 mmol) was added over a period of 1 min.
The resulting dark orange solution was stirred for 1 h at - 40 °C and was then allowed
to warm to ambient temperature. Hexane (10 cm ) was added and the solution filtered.
The filtrate obtained was evaporated, dried and the residue passed over a silica gel pad
(eluent 10:1, hexane/ethyl acetate) to afford 210a as a clear oil (0.150 g, 72%). HRMS
(C27H33O4FS requires, 472.2084. Found M+l, 472.2078). IR (neat), v : 2930, 2870,
1470, 1415, 1210, 1140, 1030. 'H NMR (300 MHz, CDC13), 5 : 0.83-0.93 (m, 3H,
CH3), 1.20-1.87 (m, 20H), 2.62 (t, 2H, J= 7.7, CH2Ph), 4.72 (dm, 2H, J= 45.6,
C//FOTfC//F), 5.00 (tt, 1H, J= 14.6, J= 4.1, CT/OTf), 7.14-7.22 (m, 3H, aromatics),
7.24-7.33 (m, 2H, aromatics). 13C NMR (75 MHz, CDC13), 6 : 14.0 (s, CH3), 22.6 (s,
CH2), 24.7 (d, J= 2.7,CH2) 24.8 (d, J= 3.3, CH2), 28.7 (s, CH2), 29.0 (s, CH2), 29.0 (s,
CH2), 30.2 (ddd, J= 21.5, J= 10.5, J= 2.2, CHFCH2), 31.1 (s, CH2), 31.7, (s, CH2), 35.8
(s, CH2), 87.51 (t, J= 24.3, CHOTf), 90.5 (dt, J= 176.9, J= 6.1, CHFCHOTfCHF), 118.3
(q, J= 318.9), 125.7 (s, aromatic), 128.3 (s, aromatic), 128.4 (s, aromatic), 142.4 (s,
aromatic). 19F NMR (282 MHz, CDC13), 5 : [-192.2] - [-191.4] (m, CHFCHOTfCH/0, -
74.4 (t, J= 3.9, CHOSOOCF3). MS m/z (rei. int. %), (Cl-isobutane): 472 (M+l, 20), 304
(M+l-OTf, 70), 283 (C21H3i+, 100).
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6.43 Preparation of trifluoro-metlianesulfonic acid 2-fluoro-l-(l-fluoro-6-phenyl-
hexyl)-nonyl ester (210b)
In a similar manner to the method described in section 6.42, (210b) was prepared as a
clear oil (0.065 g, 69) from 209b (0.070 g, 020 mmol). HRMS (C27H33O4FS requires,
472.2084. Found M+l, 472.2074). IR (neat), v : 2930, 2870, 1470, 1415, 1210, 1145,
1035. 'H NMR (300 MHz, CDC13), 5: 0.80-0.95 (m, 3H, CH3), 1.19-1.87 (m, 20H),
2.62 (t, 2H, J= 7.7, CF2Ph), 4.66 (dm, 2H, J= 46.3, CFFOTfCFF), 4.86-5.03 (m, 1H,
CFOTf), 7.14-7.22 (m, 3H, aromatics), 7.23-7.33 (m, 2H, aromatics). 13C NMR (75
MHz, CDCI3), 6 : 14.1 (s, CH3), 22.6 (s, CH2), 24.7 (s, CH2), 24.7 (s, CH2), 28.6 (s,
CH2), 29.0 (s, CH2), 29.2 (s, CH2), 29.8 (s, CH2), 29.95 (d, J= 20.7, CHFCH2), 30.96 (d,
J= 20.7, CHFCH2), 31.1, (s, CH2), 31.7 (s, CH2), 35.75 (s, CH2), 87.51 (dd, J= 23.0, J=
18.4, CHOTf), 90.5 (ddd, J= 177.2, J= 46.1, J= 4.6, CHFCHOTfCHF), 118.3 (q, J=
317.7), 125.7 (s, aromatic), 128.3 (s, aromatic), 128.3 (s, aromatic), 142.3 (s, aromatic).
19F NMR (282 MHz, CDC13), 5 : [-193.9] - [-192.6] (m, CHFCHOTfCHF), [-188.4] -
[-187.6] (m, CHFCHOTfCHF), -74.5 (d, J= 5.1, CHOSOOCF3). ). MS m/z (rei. int. %),
(CI-isobutane): 472 (M+l, 20), 304 (M+l-OTf, 70), 283 (C21H3i+, 100).
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6.44 Preparation of (6,7,8-trifluoro-pentadecyl)-benzene (188)
A solution of 1M TBAF in THF (0.25 cm3, 0.25 mmol) was added to a solution of the
tri fiate 210a (0.150 g, 0.48 mmol) in dry acetonitrile (10 cm3). The reaction mixture
was stirred at 0 °C until the triflate was consumed (TLC, hexane/Ether 9:1, 10 min). The
residue was purified by preparative TLC (elution with hexane/Ether 15:1) to obtain 188
as a white solid (0.025 g, 35%). Mp= 27 - 29 °C. HRMS (C21H34F3 requires, 343.2612.
Found M+l, 343.2626. *H NMR (500 MHz, CDC13), 6 : 0.84-0.94 (m, 3H, C//?CH2),
I.28-1.88 (m, 20H), 2.62 (t, 2H, J= 7.4, CF2-Ph), 4.35 (dm, 1H, J= 47.6,
CHFC//FCHF), 4.65 (dm, 2H, J= 48.9, CFFCHFCHF), 7.14-7.32 (m, 5H, aromatics).
13C NMR (100 MHz, CDC13), 5 : 14.1 (s, CH3), 22.6 (s, CH2) 24.6 (d, J= 4.1, CH2), 24.7
(d, J= 4.1, CH2), 28.9 (s, CH2), 29.1 (s, CH2), 29.2 (s, CH2), 30.1 (dd, J= 20.7, J= 6.3,
CHFCH2), 31.2 (s, CH2), 31.7 (s, CH2), 35.8 (s, CH2), 91.5 (ddd, J= 174.5, J= 20.7, J=
II.6, CHFCHFCHF), 91.6 (ddd, J= 173.4, J= 20.7, J= 2.0, CHFCHFCHF), 93.2 (tt, J=
183.8, J= 20.8, CHFCHFCHF), 125.8 (s, aromatic), 128.2 (s, aromatic), 128.3 (s,
aromatic), 142.5 (s, aromatic). 19F NMR (470 MHz, CDC13), 5 : [-207.6] - [-207.2] (m,
CHFCHFCHF), [-198.2] - [-197.6] (m, 2F, CHFCHFCHF). 19F NMR {'H] (470 MHz,
CDCI3), 5 : -207.4 (t, J= 12.3, CHFCHFCHF), -197.9 (d, J= 12.4, CHFCHFCHF). MS
m/z (rei. int. %), (Cl-isobutane): 343 (M+l, 20), 323 (M+l-HF, 70), 303 (M+1-2HF,
25), 283 (M+1-3HF, 30).
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6.45 Preparation of (6,7,8-trifluoro-pentadecyl)-benzene (189)
A solution of 1M TBAF in THF (0.15 cm3, 0.15 mmol) was added to a solution of the
triflate 210b (0.050 g, 0.11 mmol) in dry acetonitrile (5 cm ). The reaction mixture was
stirred at 0 °C until the triflate was consumed (TLC, hexane/Ether 12:1, 10 min). The
residue was purified by preparative TLC (elution with hexane/Ether 15:1) to obtain 189
as a clear oil (0.010 g, 27%). HRMS (C21H34F3 requires, 342.2534. Found M,
342.2436). *H NMR (500 MHz, CDCI3), 8 : 0.83-0.92 (m, 3H, CH3CH2), 1.20-1.95 (m,
20H), 2.61 (t, 2H, J= 7.7, C//2-Ph), 4.28 (dddt, 1H, J= 45.5, J= 26.3, J= 6.4, J= 1.2,
CHFCF/FCHF), 4.66 (dm, 2H, J= 47.4, CHFCHFCHF), 7.16-7.30 (m, 5H, aromatics).
13C NMR (100 MHz, CDC13), 5 : 14.0 (s, CH3), 22.6 (s, CH2) 24.3 (d, J= 2.1, CH2), 24.9
(d, J= 5.2, CH2), 28.9 (s, CH2), 29.1 (s, CH2), 29.2 (dd, J= 20.7, J= 6.3, CHFCH2), 29.6
(d, J= 25.8, CH2), 31.7 (s, CH2), 35.8 (s, CH2), 89.3 (ddd, J= 169.2, 29.0, J= 5.1,
CHFCHFCHF), 93.4 (ddd, J= 188.9, J= 19.7, J= 13.5, CHFCHFCHF). 19F NMR (470
MHz, CDCI3), 8 : [-212.2] - [-212.6] (m, CHFCHFCHF), [-201.1] - [-200.6] (m,
CHFCHFCHF), [-194.1] - [-194.5] (m, CHFCHFCHF). 19F NMR {'HI (470 MHz,
CDCI3), 8 : -212.3 (dd, J= 14.9, J= 9.2, CHFCHFCHF), -200.8 (d, J= 9.2,
CHFCHFCHF), -194.4 (d, J= 14.9, CHFCHFCHF). MS m/z (rei. int. %), (CI-
isobutane): 342 (M+l, 75), 303 (M+1-2HF, 25), 283 (M+1-3HF, 35).
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6.46 Preparation of 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafliwro-l-morpholin-4-yl-
octan-l-one (238)
A solution of the pentadecafluorooctanoyl chloride (237) in DCM (0.13 cm', 5.2 mmol)
was added dropwise to a solution of morpholine (235) (0.680 cm , 7.8 mmol) in DCM
(25 cm3) at 0 °C. The reaction was, heated under reflux for 2 h. The organic layer was
■j
evaporated under reduced pressure and the residue was washed with ether (3x15 cm )
to give the product amide 238 as a white crystalline solid (2.83 g, 96%). Mp= 47-49 °C.
'H NMR (300 MHz, CDC13), 5 : 3.7 (m, 8H). 19F NMR (282 MHz, CDC13), 5 : -126.3
(br s, 2F, CF2), -123.0 (br s, 2F, CF2), -122.2 (br s, 2F, CF2), -121.2 (br s, 2F, CF2), -
121.0 (br s, 2F, CF2), -111.2 (t, J= 10, 2F, COCF2), -81.2 (t, J= 10, 3F, CF3). MS m/z
(rei. int. %), (EI): 483 (M, 72), 114 (morpholine, 100).
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6.47 Preparation of 4-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadccafluorooctyl)-
morpholine (227)
A solution 1.5 M of Borane-THF (7 cm3, 10.5 mmol) was added dropwise to a solution
of 238 (2.7 g, 6.2 mmol) in THF (25 cm3) at 0° C. The mixture was heated under reflux
for 1 hour. The excess of borane was quenched using a solution of HC1 5% (2 cm ), and
then ether (5 cm3) was added. The organic layer was collected and dried with MgS04.
The aqueous layer was basified with 2 N NaOH and extracted into DCM (3 x 10 cm3).
The combined organic layers were evaporated under reduced pressure to give amine 227
as white solid (2.0 g, 70%). Mp= 25 °C. *H NMR (300 MHz, CDC13), 5 : 2.6 (t, J= 4.8,
4H, CH2NCH2), 2.9 (t, J= 16, 2H, CH2CF2), 3.69 (t, J= 4.8, 4H, CH2OCH2). 19F NMR
(282 MHz, CDCI3), 5 : -127.3 (br s, 2F, CF2), -124.2 (br s, 2F, CF2), -123.8 (br s, 2F,
CF2), -123.0 (br s, 2F, CF2), -122.8 (br s, 2F, CF2), -116.3 (br s, 2F, CF2), -82.1 (t, J
= 10, 3F, CFj). MS m/z (rei. int. %), (EI): 469 (M, 46), 451 (M-H20, 100).
192
6.48 Preparation of 4-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Pentadecafluoro-octyl)-
morpholine 4-oxide (22S)
A solution of compound 227 (2.0 g, 4.2 mmol) in DCM (15 cm ) was added to a
suspension of mCPBA (1.0 g, 5.8 mmol) in DCM (20 cm3) at 0 °C. The mixture was
stirred at 4° C for 12 hours. An excess of diluite NaOH IN (5 cm3) was added to
neutralise residual mCPBA. Distilled water (10 cm3) was added and the product was
extracted into DCM (3 x 25 cm3). The organic layer was filtered and the solvent
evaporated under reduced pressure to give a compound 228 as a white crystalline solid
(1.63 g, 80%). Mp= 143-145 °C. *H NMR (300 MHz, CDC13), 5 : 3.20 (d, J= 10, 2H,)
3.60-3.65 (m, 4H), 4.10 (t, J= 16, 2H, CH2), 4.50 (t, J= 11, 2H, C//2CF2). 13C NMR (75
MHz, CDC13), 5 : 61.4 (CH2OCH2) 66.1 (CH2NCH2), 69.5 (t, J= 19, CH2CF2). ,9F NMR
(282 MHz, CDCI3), 5 : -126.4 (br s, 2F, CF2), -123.3 (br s, 2F, CF2), -123.0 (br s, 2F,
CF2), -122.2 (br s, 2F, CF2), -121.6 (br s, 2F, CF2), -113.1 (br s, 2F, CH2CF2), -81.3 (t,
J= 10, 3F, CF3). MS m/z (rel. int. %), (EI): 483 (M, 72), 114 (morpholine, 100).
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Cynnamyl bromide 241 (0:098 g, 0.50 mmol) was added to a solution of N-oxide 228
(0,267 g, 0.55 mmol) in dry acetonitrile (20 cm3) and the reaction mixture was stirred
under reflux. The formation of cinnamyl aldehyde (242) was monitored by 'H NMR
and after 30 h reflux the conversion reached 50%.
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6.50 Preparation of 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptaclecafluoro-N-[(lS)-l-
phenylethyl]-l-decanamine (229).
A mixture of (lS)-l-phenylethylamine (243) (1.69 g, 13.9 mmol), K2CO3 (2.0 g) and
perfluorooctyliodide iodide 236 (4.0 g, 6.98 mmol) in dry acetonitrile (30 cm3) was
reacted under reflux for 24 h. After filtration the solvent was evaporated, and the
product was purified over silica gel column using hexane: ethylacetate 70/30 as eluent
to give 229 (2.1 g, 54%) as a yellow oil. [a]D20 = - 16.2 (c= 0.52, DCM). HRMS
(C,8H15NF,7 requires, 568.0933. Found M+l, 568.0914). IR (neat), v : 3065, 3030,
2970, 1450, 1210, 1150, 705. NMR (300 MHz, CDC13), 5 : 1.32 (d, 3H, J= 6.6,
CH3), 1.40 (br, IH, NFT), 2.11-2.41 (m, 2H, C/72Rf), 2.69-2.90 (m, 2H, C/FNH), 3.78
(q, 1H, J= 6.6, CH), 7.21-7.38 (m, 5H, aromatics). 13C NMR (75 MHz, CDC13), 8 : 24.3
(s, CH3), 31.6 (t, J= 21.5, RfCH2), 39.2 (t, J= 3.8, NHCH2), 58.3 (s, CH), 107.5-122.3
(m, CF2), 126.4 (s, aromatic), 127.1 (s, aromatic), 128.6 (s, aromatic), 145.0 (s,
aromatic). 19F NMR (282 MHz, CDC13), 8 : -126.7 (br s, 2F, CF2), -124.2 (br s, 2F,
CF2), -123.7 (br s, 2F, CF2), [-122.8] - [-121.7] (m, 6F), -114.2 (br s, 2F, CF2), [-81.6]
- [-81.2] (m, 3F, CF5). MS m/z (rei. int. %), (EI): 552 (M-Me, 30), 490 (M-Ph, 10), 147
(M-Rf, 13), 105 (C7H7N+, 11).
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6.51 Preparation of 3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-N-
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-lieptadecafluorodecyl)-N-[( 1S)-1-
phenyletliylJoctanamide (249).
Pentadecafluorooctanoylchloride 236 (0.96 cm , 3.83 mmol) was added to a solution of
229 (2.0 g, 3.53 mmol) and TEA (0.74 cm3_ 5.30 mmol) in DCM (30 cm3) at 0° C. The
reaction mixture was stirred under nitrogen for 12 h. The organic layer was then washed
with NaHC03 5% solution (30 cm3), sat. NH4C1 (30 cm3) and CuS04 solution (30 cm3)
and then dried over MgS04 evaporated to afford 249 as a colourless oil (3.3 g, 97%).
This material was used without further purification. [a]D20 = - 17.36 (c= 0.70, DCM).
MALDI TOF (C26H13F32NNaO requires, 986.0384. Found M+Na 986.0467). *H NMR
(300 MHz, CDC13), mixture of two rotamers in ratio 5:1 (M, 111), 8 : 1.61 (d, 3H, J= 7.2,
CH3 m) 1.70 (d, 3H, J= 6.8, CH3 M), 1.99-2.15 (m, 2H, CH2-Rf m), 2.18-2.43 (m, 2H,
CZ/2-Rf M) 3.27-3.56 (m, 2H, CH2-N M), 3.58 -3.74 (m, 2H, C//2-N m) 5.49 (q, 1H,
CH, J= 6.6 M), 5.96 (q, IH, CH, J= 7.2 m) 1.30-7.47 (m, 5H, aromatics). 13C NMR
(75.5 MHz, CDCI3), 8 : 15.7 (s, CH3,m), 17.3 (s, CH3M), 28.7 (t, J= 24.9, RfCH2), 35.9
(s, NCH2 m), 36.6 (s, NCH2,M), 54.6 (s, CH, m), 55.2 (s, CH, M), 108.0-122.3 (m, CF),
127.3 (s, aromatic), 128.0 (s, aromatic, m), 128.8 (s, aromatic m) 129.1 (s, aromatic, M)
137.1 (s, aromatic quaternary), 167.2 (C=0) 19F NMR (282 MHz, CDC13), 8 : -126.7 (br
s, 2F, CF2), -124.3 (br s, 2F, CF2), -123.6 (br s, 2F, CF2), [-123.5] - [-122.1] (m, 12F), -
121.4 (br s, 2F, CF2), -120.5 (br s, 2F, CF2), -115.4 (br s, 2F, CF2), -110.4 (br s, 2F,
CF2), [-81.5] - [-81.1] (m, 6F). MS m/z (rei. int. %), (MAFDI TOF): 986 (M+23, 100)
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A solution of Borane-THF complex 1.5 M (24 cm , 36 mmol) was added dropwise to a
solution of 249 (3.3 g, 3.4 mmol) in THF (25 cm3) at 0° C and the mixture was stirred
under for 24 hour. The excess borane was destroyed by dropwise addition of water at 0°
C. Ether (10 cm3) then was added and the combined organic layers were collected and
dried over MgSC>4 and evaporated. The resultant residue was purified over silica using
hexane:ether 95:5 as the eluent to afford 230 as a clear oil (1.78 g, 55%). [cc]D20 = +0.25
(c— 2.0, DCM). MALDI TOF (C26H15F32NNa requires, 972.0590. Found M+Na
971.8840). 'H NMR (300 MHz, CDC13), 8 : 1.35 (d, 3H, J= 6.8, CH3), 1.90-2.30 (m,
2H, CH2-Rf ), 2.83 (t, 2H, J= 7.8 RfC7/2N ), 2.97-3.33 (m, 2H, CH2-N), 3.94 (q, 1H, J=
6.8, CH), 7.14-7.34 (m, 5H, aromatics). 13C NMR (75 MHz, CDC13), 8 : 16.1 (s, CH3>),
30.9 (t, J= 19.3, RfCH2), 43.9 (s, NCH2 ) 51.3 (t, J= 20.5, RfN-CH2-Rf), 61.2 (s,
CH3CH,), 105.0-122.3 (m, CF), 127.5 (s, aromatic), 127.6 (s, aromatic), 128.0 (s,
aromatic), 141.6 (s, aromatic quaternary) 19F NMR (282 MHz, CDC13), 8 : [-127.2] - [-
126.6] (m, 4F), [-124.5] - [-123.9] (m, 4F), -123.5 (br s, 2F, CF2), [-122.9] - [-122.1]
(m, 12F), -117.6 (br s, 2F, CF2), -115.0 (br s, 2F, CF2), [-81.7] - [-81.4] (m, 6F).
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6.53 Preparation of 4,4,5,5,6,6,7,7,S,S,9,9,10,10,ll,ll,ll-heptadecaflnoro-N-[(lR)-
l-plienylethyl]-l-undecanamine (231)
A mixture of (lR)-l-phenylethylamine (252) (0.366 g, 3.0 mmol), K2C03 (1.5 g), TEBA
(0.067 g, 0.3 mmol) and perfluorooctyliodide iodide (251) (1.78 g, 3.03 mmol) in dry
acetonitrile (20 cm3) was reacted under reflux for 8 h. The suspension was cooled to
room temperature and diluted with ether (40 cm ). After filtration of the inorganic salts,
the organic layer was washed with H20 (2 x 15 cm3), sat. NH4CI (15 cm3) and dried
over MgSC>4. The solvent was evaporated, and the product was purified over silica
(flash chromatography) using hexane: ethyl acetate 80/20 as the eluent and yielding 231
(1.22 g , 70%) as a pale yellow oil. [a]D20 = +13.2 (c= 0.2, Ether). HRMS (ESI)
(Ci9H16F17N requires, 582.10890. Found M+l, 582.11288). *H NMR (300 MHz,
CDCI3), 5 : 1.45 (d, 3H, J= 6.6, CH3), 1.43 (br, IH, NTT), 1.65-1.76 (m, 2H,
RfC//2CH2), 1.98-2.20 (m, 2H, RfCH2C//2), 2.43-2.63 (m, 2H, C//2NH), 3.73 (q, 1H, J=
6.6, CH), 7.23-7.35 (m, 5H, aromatics). 13C NMR (75 MHz, CDC13), 6 : 21.0 (s, CH3),
24.4 (s, CH2CH2CH2), 28.8 (t, J= 21.9, RfCH2), 46.4 (s, NHCH2), 58.4 (s, CH), 107.5-
122.3 (m, Rf), 126.1 (s, aromatic), 127.9 (s, aromatic), 128.6 (s, aromatic), 145.5 (s,
aromatic quaternary). 19F NMR (282 MHz, CDCI3), 8 : -126.5 (br s, 2F, GF2), -123.9 (br
s, 2F, CFi), [-122.2] - [-122.0] (m, 6F), -114.7 (br s, 2F, CF2), [-81.2] - [-81.3] (m, 3F,
CF3).
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6.54 Preparation of 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-
(4,4,5,5,6,6,7',7,8,8,9,9,10,10,11,11,ll-heptadecafluoroundecyl)-N-[(lR)-l-
phenylethyljundecanamide (254).
Acylchloride (253) (0.39 g, 0.76 mmol) was added to a solution of 231 (0.305 g, 0.51
mmol) and TEA (0.14 cm3, 1.00 mmol) in DCM (10 cm3) at 0° C. The reaction mixture
was stirred at RT for 12 h. The organic layer was then washed with water (10 cm3), sat.
NH4CI (10 cm3) and sat. CuSCE (10 cm3) and was then dried over MgSCE to afford a
254 as a colourless oil (0.45 g, 84%). This material was used without further
purification. [a]D20 = + 11.8 (c= 0.2, Ether). HRMS (ESI) (C3oEli9F34NNaO requires,
1078.08204. Found M+Na, 1078.13382). 3H NMR (300 MHz, CDC13), mixture of two
rotamers in ratio 2:1 (M, m), 5 : 1.53 (d, 3H, J= 7.2, CH3 m) 1.66 (d, 3H, J= 7.0, CH3 M)
1.70 (d, 3H, J= 6.8, CH3 M), 2.4-2.7 (m, 4H, Ctf2-Rf), 3.00-3.31 (m, 2H, C//2-NH ),
5.12 (q, IH, CH, J= 7.2, M), 6.01 (q, IH, CH, J= 6.8 m) 7.22-7.39 (m, 5H,
aromatics).13C NMR (75 MHz, CDC13), 5 : 16.9 (s, RfCH2CH2CH2, m), 18.7 (s,
RfCH2CH2CH2, M), 20.4 (s, RfCH2CH2CO, M), 22.1 (s, RfCH2CH2CO, m), 25.1 (s,
CH3, M + 772), 26.9-27.9 (m, RfCH2CH2CO, M + m), 29.1 (t, J= 23.5, RfCH2CH2CH2, m
+ M), 42.9 (s, RfCH2CH2CH2, M), 43.3 (s, RfCH2CH2CH2,772), 52.1 (s, CH, m), 55.7 (s,
CH, M), 107.0-119.9 (m, Rf), 127.0 (s, aromatic), 128.0 (s, aromatic), 128.3 (s,
aromatic), 128.5 (s, aromatic), 129.1 (s, aromatic), 129.3 (s, aromatic), 140.1 (s,
aromatic quaternary, M), 140.6 (s, aromatic quaternary, in), 170.29 (C=O).10F NMR
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(282 MHz, CDCI3), 8 : -126.7 (br s, 4F), -124.0 (br s, 4F), -123.1 (br s, 4F), [-122.9] - [-
121.8] (m, 12F), -114.8 (br s, 2F, CF2), -113.0 (br s, 2F, CF2), [-81.5] - [-81.8] (m, 6F).
6.55 Preparation of 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecaflxioro-N-
(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,1 l-lieptadecafluoroundecyl)-N-[(lR)-l-
phenylethyl]-l-undecanamine (232)
A solution of Borane-THF complex 1.5 M (3.0 cm , 4.5 mmol) was added dropwise to a
solution of 254 (0.45 g, 0.43 mmol) in THF (15 cm3) at 0° C. The mixture was then
stirred under nitrogen for 24 h. The excess borane was destroyed by adding water
0 ^
dropwise at 0 C. Ether (15 cm ) was then added and the combined organic layers were
collected and dried over MgSC>4 and evaporated. The residue was purified over silica
using hexane:ether 95:5 as the eluent to afford compound 232 as a pale yellow oil (0.23
g, 51%). [a]D20 = + 2.0 (c= 0.2, Ether). HRMS (ESI) (C30H21F34N requires, 1041.11300.
Found M, 1042.13368). !H NMR (300 MHz, CDC13), 6 : 1.35 (d, 3H, J= 6.9, CH3),
1.64-1.74 (m, 8H, CZ/2Rf) 1.76-2.11 (m, 8H, CH2CH2Rf ), 2.39-2.62 (m, 4H, C772NH ),
3.89 (q, 2H, J= 6.9, CH), 7.22-7.38 (m, 5H, aromatics). 13C NMR (75 MHz, CDC13), 5 :
13.5 (s, CH3), 18.4 (s, CH2CH2CH2), 28.4 (t, J= 21.9, RfCH2), 48.3 (s, NHCH2), 57.5 (s,
CH), 106.1-123.5 (m, Rf), 126.9 (s, aromatic), 127.7 (s, aromatic), 127.9 (s, aromatic),
142.8 (s, aromatic quaternary). 19F NMR (282 MHz, CDC13), 5 : -126.6 (br s, 4F), -123.8
(br s, 4F), 123.1 (br s, 4F), [-122.9] - [-121.8] (m, 12F), -114.9 (br s, 4F), -81.6 (t, J=
10, 6F, CF3).
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6.56 Preparation of 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-
(4,4,5,5,6,6,7,7,8,8,9,9,10,10,ll,ll,ll-heptadecafluoroundecyl)-N-[(lR)-l-
phenylethyl]-l-undecanamine (265)
Oxalyl chloride (0.12 cm , 1.3 mmol) was added dropwise to a solution of the amine
229 (1.36 g, 2.4 mmol) and TEA (0.5 cm3, 3.6 mmol) in dry DCM (20 cm3) at 0° C. and
the resultant mixture was stirred for 6 hours at RT. The organic layer was then washed
with water (20 cm3) and sat. CuSCF (20 cm3) and then dried over MgSCF and
evaporated to give 265 as a white solid (0.74 g, 53%) which was used for the next step
without further purification. HRMS (MALDI TOF) (C38H26F34N2Na02 requires,
1211.10. Found M+Na, 1210.96). 'H NMR (300 MHz, CDC13), mixture of four
rotamers in ratio 2:2:1:0.5 only the major is reported. 5 : 1.74 (d, 6H, J= 7.1, CH3),
2.35-2.60 (m, 4H, C//2Rf), 3.27-3.56 (m, 4H, CH2NU), 5.49 (q, 2H, J= 6.6, CH), 7.30-
7.47 (m, 10H, aromatics); 13C NMR (75 MHz, CDC13), 5 :17.5 (s, CH3,), 34.4, (t, J=
24.9, RfCH2), 36.7 (s, NCH2, ), 51.9 (s, CH), 108.0-120.3 (m, Rf), 127.2 (s, aromatic),
128.5 (s, aromatic), 128.7 (s, aromatic), 128.9 (s, aromatic), 129.0 (s, aromatic), 129.1
(s, aromatic), 138.2 (s, aromatic quaternary), 164.9 (s, C=0). 19F NMR (282 MHz,
CDC13), 5 : [-127.5] - [-126.1] (m, 4F), [-124.9] - [-123.1] (m, 4F), [-123.5] - [-120.9]
(m, 16F), [-115.9] - [-114.9] (m, 4F), [-81.8] - [-81.1] (m, 6F).
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6.57 Preparation of N\N2-bis(3,3/M,5,5,6,6/7,7,8,8,9,9,10,10,10-
heptadecafluorodecyl)-N1,N2-bis[(lS)-l-phenylethyl]-l,2-ethanediamine
(233).
A solution of 265 (0.740 g, 0.63 mmol) in dry THF (5 cm3) was added via syringe to a
suspension of LÌAIH4 (0.12 g, 3.10 mmol) in THF (5 cm3) at 0° C. The reaction mixture
was stirred for 12 h at RT. The excess of hydride was then destroyed by dropwise
addition of water until formation of a crystalline solid was observed. The suspension
was then filtered and the solid washed with ether. The combined organic layers were
collected and dried with MgSOzj, and evaporated to afford compound 233 as a white
solid that was recrystallised from ether/MeOH (0.405 g, 56%). Mp= 71-73 °C. [a]D20
= +6.47 (c= 0.14, DCM). (MALDI TOF) (C38H28F34N2Na requires, 1161.1944. Found
M+Na, 1161.1932). 'H NMR (300 MHz, CDC13), 5 : 1.22 (d, 6H, J= 6.7, CH3), 1.92-
2.13 (m, 4H, CH2Rf ), 2.26-2.45 (m, 4H, CH2CH2), 2.55 - 2.83 (m, 4H, J= 7.8
RfCH2NH ), 3.64 (q, 1H, J= 6.7, CH), 7.11-7.26 (m, 10H, aromatics); 13C NMR (75.4,
CDCI3), 5 : 16.9 (s, CH3j), 29.5 (t, J= 20.4, RfCH2), 42.4 (s, NHCH2 ) 49.6 (s,
NHCH2CH2NH), 60.1 (s, CH,) 105.0-122.3 (m, Rf), 127.05 (s, aromatic), 127.5 (s,
aromatic,), 128.2 (s, aromatic m) 143.5 (s, aromatic quaternary). 19F NMR (282 MHz,
CDCI3), 8 : [-126.8] - [-126.5] (m, 4F) [-124.2] - [-123.8] (m, 4F).-123.3 (br s, 2F,
CF2), [-122.7] - [-122.1] (m, 12F), [-114.8] - [-114.4] (m, 4F), -81.3 (t, J= 10.3, 6F,
CF3).
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6.58 Preparation of AT1 A2-bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-
heptadecafluorodecyO-A^jA^-bistQR^l-phenylethyllethandiamide (266)
Amine (231) (1.15 g, 1.97 mmol) and triethylamine (0.39 cm3, 2.81 mmol) were
o r\
dissolved in ether (20 cm ) and the solution was cooled to 0 C. A solution of oxalyl
chloride (0.082 cm3, 0.94 mmol) in dry ether was then added dropwise. The solution
was stirred at 0 °C for 1 hour and then was allowed to warm to room temperature and
left stirring over night. The reaction was filtered and the filtrate washed with water and
brine and dried over sodium sulphate. The ether was removed under vacuum and the
crude product purified over silica using 20% ethyl acetate and 80% hexane. The product
(266) was recovered as colourless oil (0.76 g, 67%). HRMS (ESI) (C3oHi9F34NNaO
requires, 1078.08204. Found M+Na, 1078.13382). !H NMR (300 MHz, CDC13),
product exists as four rotomers, 8 : 2.03- 1.56 (m), 3.31-3.07 (m), 5.04 (q), 5.15 (q),
5.79 (q), 5.92, (q, J= 7.2), 7.42-7.27 (m, 10H). 13C NMR (75 MHz, CDC13), 5 : 16.9 (s),
17.1 (s), 18.2 (s), 19.9 (s), 18.7 (s), 21.9 (s), 22.2 (s), 28.9 (q, J= 91.1 ), 41.3 (s), 41.6
(s), 44.4 (s), 44.8 (s), 52.0 (s), 52.2 (s), 56.4 (s), 56.6 (s), 125 -102 (m), 127.8 (d, J=
40.2),128.6 (t, J= 37.8), 129.2 (s), 139.0 (s), 139.3 (s), 139.9 (s), 165.4 (s), 165.6 (s).
19F (282 MHz, CDC13), 5 : -126.6 (s), -124.0 (s), -123.9 (s), -123.2 (s), -122.4 (s), [-
114.8] - [-114.4] (m), -81.2 (m), -81.3 (m).
204
6.59 Preparation of /V1^V2-bis(3,3,4,4,5,5,6,6J7,7,8,8,9,9,10,10,11,ll,11-
1 2
heptadecafluorodecyl)-N -bis[(lR)-l-phenylethyl]ethandiamine (234)
Lithium aluminium hydride (0.035 g, 0.91 mmol) was suspended in dry ether (10 cm )
and cooled to 0 °C. A solution of amide (266) (0.55 g, 0.45 mmol) in ether (10 cm3) was
added dropwise to the suspension. The reaction was stirred for 30 min at 0 °C and was
then hydrolysed by the dropwise addition of water until a white precipitate formed. The
reaction was filtered and the filtrate was dried over sodium sulfate. The solvent was
evaporated to leave the crude product which was purified by column chromatography
20% ethyl acetate and 80% hexane. Finally the product 234 was recrystallised from
methanol and ether to give the title compound as a white solid (0.080 g, 15%). Mp= 64 -
66 °C. [a]20D= -1.0 (c= 0.2, Ether). Calcd. C 40.42, H 2.88, N 2.36: Found C 40.70, H
3.11, N 2.91. HRMS (ESI) (C30H22F34N requires, 1042.12082. Found M+l,
1042.13368). 'H NMR (300 MHz, CDC13), 5 : 1.27 (d, J= 6.7), 1.63- 1.51 (m, 4H), 1.96
(m, 4H), 2.51- 2.27 (m, 8H), 3.74 (q, J= 6.7, 2H), 7.30 - 7.18 (m, 10H). 13C NMR (75
MHz, CDCI3), 5 : 16.3 (s), 19.2 (s), 29.0 (t), 49.9 (s), 50.2 (s), 60.0 (s), 127.2 (s), 128.0,
(s), 128.4 (s), 144.3 (s).19F (282 MHz, CDC13), 5 : -126.6 (s, 4F), -123.9 (s, 4F), -123.2
(s, 4F), -122.4 (s, 8F), -114.5 (s, 4F), -81.1 (m, 6F).
205
References for chapter 6
W. L. F. Armarego and D. D. Perrin, Purification of Laboratory Chemicals',
Elsevier, 1996.
L. J. Alvey, D. Rutherford, J. J. Juliette and J. A. Gladysz, J. Org. Chem., 1998,
63, 6302.
T. Okhuma, M. Koizumi, H. Doucet, T. Pham, M. Kozawa, K. Murata, T.
Yokozawa, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 1998, 120, 13529.
206
• JL Appendix one: X-Ray crystallographic data.
A.1.1 General experimental
Data for all compounds were measured on a Bruker SMART diffractometer with
graphite monochromated Mo-Ka radiation (k = 0.7107) using a 0.3° width steps
accumulating area detector frames spanning a hemisphere of recripocal space for both
structures; the reflections were corrected for Lorentz and polarisation effects.
Absorption effects were corrected on the basis of multiple equivalent reflections.
The structures were solved by direct methods and refined by full matrix least squares
on F using the program SHELXTL. All hydrogen atoms were included in calculated
positions using a riding model. All non - hydrogen atoms were refined as anisotropic
A.1.2 X-Ray data for chapter 2























Completeness to theta = 23.23°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Extinction coefficient








a = 5.9721(3) À oc= 90°
b = 8.5759(4) À (3= 90°














Full-matrix least-squares on F2
2244/0 / 182
0.872
R1 =0.0344, wR2 = 0.0647
R1 =0.0474, wR2 = 0.0678
7(4)
0.055(4)
0.071 and -0.076 e.A"3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (À2x 103)


































































































Symmetry transformations used to generate equivalent atoms:
A-210
Table 4. Anisotropic displacement parameters (A2x 103) for 91. The anisotropic
displacement factor exponent takes the form: -2n2[ h2a*2Un + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 TJ i2
C(1) 57(1) 51(1) 44(1) KD -1(1) 0(1)
N(2) 64(1) 51(1) 48(1) -2(1) 2(1) -5(1)
C(3) 48(1) 48(1) 50(1) 2(1) 2(1) -2(1)
C(4) 50(1) 50(1) 46(1) KD -2(1) -2(1)
C(5) 43(1) 48(1) 48(1) KD -4(1) -3(1)
C(6) 47(1) 47(1) 48(1) -1(1) 0(1) -3(1)
C(7) 56(1) 59(1) 58(1) 2(1) 10(1) -1(1)
C(8) 68(1) 53(1) 69(1) 10(1) 11(1) -9(1)
C(9) 65(1) 47(1) 73(1) 2(1) 7(1) -5(1)
C(10) 61(1) 55(1) 54(1) -6(1) KD -5(1)
C(11) 87(2) 57(1) 61(1) -4(1) 15(1) 4(1)
C(12) 64(1) 52(1) 60(1) 5(1) 9(1) -2(1)
C(13) 94(2) 64(1) 62(1) 12(1) -2(1) -1(1)
C(14) 81(1) 66(1) 96(1) 12(1) -2(1) -23(1)
C(15) 54(1) 48(1) 46(1) 0(1) 2(1) -6(1)
C(16) 67(1) 80(1) 51(1) -2(1) -3(1) -2(1)
C(17) 95(2) 118(2) 51(1) -16(1) 5(1) 3(2)
C(18) 88(2) 100(2) 69(1) -14(1) 26(1) 5(2)
C(19) 64(1) 82(1) 72(1) -6(1) 10(1) 11(1)
C(20) 60(1) 71(1) 56(1) -7(1) 0(1) 3(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (À2x 103)
for 91.
x y z U(eq)
H(3A) 1382 9873 939 58
H(4A) 5113 10427 1483 58
H(7A) 7253 11790 42 69
H(8A) 7313 14449 135 76
H(9A) 5698 15565 743 74
H(10A) 4104 14003 1272 68
H(11A) 6648 7675 219 103
H(11B) 8470 8973 279 103
A-211
H(11C) 6569 9187 -69 103
H(12A) 802 8750 1627 70
H(13A) 2994 6663 1866 110
H(13B) 4420 8195 1842 110
H(13C) 4647 6928 1475 110
H(14A) -196 6262 1386 121
H(14B) 1219 6509 960 121
H(14C) -911 7533 1045 121
H(16A) 4385 11291 2181 79
H(17A) 2192 12558 2693 106
H(18A) -1140 13670 2493 103
H(19A) -2340 13487 1781 87
H(20A) -183 12245 1269 75




C( 1 )-N(2)-C(3)-C(4) -36.0(2)
N(2)-C(3)-C(4)-C(15) -179.24(13)
C( 12)-C(3)-C(4)-C( 15) -54.5(2)
N(2)-C(3)-C(4)-C(5) 53.09(18)
C(12)-C(3)-C(4)-C(5) 177.80(15)






C( 10)-C(5)-C(6)-C( 1 ) -177.41(17)
C(4)-C(5)-C(6)-C( 1) 5.8(2)
N(2)-C( 1 )-C(6)-C(5) 16.1(2)
C(11)-C(1)-C(6)-C(5) -165.34(16)










N(2)-C(3)-C( 12)-C( 14) -63.0(2)
C(4)-C(3)-C(12)-C(14) 170.55(15)
N(2)-C(3)-C( 12)-C( 13) 62.18(18)
C(4)-C(3)-C( 12)-C( 13) -64.2(2)
C(5)-C(4)-C( 15)-C( 16) -114.07(18)
C(3)-C(4)-C( 15)-C( 16) 121.07(16)
C(5)-C(4)-C( 15)-C(20) 64.8(2)
C(3)-C(4)-C(15)-C(20) -60.1(2)
C(20)-C( 15)-C( 16)-C( 17) -0.5(3)
C(4)-C( 15)-C(16)-C( 17) 178.39(18)
C( 15)-C( 16)-C( 17)-C( 18) 0.0(3)
C(16)-C(17)-C(18)-C(19) 0.6(4)
C( 17)-C( 18)-C( 19)-C(20) -0.7(3)
C( 18)-C( 19)-C(20)-C( 15) 0.2(3)
C( 16)-C( 15)-C(20)-C( 19) 0.4(3)
C(4)-C( 15)-C(20)-C( 19) -178.51(16)
Symmetry transformations used to generate equivalent atoms:
A. 1.2.2 X-Ray data for 93



















Completeness to theta = 23.28°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]








a = 9.4794(3) A a= 90°.
b = 10.2277(3) A (3= 90°.






.1 x .1 x .07 mm3
2.08 to 23.28°.
-10<=h<=10, -1 l<=k<=10, -19<=1<=21
8352




Full-matrix least-squares on F2
2729 / 0 / 227
0.957
R1 =0.0460, wR2 = 0.0776




Largest diff. peak and hole
1(5)
0.020(2)
0.170 and -0.165 e.À"3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (À2x 103)
for 93. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(1) 1854(2) 8531(2) 1848(1) 47(1)
N(2) 529(2) 8680(2) 1740(1) 52(1)
C(3) -381(2) 8940(2) 2333(1) 47(1)
C(4) 79(2) 8148(2) 2962(1) 46(1)
C(5) 1632(2) 8423(2) 3096(1) 48(1)
C(6) 2504(2) 8613(2) 2532(1) 48(1)
C(7) 3922(3) 8892(3) 2634(1) 64(1)
C(8) 4488(3) 8925(3) 3284(1) 74(1)
C(9) 3632(3) 8675(3) 3835(2) 73(1)
C(10) 2212(3) 8438(2) 3745(1) 59(1)
C(ll) 2744(2) 8260(2) 1230(1) 48(1)
C(12) 2447(3) 8878(2) 621(1) 57(1)
C(13) 3223(3) 8607(2) 38(1) 63(1)
C(14) 4295(3) 7700(3) 59(1) 64(1)
C(15) 4590(3) 7070(3) 658(1) 64(1)
C(16) 3825(3) 7349(2) 1246(1) 59(1)
C(17) -1919(2) 8732(2) 2124(1) 56(1)
C(18) -2224(3) 7330(3) 1924(1) 74(1)
C(19) -2343(3) 9654(3) 1550(1) 84(1)
C(20) -869(2) 8350(2) 3578(1) 49(1)
C(21) -981(3) 9558(3) 3889(1) 60(1)
C(22) -1847(3) 9740(3) 4451(1) 67(1)
C(23) -2640(3) 8720(3) 4690(1) 74(1)
C(24) -2554(3) 7526(3) 4389(1) 76(1)
C(25) -1660(3) 7334(3) 3831(1) 63(1)
A-215





































































Symmetry transformations used to generate equivalent atoms:
A-217
Table 4. Anisotropic displacement parameters (À2x IO3) for 93. The anisotropic
displacement factor exponent takes the form: -2ti2[ h2a*2U" + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
C(l) 45(1) 53(2) 43(1) -1(1) 3(1) -3(1)
N(2) 50(1) 64(1) 41(1) 3(1) 4(1) -1(1)
C(3) 48(2) 53(1) 41(1) -2(1) 3(1) 2(1)
C(4) 50(2) 47(1) 42(1) -1(1) 4(1) 0(1)
C(5) 49(1) 48(1) 45(2) -4(1) -2(1) 4(1)
C(6) 44(1) 57(2) 44(1) -4(1) -3(1) 1(1)
C(7) 54(2) 87(2) 50(2) -11(2) 4(1) -4(1)
C(8) 51(2) 110(2) 60(2) -18(2) -10(2) -6(2)
C(9) 66(2) 103(2) 51(2) -15(2) -12(2) 7(2)
C(10) 56(2) 80(2) 41(2) -2(1) 2(1) 3(1)
C(ll) 45(1) 60(2) 40(1) -4(1) 2(1) -4(1)
C(12) 54(2) 65(2) 51(2) -1(1) 5(1) 0(1)
C(13) 67(2) 79(2) 45(2) 3(2) 6(1) -1(2)
C(14) 55(2) 85(2) 52(2) -7(2) 13(1) -5(2)
C(15) 53(2) 81(2) 59(2) -9(2) 6(1) 10(1)
C(16) 57(2) 73(2) 46(2) -1(1) -2(1) 4(1)
C(17) 47(2) 70(2) 51(2) KD 2(1) 3(1)
C(18) 62(2) 86(2) 73(2) -2(2) -14(2) -11(2)
C(19) 68(2) 100(2) 84(2) 24(2) -13(2) 15(2)
C(20) 52(2) 54(2) 39(1) 0(1) 1(1) 3(1)
C(21) 61(2) 64(2) 54(2) -9(2) 8(1) -2(1)
C(22) 72(2) 74(2) 56(2) -13(2) 4(2) 8(2)
C(23) 78(2) 94(2) 49(2) 0(2) 18(2) 8(2)
C(24) 92(2) 81(2) 54(2) 6(2) 16(2) -7(2)
C(25) 84(2) 58(2) 47(2) 2(1) 12(2) -3(1)
A-218
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (À2x IO3)
for 93.
x y z U(eq)
H(3A) -273 9867 2448 57
H(4A) 7 7223 2836 56
H(7A) 4499 9059 2260 76
H(8A) 5438 9114 3348 89
H(9A) 4013 8665 4273 88
H(10A) 1640 8287 4123 71
H(12A) 1716 9483 601 68
H(13A) 3020 9040 -368 76
H(14A) 4815 7517 -332 77
H(15A) 5307 6451 673 77
H(16A) 4040 6922 1652 70
H(17A) -2508 8939 2521 67
H(18A) -3199 7249 1797 111
H(18B) -2028 6764 2303 111
H(18C) -1639 7089 1544 111
H(19A) -3311 9502 1430 126
H(19B) -1755 9500 1159 126
H(19C) -2232 10543 1699 126
H(21A) -467 10260 3718 72
H(22A) -1889 10551 4664 81
H(23A) -3239 8844 5061 89
H(24A) -3093 6835 4554 91
H(25A) -1599 6513 3629 75
A-219
Table 6. Torsion angles [°] for 93.
C(6)-C(l)-N(2)-C(3) -0.2(3)
C( 11 )-C( 1 )-N(2)-C(3) 179.7(2)
C( 1 )-N(2)-C(3)-C( 17) -165.48(19)











C( 10)-C(5)-C(6)-C( 1 ) 177.3(2)
C(4)-C(5)-C(6)-C( 1 ) -0.1(3)
N(2)-C(l)-C(6)-C(7) -157.6(2)
C(11)-C(1)-C(6)-C(7) 22.5(3)
N(2)-C( 1 )-C(6)-C(5) 21.2(3)
C(11)-C(1)-C(6)-C(5) -158.7(2)
C(5)-C(6)-C(7)-C(8) 2.9(4)



















N(2)-C(3)-C( 17)-C( 18) 63.7(2)
C(4)-C(3)-C( 17)-C( 18) -62.0(3)
N(2)-C(3)-C(17)-C(19) -60.6(3)













Symmetry transformations used to generate equivalent atoms:
A-221
A. 1.2.2 X-Ray data for 96



















Completeness to theta = 70.18°
Absorption correction
Max. and min. transmission
Refinement method









a = 8.9943(18) A a=90°.
b = 17.942(4) A (3= 90°.














Full-matrix least-squares on F2
5550/2/370
A-222
Goodness-of-fit on F2 0.992
Final R indices [I>2sigma(I)] R1 = 0.0649, wR2 = 0.1642
R indices (all data) R1 = 0.0858, wR2 = 0.1763
Absolute structure parameter -0.1 (2)
Extinction coefficient 0.0041(6)
Largest diff. peak and hole 0.208 and -0.168 e.A-3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (À2x 103)
for 96. U(eq) is defined as one third of the trace of the orthogonalized U'l tensor.
X y z U(eq)
F(l) 6781(2) 3451(1) 8497(1) 65(1)
C(l) 7084(3) 3395(2) 7784(1) 50(1)
C(2) 6568(3) 4138(2) 7469(1) 51(1)
N(3) 7547(3) 4736(1) 7693(1) 51(1)
C(4) 8311(3) 5163(2) 7255(1) 53(1)
0(4) 8277(3) 5082(2) 6627(1) 73(1)
C(5) 9256(5) 5753(2) 7580(2) 81(1)
C(6) 4967(4) 4317(2) 7641(2) 72(1)
C(7) 6226(3) 2727(2) 7512(2) 51(1)
C(8) 5927(6) 2643(3) 6826(2) 99(2)
C(9) 5229(7) 2013(3) 6572(2) 107(2)
C(10) 4803(4) 1464(2) 7002(2) 76(1)
0(11) 5066(5) 1536(2) 7680(2) 87(1)
0(12) 5755(4) 2166(2) 7943(2) 71(1)
0(13) 8717(4) 3246(2) 7712(2) 64(1)
0(14) 9451(5) 3370(3) 7103(3) 106(2)
0(15) 10929(8) 3185(4) 7039(5) 159(3)
0(16) 11707(6) 2874(4) 7557(7) 181(5)
0(17) 11011(7) 2755(4) 8167(6) 161(4)
0(18) 9499(5) 2931(3) 8261(3) 105(2)
F(21) 10299(2) 4844(1) 11053(1) 73(1)
0(21) 10544(3) 4808(2) 10329(1) 60(1)
C(22) 9118(3) 4466(2) 10036(2) 60(1)
N(23) 7835(3) 4924(2) 10198(1) 58(1)
C(24) 6964(4) 5243(2) 9726(1) 56(1)
0(24) 7225(3) 5213(2) 9106(1) 78(1)
0(25) 5642(5) 5640(2) 9991(2) 77(1)
C(26) 8857(4) 3668(2) 10290(2) 81(1)
A-223
C(27) 11908(3) 4334(2) 10213(2) 63(1)
C(28) 12229(4) 4055(3) 9567(2) 103(2)
C(29) 13494(5) 3635(3) 9450(2) 106(2)
C(30) 14497(5) 3489(3) 9969(3) 98(1)
C(31) 14200(5) 3788(3) 10610(3) 97(1)
C(32) 12909(4) 4203(2) 10731(2) 76(1)
C(33) 10830(4) 5603(2) 10095(2) 69(1)
C(34) 10740(9) 5809(4) 9432(2) 162(4)
C(35) 11066(10) 6513(4) 9208(3) 173(4)
C(36) 11520(8) 7033(3) 9652(3) 125(2)
C(37) 11741(12) 6839(3) 10309(3) 157(3)
C(38) 11379(8) 6120(3) 10538(2) 123(2)







































































































Symmetry transformations used to generate equivalent atoms:
A-226
Table 4. Anisotropic displacement parameters (À2x IO3) for 96. The anisotropic
displacement factor exponent takes the form: -2n2[ h2 a*2Un + ... + 2 h k a* b* U12 ]
U" U22 U33 U23 U13 U12
F( 1) 94(1) 61(1) 41(1) -3(1) 4(1) 3(1)
C(l) 60(2) 52(2) 39(1) -4(1) 5(1) -9(1)
C(2) 61(2) 50(2) 42(1) -2(1) -3(1) -5(1)
N(3) 70(1) 47(2) 36(1) -5(1) 0(1) -8(1)
C(4) 63(2) 57(2) 38(1) 4(1) -4(1) -5(1)
0(4) 91(2) 91(2) 37(1) 9(1) -5(1) -25(1)
0(5) 105(3) 77(3) 61(2) 4(2) -8(2) -38(2)
0(6) 70(2) 59(2) 87(2) 0(2) -2(2) -1(2)
0(7) 52(1) 48(2) 53(2) -4(1) 7(1) -2(1)
0(8) 165(4) 81(3) 50(2) -8(2) 13(2) -60(3)
0(9) 175(5) 85(3) 59(2) -15(2) 11(3) -61(3)
C(10) 81(2) 62(2) 86(2) -6(2) -3(2) -20(2)
0(11) 103(3) 63(3) 95(3) 19(2) -6(2) -27(2)
0(12) 96(2) 61(2) 57(2) 13(2) -12(2) -16(2)
0(13) 60(2) 49(2) 82(2) -18(2) 3(2) -4(1)
0(14) 82(3) 95(4) 142(4) -4(3) 40(3) 8(2)
0(15) 107(5) 100(5) 271(10) -13(5) 107(6) 8(4)
0(16) 51(3) 76(4) 416(15) -64(6) 37(6) -12(3)
0(17) 63(3) 113(5) 308(11) -40(6) -61(5) 15(3)
0(18) 74(2) 102(4) 137(4) -16(3) -39(3) 7(2)
F(21) 77(1) 106(2) 37(1) 7(1) 2(1) -10(1)
0(21) 63(2) 86(2) 32(1) 7(1) 2(1) -8(2)
C(22) 57(2) 77(2) 44(1) 6(1) 2(1) -3(2)
N(23) 57(1) 82(2) 35(1) 6(1) 2(1) KD
0(24) 71(2) 59(2) 37(1) 5(1) -3(1) -8(2)
0(24) 104(2) 93(2) 36(1) 0(1) -6(1) 8(2)
0(25) 97(3) 74(3) 61(2) 4(2) -3(2) 18(2)
C(26) 66(2) 78(3) 99(3) 14(2) -4(2) -5(2)
C(27) 54(2) 81(2) 53(2) 5(2) -1(1) -10(2)
C(28) 61(2) 181(5) 65(2) -12(3) -1(2) 10(3)
C(29) 63(2) 163(5) 94(3) -25(3) 14(2) 0(3)
C(30) 61(2) 107(4) 128(4) -7(3) -4(2) -5(2)
0(31) 82(3) 93(3) 115(4) 8(3) -35(3) 3(2)
C(32) 78(2) 84(3) 65(2) 5(2) -16(2) -1(2)
C(33) 69(2) 90(3) 48(2) 6(2) 4(1) -6(2)
A-227
C(34) 252(8) 168(6) 66(3) 52(3) -53(4) -148(6)
C(35) 263(9) 170(6) 85(3) 58(4) -60(4) -140(7)
C(36) 180(6) 96(4) 99(4) 26(3) 23(4) -15(4)
C(37) 303(11) 77(4) 90(3) -17(3) -2(5) -7(5)
C(38) 226(7) 76(4) 67(2) -8(2) -19(3) -2(4)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for 96.
X y z U(eq)
H(2A) 6650 4097 6966 61
H(3N) 7500(40) 4870(20) 8183(5) 77(10)
H(5A) 9759 6030 7226 121
H(5B) 9975 5525 7879 121
H(5C) 8638 6084 7844 121
H(6A) 4696 4782 7431 108
H(6B) 4854 4354 8132 108
H(6C) 4334 3929 7468 108
H(8A) 6199 3019 6521 118
H(9A) 5053 1969 6101 128
H(10A) 4333 1041 6831 91
H(11A) 4780 1157 7979 105
H(12A) 5900 2210 8416 86
H(14A) 8949 3581 6731 128
H(15A) 11407 3277 6622 191
H(16A) 12700 2745 7498 217
H(17A) 11545 2551 8533 194
H(18A) 9030 2839 8680 125
H(22A) 9217 4449 9532 71
H(23N) 7560(40) 4950(20) 10686(5) 75(10)
H(25A) 5093 5845 9611 116
H(25B) 5951 6034 10293 116
H(25C) 5023 5297 10240 116
H(26A) 7959 3476 10090 121
H(26B) 8770 3667 10784 121
H(26C) 9681 3360 10156 121
H(28A) 11583 4151 9203 123
A-228
H(29A) 13671 3447 9011 128
H(30A) 15340 3201 9891 118
H(31A) 14871 3713 10969 116
H(32A) 12729 4393 11170 91
H(34A) 10441 5456 9109 195
H(35A) 10971 6630 8742 207
H(36A) 11680 7520 9507 150
H(37A) 12137 7183 10618 188
H(38A) 11518 5996 11000 148
Table 6. Torsion angles [°] for 96.
F(l)-C(l)-C(2)-N(3) 69.5(3)
C( 13)-C( 1)-C(2)-N(3) -47.9(3)
C(7)-C( 1 )-C(2)-N(3) -173.5(2)
F(l)-C(l)-C(2)-C(6) -54.4(3)
C( 13)-C( 1 )-C(2)-C(6) -171.8(3)





F( 1 )-C( 1 )-C(7)-C(8) 160.6(4)














C(7)-C( 1 )-C( 13)-C( 14) 83.3(4)
C(2)-C(l)-C(13)-C(14) -44.5(4)
A-229
F( 1 )-C( 1 )-C( 13)-C( 18) 22.9(4)
C(7)-C( 1 )-C( 13)-C( 18) -92.8(4)
C(2)-C( 1 )-C( 13)-C( 18) 139.4(3)
C(18)-C(13)-C(14)-C(15) 0.2(7)
C( 1)-C( 13)-C( 14)-C( 15) -175.9(5)
C(13)-C(14)-C(15)-C(16) 0.4(10)
C( 14)-C( 15)-C( 16)-C( 17) -1.2(11)
C(15)-C(16)-C(17)-C(18) 1.5(10)
C( 14)-C( 13)-C( 18)-C( 17) 0.1(7)
























C(21 )-C(27)-C(32)-C(31 ) -177.4(4)
C(30)-C(31 )-C(32)-C(27) -0.9(7)














Symmetry transformations used to generate equivalent atoms:
Table 7. Hydrogen bonds for 96 [À and °],
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
N(3)-H(3N)...0(24) 0.9798(11) 1.906(6) 2.882(3) 173(3)
N(23)-H(23N)...0(4)#1 0.9799(11) 1.971(7) 2.943(3) 171(3)







X-Ray data for chapter 4
X-ray data for 199b



















Completeness to theta = 23.43°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
199b.
mndhl3






a = 13.519(8) A















Full-matrix least-squares on F2





Goodness-of-fit on F2 0.890
Final R indices [I>2sigma(I)] R1 = 0.1009, wR2 = 0.2209
R indices (all data) R1 = 0.2271, wR2 = 0.2727
Absolute structure parameter -9(4)
Extinction coefficient 0.056(5)
Largest diff. peak and hole 0.393 and -0.364 e.À 3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (À2x 103)
for 199b. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
x y z U(eq)
C(l) -5996(4) 9575(12) 2061(4) 46(2)
C(2) -6958(4) 8298(12) 1623(3) 32(2)
F(2) -6925(2) 5655(7) 1853(2) 45(1)
0(3) -7779(3) 9285(8) 2772(2) 40(1)
C(3) -7883(4) 9469(12) 1836(3) 30(2)
F(4) -8962(3) 7855(8) 463(2) 57(1)
C(4) -8900(4) 8112(13) 1408(3) 43(2)
C(5) -9862(4) 9400(12) 1461(3) 29(2)
C(6) -10857(4) 7975(13) 957(4) 40(2)
C(7) -11845(4) 9331(12) 1021(3) 37(2)
C(8) -12780(4) 8034(13) 428(3) 42(2)
C(9) -13768(4) 9355(14) 440(4) 59(2)
C(ll) -5953(4) 14437(12) 5169(3) 44(2)
F(12) -6889(3) 18354(7) 4789(2) 50(1)
C(12) -6985(4) 15714(12) 5055(3) 38(2)
0(13) -7635(3) 14223(8) 3510(2) 36(1)
C(13) -7893(4) 14481(12) 4352(3) 29(2)
F(14) -9028(2) 16138(7) 5068(2) 47(1)
C(14) -8873(4) 15905(13) 4209(3) 32(2)
C(15) -9816(4) 14452(12) 3621(3) 28(2)
C(16) -10785(4) 15891(13) 3572(3) 38(2)
0(17) -11766(4) 14400(12) 2993(3) 34(2)
0(18) -12747(4) 15607(14) 3063(4) 42(2)
0(19) -13697(4) 14101(13) 2539(3) 53(2)
A-234

















































Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (À2x IO3) for 199b. The anisotropic
displacement factor exponent takes the form: -27t2[ h2 a*2Uu + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
C(l) 33(3) 46(4) 58(4) 1(4) 13(3) -5(3)
C(2) 41(3) 30(4) 22(3) 8(3) 4(2) -4(3)
F(2) 76(2) 31(2) 30(2) -8(2) 16(1) 4(2)
0(3) 65(2) 32(3) 25(2) 5(2) 16(2) 4(2)
C(3) 47(3) 29(4) 16(2) 15(3) 12(2) 6(3)
F(4) 80(2) 68(3) 30(2) -7(2) 31(2) -2(2)
C(4) 76(4) 41(4) 23(3) -4(3) 30(3) -4(4)
C(5) 52(3) 24(3) 11(2) 5(3) 9(2) 16(3)
C(6) 45(4) 41(4) 26(3) 1(3) -1(3) -6(3)
C(7) 58(4) 26(4) 19(3) 7(3) 0(3) -12(4)
C(8) 60(4) 38(4) 26(3) 9(3) 11(3) 14(4)
C(9) 51(4) 82(6) 42(3) -15(4) 10(3) 11(4)
C(ll) 65(4) 28(4) 34(3) -3(3) 7(3) 15(4)
F(12) 76(2) 41(2) 17(2) -3(2) -11(2) -5(2)
C(12) 74(4) 19(3) 12(3) 4(3) -3(3) -11(4)
0(13) 61(2) 39(3) 9(2) -7(2) 11(2) -11(2)
C(13) 46(3) 25(3) 14(2) -1(3) 6(2) 6(3)
F(14) 69(2) 66(3) 5(1) -11(2) 8(1) 8(2)
C(14) 42(3) 39(4) 18(3) -3(3) 12(2) 3(3)
C(15) 43(3) 23(3) 19(2) 2(3) 9(2) -9(3)
C(16) 63(4) 32(4) 16(3) 8(3) 7(3) -26(3)
A-236
C(17) 43(3) 31(4) 22(3) 8(3) 3(2) 6(3)
C(18) 52(4) 36(4) 27(3) -2(4) -8(3) -11(4)
C(19) 57(4) 63(5) 24(3) 14(4) -14(3) -2(4)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for 199b.
x y z U(eq)
H(1 A) -5434 8716 1884 68
H(1B) -5867 9448 2712 68
H(1C) -6032 11429 1885 68
H(2A) -7067 8422 961 38
H(30) -7723 11053 3030 48
H(3A) -7941 11362 1656 36
H(4A) -8874 6310 1670 52
H(5A) -9880 11203 1218 35
H(5B) -9846 9552 2099 35
H(6A) -10876 7830 318 48
H(6B) -10840 6171 1199 48
H(7A) -11878 9273 1649 44
H(7B) -11832 11198 846 44
H(8A) -12725 8025 -193 50
H(8B) -12799 6184 620 50
H(9A) -14350 8413 41 88
H(9B) -13763 11175 235 88
H(9C) -13835 9340 1051 88
H(11A) -5430 15364 5635 66
H(11B) -5771 14519 4603 66
H(11C) -5986 12597 5345 66
H(12A) -7143 15724 5645 46
H(130) -7428 15938 3332 43
H(13A) -7996 12671 4562 35
H(14A) -8817 17687 3956 39
H(15A) -9740 14244 3010 34
H(15B) -9853 12676 3870 34
H(16A) -10753 17650 3309 45
H(16B) -10849 16143 4185 45
A-237
H(17A) -11760 14410 2358 40
H(17B) -11737 12547 3192 40
H(18A) -12790 17435 2838 51
H(18B) -12738 15674 3702 51
H(19A) -14317 14961 2613 79
H(19B) -13663 12295 2764 79
H(19C) -13723 14079 1903 79
















F( 12)-C( 12)-C( 13)-0( 13) 67.7(6)
C(ll)-C(12)-C(13)-0(13) -51.4(6)
0(13)-C(13)-C(14)-F(14) -177.7(4)
C( 12)-C( 13)-C( 14)-F( 14) -54.0(6)
0(13)-C(13)-C(14)-C(15) 65.6(6)
C(12)-C(13)-C(14)-C(15) -170.7(5)
F( 14)-C( 14)-C( 15)-C( 16) 59.0(6)




Symmetry transformations used to generate equivalent atoms:
A-238
Table 7. Hydrogen bonds for 199b [A and °].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
0(3)-H(30)...0(13) 0.98 1.77 2.747(6) 179.0
0( 13)-H( 130)...F(2)#1 0.98 2.58 3.079(5) 111.5




A.1.4 X-Ray data for chapter 5
A. 1.4.1 X-Ray data for 228




















Completeness to theta = 23.26°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Extinction coefficient




a = 14.2132(6) À cx= 90°.
b = 5.0864(3) À (3= 103.738(2)°














Full-matrix least-squares on F2
2309 / 0 / 272
0.933
R1 =0.0567, wR2 = 0.1333
R1 =0.1195, wR2 = 0.1609
0.0017(8)
0.554 and -0.226 e.A"3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (À2x 103)
for 228. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
F(l) -2314(3) 8366(8) 542(2) 95(1)
F(2) -2596(2) 4339(8) 713(2) 89(1)
F(3) -2536(3) 5553(9) -146(2) 100(1)
C(l) -2150(4) 5859(15) 407(3) 64(2)
C(2) -1060(4) 5373(12) 555(3) 54(2)
F(4) -673(2) 6992(7) 232(1) 66(1)
F(5) -971(2) 2860(7) 365(2) 80(1)
C(3) -511(3) 5575(12) 1198(2) 48(1)
A-241
F(6) -862(2) 3859(7) 1527(1) 70(1)
F(7) -675(2) 8030(7) 1383(2) 82(1)
C(4) 593(4) 5253(11) 1326(2) 46(1)
F(8) 775(2) 2999(7) 1051(2) 74(1)
F(9) 983(2) 7159(7) 1068(1) 75(1)
C(5) 1140(4) 5019(11) 1978(2) 40(1)
F(10) 820(2) 6923(7) 2279(1) 75(1)
F( 11) 917(2) 2724(7) 2182(2) 76(1)
C(6) 2253(3) 5260(10) 2102(2) 36(1)
F(12) 2574(2) 3712(6) 1716(1) 53(1)
F(13) 2477(2) 7753(5) 1994(1) 52(1)
C(7) 2840(4) 4507(10) 2728(2) 41(1)
F(14) 2411(2) 5778(6) 3117(1) 56(1)
F(15) 2711(2) 1932(6) 2805(1) 56(1)
C(8) 3895(3) 5324(9) 2833(2) 36(1)
N(9) 4572(3) 3864(7) 3316(2) 33(1)
0(9) 4708(2) 1292(6) 3151(1) 41(1)
C(10) 4244(4) 3885(10) 3888(2) 43(1)
C(ll) 5006(4) 2757(11) 4382(2) 52(2)
0(12) 5881(3) 4246(7) 4472(2) 58(1)
0(13) 6237(4) 4139(11) 3954(2) 49(2)
0(14) 5533(3) 5309(10) 3435(2) 40(1)










































































































































N(9)-C( 10)-H( 1 OA) 109.4
C(11)-C(10)-H(10B) 109.4
N(9)-C(10)-H(10B) 109.4










C( 14)-C( 13)-H( 13A) 109.3
0(12)-C(13)-H(13B) 109.3
C(14)-C(13)-H(13B) 109.3







Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (À2x IO3) for 228. The anisotropic
displacement factor exponent takes the form: -27t2[ h2 a*2Uu + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
F(l) 66(2) 86(3) 129(4) -4(3) 15(2) 24(2)
F(2) 50(2) 112(3) 109(3) 21(3) 24(2) -10(2)
F(3) 69(2) 148(4) 67(3) -5(3) -15(2) -2(3)
C(l) 49(4) 84(5) 55(4) 0(4) 4(3) -1(4)
C(2) 50(4) 54(4) 55(4) -1(3) 8(3) -2(3)
F(4) 61(2) 85(3) 52(2) 15(2) 15(2) -7(2)
F(5) 78(2) 71(3) 87(3) -23(2) 12(2) 3(2)
A-245
C(3) 38(3) 63(4) 43(3) -1(3) 8(3) 4(3)
F(6) 55(2) 97(3) 60(2) 27(2) 20(2) -9(2)
F(7) 81(2) 82(3) 76(3) -25(2) 8(2) 31(2)
C(4) 52(3) 44(3) 43(3) 2(3) 14(3) -8(3)
F(8) 60(2) 85(3) 70(2) -31(2) 1(2) 19(2)
F(9) 52(2) 106(3) 63(2) 34(2) 8(2) -15(2)
C(5) 43(3) 39(3) 40(3) 1(3) 14(3) -1(3)
F(10) 54(2) 114(3) 55(2) -35(2) 9(2) 22(2)
F(11) 52(2) 85(3) 82(2) 40(2) 1(2) -19(2)
C(6) 41(3) 33(3) 39(3) -4(2) 16(3) -4(2)
F( 12) 47(2) 63(2) 51(2) -21(2) 15(2) 8(2)
F( 13) 57(2) 36(2) 62(2) 10(2) 10(2) -7(2)
C(7) 50(3) 32(3) 42(3) -5(3) 15(3) -4(2)
F(14) 45(2) 84(2) 41(2) -9(2) 17(2) 6(2)
F(15) 52(2) 39(2) 70(2) 10(2) 3(2) -11(1)
C(8) 37(3) 29(3) 43(3) -1(2) 12(2) 1(2)
N(9) 36(2) 29(2) 36(2) 1(2) 11(2) 1(2)
0(9) 53(2) 23(2) 46(2) -5(2) 10(2) 4(2)
C(10) 48(3) 47(3) 37(3) 0(3) 17(3) 2(3)
C(ll) 64(4) 54(4) 41(3) 1(3) 16(3) -5(3)
0(12) 62(3) 68(3) 43(2) -1(2) 10(2) -2(2)
C( 13) 48(3) 56(4) 44(3) -2(3) 10(3) -3(3)
C(14) 38(3) 42(3) 42(3) -3(3) 10(2) -4(3)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for 228.
X y z U(eq)
H(8A) 4104 5078 2469 43
H(8B) 3944 7185 2926 43
H(10A) 4104 5676 3984 51
H(10B) 3653 2866 3840 51
H(11A) 4776 2762 4742 63
H(11B) 5133 949 4291 63
H(13A) 6360 2323 3868 59
H(13B) 6846 5087 4020 59
H(14A) 5798 5210 3089 48
H(14B) 5431 7148 3513 48
A-246
Table 6. Torsion angles [°] for 228.
F(3)-C( 1 )-C(2)-F(4) 57.3(7)
F(2)-C( 1 )-C(2)-F(4) -179.5(5)
F(l)-C(l)-C(2)-F(4) -60.7(7)
F(3)-C( 1 )-C(2)-F(5) -57.9(7)
F(2)-C( 1 )-C(2)-F(5) 65.3(7)
F( 1 )-C( 1 )-C(2)-F(5) -175.9(5)
F(3)-C( 1 )-C(2)-C(3) -178.0(6)
F(2)-C( 1 )-C(2)-C(3) -54.9(8)
F( 1 )-C( 1)-C(2)-C(3) 63.9(7)
F(4)-C(2)-C(3)-F(6) -177.0(4)
F(5)-C(2)-C(3)-F(6) -58.8(6)
C( 1 )-C(2)-C(3)-F(6) 59.1(7)
F(4)-C(2)-C(3)-F(7) 66.3(5)
F(5)-C(2)-C(3)-F(7) -175.5(4)
C( 1 )-C(2)-C(3)-F(7) -57.6(7)
F(4)-C(2)-C(3)-C(4) -52.2(7)
F(5)-C(2)-C(3)-C(4) 65.9(6)





























F( 13)-C(6)-C(7)-F( 15) -172.3(3)
F( 12)-C(6)-C(7)-F( 15) -57.4(5)
C(5)-C(6)-C(7)-F( 15) 64.8(5)


















0( 12)-C( 13)-C( 14)-N(9) -59.3(5)
0(9)-N(9)-C( 14)-C( 13) -64.6(5)
C(8)-N(9)-C( 14)-C( 13) 174.6(4)
C( 10)-N(9)-C( 14)-C( 13) 54.2(5)
Symmetry transformations used to generate equivalent atoms:
A-248
A-249
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